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Abstract
Introduction: Community mortality for ruptured abdominal aortic aneurysm (AAA)
exceeds 80% and the operative mortality is 30-70%. Elective repair of AAA virtually
eliminates the risk of rupture and is associated with an operative mortality of 5-10%.
The decision to operate on an asymptomatic AAA, therefore, involves weighing the
risk of rupture against that of surgical intervention. Rupture is related to maximum
diameter, growth rate and possibly blood pressure, but no size ofAAA is entirely free
of rupture risk. A variable that provides a more precise quantification of rupture risk on
an individual patient basis is required to improve the clinical and cost-effectiveness of
surgery. AAA wall distensibility, which is measurable non-invasively, may be related
to aortic wall structure and thus aneurysm growth and rupture.
Aims: The primary aim was to determine the relationships between AAA wall
distensibility, diameter, expansion and risk of rupture. Secondary aims were to
evaluate the variability of the technique and to assess the error caused by use of
brachial, as opposed to central, blood pressure.
Methods: Distensibility [pressure-strain elastic modulus (Ep) and stiffness (P)] was
measured using a real time B-mode ultrasound scanner with echo-tracking software
(Diamove). Brachial pressure was measured using automated sphygmomanometry
(Omron, Japan). Central aortic pressure was derived using pulse wave analysis
(Sphygmocor). Follow-up was 6-monthly for a median (IQR) period of 19.7 (9.2-
29.9) months. Outcome measures included ruptured AAA and surgical repair of intact
AAA. Death certificate information was collected on those who died before the end of
the study.
Results: 210 patients (163 males and 47 females) were recruited. Median (IQR) age
was 72 (68-77) years, AAA diameter 48 (41-54) mm, BP 140/80 (128-160/ 72-90)
mmHg, Ep 2.91 (1.99-4.37) 105Nm"2, and p 19.4 (14.4-29.4). Intra- and inter-observer
CVme for directly measured variables were low (<10%) while CVME for the derived
variables were higher (<35%). The CVME is a parametric test; however, when these
skewed data were logged to normality intra-observer CVMe for p was <10%. Bland-
Altman plots showed that Ep and p calculated using brachial, as opposed to derived
central pressure, were systematically over-estimated by 11% (p=0.001) and 5%.
(p=0.040) respectively. At baseline, AAA in the rupture group tended towards being
more distensible than the intact AAA but this did not attain statistical significance. At
last follow-up, the rate and direction of change in distensibility were not related to
diameter or expansion. Cox proportional hazard model showed that, after adjusting
for age and sex, female gender, larger AAA diameter, higher diastolic pressure and a
larger proportional increase in distensibility were related to a shorter time to rupture
(all p<0.01).
Conclusions: The relationships between AAA distensibility and rupture are complex
and depend upon AAA diameter, gender and/or outcome group. Change in
distensibility over time appears to be related to rupture risk. An increase in




105Nm"2 - 105 Newtons per metre2
a.u. - Arbitrary units
AAA - Abdominal aortic aneurysm
ACE inhibitor Angiotensin converting enzyme inhibitor
C - Compliance
Ca channel blocker - Calcium channel blocker
CABG - Coronary artery bypass graft
CI - Confidence interval




DBP - Diastolic blood pressure
Dch - Diameter change
Dmax - Maximum diameter
Ep - Pressure-strain elastic modulus
GTF - Generalised transfer function
HT - Hypertension
IQR - Interquartile range
MAP - Mean arterial pressure
mm - Millimetres
mrnllg - Millimetres ofmercury
MMP - Matrix metalloproteinases
N - Number analysed
P - Significance level
PP - Pulse pressure
PWV - Pulse wave velocity
RR - Relative risk
SBP - Systolic blood pressure
SD - Standard deviation
SE - Standard error
SMC - Smooth muscle cell
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Chapter 1. Epidemiological Review
1.1 AAA
1.1.1 Definitions
An abdominal aortic aneurysm (AAA) may be defined as a localised dilatation of the
abdominal aorta. AAA usually arise below the renal arteries (Figure 1.1), but around
20% also involve the suprarenal aorta. In men aged 65-75 years, the normal inffarenal
aortic diameter is approximately 2cm (Hollier and Wisselink, 1996). The human aorta
undergoes expansion throughout life, with a more rapid rate of expansion occurring
over the age of 60 years (Lanne et al, 1994, Grimshaw et al, 1995). Sonesson et al
(1993) found that the healthy male aorta expands by 30% between the ages of 25-70
years. Grimshaw et al (1995) observed that non-aneurysmal aortic dilatation occurs in
12.5%-25% of the population with increasing age. These observations imply that the
threshold for distinguishing between normal and abnormal aortic diameter is age-
dependent.
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Figure 1.1. Percutaneous transluminal angiogram of an infirarenal AAA, showing the
kidneys (A) and the renal arteries (B) above the AAA (C).
Courtesy ofDr P Allan, Department ofRadiology, Royal Infirmary of Edinburgh.
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Several definitions ofAAA have been proposed:
(1) Grimshaw et al (1995) suggested that in males at any age, the upper limit for
'normal' aortic diameter should result in 6% of the population having an
'aneurysm'. By this definition in males, the upper limit of normality in abdominal
aortic diameter in 60 year olds should therefore be 24mm; in 70 year olds, 32mm;
and in 75 year olds, 37mm.
(2) The Society for Vascular Surgery and the International Society ofCardiovascular
Surgery (SVS/ISCVS) defines an aneurysm as a 50% increase in the normal aortic
diameter, adjusted for gender and radiological modality (Johnston et al, 1991) but
not age. Moher et al (1992) calculated mean aortic diameter in unaffected males to
be 2.0cm. An AAA could therefore be said to be present when the maximum
intfarenal diameter reaches 3.0cm. This definition, however, results in a higher
prevalence ofAAA because it will include age-related, non-aneurysmal dilataion.
(3) Sterpetti et al (1987) suggested that an infrarenal AAA should be defined by the
presence of an infra- to suprarenal diameter ratio of >1.5. However B-mode
ultrasonography cannot reliably image the suprarenal aorta making calculation of
this ratio difficult for screening purposes.
(4) Collin (1990) deemed an infrarenal AAA to be present when the maximal diameter
was > 4.0cm, or when it exceeded the maximum diameter of the aorta between the
origin of the superior mesenteric and left renal arteries by 0.5cm. This definition
has the advantage ofpreventing unnecessary follow-up of age-related dilatation,
although fast growing AAA may be missed if follow-up is deemed unnecessary in
small AAA. The use of a larger diameter in this definition produced the lowest
frequency and prevalence rates in Moher et a/'s (1992) study.
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None of these definitions is perfect. For the purposes of this thesis, therefore, an AAA
has been defined as a maximal infrarenal antero-posterior diameter of > 3.0cm (Moher
et al 1992, Bengtsson et al 1996).
1.1.2 Classification
Aneurysms are usually classified according to their pathology, shape, site and
aetiology:
True aneurysm: - The aneurysm wall comprises all three layers of the normal arterial
wall. The vast majority ofAAA are of this type (Figure 1.2).
False aneurysm: - The aneurysm wall comprises only compressed peri-adventitial
tissue. It usually occurs following trauma or at the site ofgraft-arterial anastomoses.
4
Figure 1.2. A true AAA involving the full thickness of the wall
Courtesy ofDr K McLaren, Department ofPathology, University ofEdinburgh.
Fusiform aneurysm: - The aneurysm is spindle shaped and most AAA are of this type
(Figure 1.3).
Saccular aneurysm: - The aneurysm is an out-pouching of the arterial wall localised
to one side of the artery (Figure 1.4).
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Atherosclerotic aneurysm: - Historically those AAA thought not to be due to a
specific and recognised cause such as connective tissue disorder, trauma or infection
have been termed atherosclerotic. However, it has become increasingly apparent that
the majority ofAAA are not due to atherosclerosis but to a distinct disease process. For
example, in AAA formation most of the pathological changes occur in the media
whereas in athersclerosis the pathological damage is predominantly subintimal (Hollier
and Wisselink, 1996, Stonebridge and Ruckley, 1996). The SVS/ISCVS have therefore
recommended the term 'non-specific', rather than 'atherosclerotic', be used (Johnston
et al 1991).
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Inflammatory aneurysm: - Inflammatory AAA account for around 5-10% ofall AAA
and are characterised by marked retroperitoneal fibrosis, lymphocytic and plasma cell
infiltration. It is said that these AAA are less prone to rupture but there is no
convincing evidence for this. However, surgical repair is undoubtedly made more
hazardous because of the dense fibrosis between the AAA wall and adjacent structures
(Stonebridge and Ruckley, 1996).
1.1.3 Site of aneurysmal development
Aortic aneurysms most commonly affect the infrarenal aorta but can also affect the
suprarenal and thoracic segments. The distal aorta appears to be at particular risk,
possibly because of its reduced number of elastic lamellae (when compared with the
thoracic aorta) and the lack of vasa vasora. Reflected waves from the aortic bifurcation
may also present a hazard by increasing systolic and pulse pressure. However many
patients with AAA also have peripheral aneurysms suggesting that it may be a systemic
disease (Hollier and Wisselink 1996).
1.1.4 Clinical presentation
Most patients (75%) with AAA are asymptomatic and their aneurysms tend to be
diagnosed incidentally during radiological or physical examination carried out for
another reason (Hollier and Wisselink 1996) (Figure 1.5). The majority probably die
with an intact AAA rather than of a ruptured AAA.
Symptoms are caused by pressure on adjacent structures, embolisation, dissection,
thrombosis or rupture and include:
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(1) Pain - This may be due to pressure on adjacent structures or nerves and typically
radiates to the back or loins;
(2) Embolisation - This may lead to 'blue toe' syndrome if emboli are small, or acute
lower limb ischaemia if large;
(3) Rupture - Sudden onset ofmid-abdominal and/or flank pain with shock and a
pulsatile abdominal mass typically suggests AAA rupture. The pain can be severe,
constant and unaffected by position or it can be more subtle, lasting for several
hours or days. The latter type ofpain may be from small tears in the AAA wall that
are temporarily sealed by thrombus but this will eventually lead to rupture (Hollier
and Wisselink 1996).
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Figure 1.5. Ultrasound of longitudinal view of anteroposterior section ofAAA.
Courtesy ofDr P Allan, Department ofRadiology, Royal Infirmary ofEdinburgh.
1.2 Aetiology ofAAA
1.2.1 Epidemiological difficulties
Epidemiological data on AAA are difficult to gather because;
a) The disease is mostly asymptomatic.
b) Many patients present for the first time with rupture.
c) Many AAA-related deaths are probably misdiagnosed, for example as sudden
cardiac death, because a post mortem is not performed.
d) The lack of a universally accepted definition ofAAA causes difficulty in
determining the prevalence of the disease (section 1.1.1).
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1.2.2 Trends in AAA
The prevalence ofAAA varies enormously depending on the definition used and the
methodology employed (Moher et al 1992) (Table 1.1). Post mortem studies provide
frequency rates but unless necropsy rates are 100% they cannot estimate prevalence in
the population. Post mortem studies are usually retrospective and the diagnostic criteria
are rarely clarified prior to diagnosis, making comparison with other studies difficult
(Bengtsson et al 1996).
There is evidence of a recent rise in the prevalence ofAAA in Western countries. For
example, in Sweden, Bengtsson et al (1996) found that age-standardised AAA
frequency from 1958 to 1986 had increased annually at a rate of4.7% in men and 3.0%
in women. In the Netherlands, Reitsma et al (1996) found that between 1972 and 1992
AAA-related mortality in males increased from 3.1 to 8.1 per 100,000, and in females
from 1.4 to 2.2 per 100,000. In the same study, total hospital admissions for non-
ruptured AAA increased 13-fold in males and 6-fold in females. In the UK, AAA
prevalence is estimated to range from 1.3 to 8.4 % (Lucarroti et al 1993, Scott et al
1995, Smith et al 1993) (Table 1.1).
The reported incidence rate ofAAA rupture ranges from 2.9 (Armour 1977) to 14.1
(Thomas and Stewart 1988) per 100,000 per year. Surgical workload has undoubtedly
increased in the last two decades (Crawford 1990, Castleden and Mercer 1980, Melton
et al 1984). In the Edinburgh Regional Vascular Unit, 85.4 % ofpatients presenting
with rupture were operated between 1989 and 1994 compared with 77% presenting
bwteen 1983 and 1988 (Bradbury et al 1997) (Figure 1.6).
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Table 1.1. Prevalence and frequency ofAAA from a selection of studies.
Prevalence (%) Definition and inclusion criteria









>1.5 x infrarenal aortic diameter*
>1.5 x suprarenal aortic diameter**







age 65-79 yrs } all >2.9cm
age >80 yrs
Scott et al 1995 3.0
1.3
males, 65-80 yrs, >2.9cm





males, 65-75 yrs, >2.9cm





males, 65 yrs, >2.5cm








males, 75-79 yrs, >3cm
females, 75-79 yrs, >3cm
* Johnston et al (1991); ** Sterpetti et al (1987); ® Collin (1990)
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Figure 1.6. Number of, and indication for, AAA repair between 1976 and 1996 in the
Edinburgh Regional Vascular Centre.
[J Asymptomatic; § Symptomatic elective; | Symptomatic emergency;
H Rupture
1.2.3 Prognosis ofAAA
In the UK, it is estimated that 1.7% ofmen aged 65-74 years die from AAA (Collin
1990). Approximately 900 people die annually from ruptured AAA in Scotland
(Naylor et al 1988). Many of these patients do not reach hospital alive (Drott et al
1992, Choksy et al 1999) and of those who do, approximately 40-55% will die (Samy
et al 1994, Bradbury et al 1997). Despite considerable surgical and anaesthetic
specialisation, the mortality associated with (attempted) repair of ruptured AAA shows
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no sign of decreasing, and may in fact be rising. This is likely to be due to increased
numbers of elderly and infirm patients being operated (Bengtsson et al 1996).
Natural history:- In 1950, before surgical repair was available, Estes et al (1950)
found the 1-year survival ofAAA subjects to be 60%, and the 5-year survival to be
only 19%. Furthermore, 63% of these patients died from AAA rupture. Although this
study is now 50 years old and no recent, non-interventional, natural history data are
available, other data support this poor prognosis (Klippel and Butcher 1966, Darling et
al 1977). On the basis of these data it has generally been taught that the majority of
patients with AAA should undergo surgical repair. More recently however, the UK
Small Aneurysm Trial (UKSAT) found that over a three year period, the annual rupture
rate of a cohort of subjects with AAA 3-6cm in diameter was 2.2% when undergoing
ultrasound surveillance. This included patients deemed unfit for surgery. Annual
rupture rate in the 4-5.5cm group who were randomised to surgery or observation was
found to be only 1% with ultrasound surveillance (Brown and Powell 1999).
Rupture risk:- Age- and sex-adjusted maximum diameter is currently believed to be
the most important and easily measurable variable affecting rupture risk (Millis et al
1992). Around 20% of 5-7cm AAA ruptured within a year. The annual risk of rupture
progressively increases with aneurysm size to around 60% if the diameter is greater
than 10cm (Darling 1970, Millis et al 1992) (Table 1.2). The UKSAT reported crude
rupture rates (per 100 person-years) to be 0.3 in AAA of <3.9cm, 1.5 in AAA of4.0-
4.9cm and 6.5 in AAA of 5.0-5.9cm (Brown and Powell 1999). These diameters were
those known or estimated at time of rupture.
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Although without surgery ruptured AAA is universally fatal, the results of (attempted)
repair remain disappointingly high (Table 1.3) and show no sign of improving
(Bradbury et al 1998). Mortality following emergency repair of ruptured AAA in non-
specialist centres can be as high as 50% (Katz et al 1994, Johnston 1994). By contrast,
the mortality associated with elective repair has fallen to about 6%. The challenge,
therefore, is to be able to identify those individual patients at highest risk of rupture
and lowest risk ofelective repair, and operate upon them at the earliest opportunity.
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Table 1.2. Estimated risk of survival, rupture and surgical repair.








5 year risk of rupture (all sizes)
5 year risk ofelective repair (all sizes)




5 year risk of rupture
5 year risk of elective repair




5 year risk of rupture
5 year risk of elective repair
Galland et al (1998)
21%
42%
NData from 1950 when ultrasonic follow-up and surgical repair were not available
Table 1.3. 30-day mortality following surgical repair ofAAA.
30-day mortality*
(%)
Elective asymptomatic repair 6.1
Elective symptomatic repair 5.8
Emergency symptomatic non-ruptured repair 14.1
Emergency rupture repair 37.0
*Also same-admission mortality as some die after 30 days but during initial admission
(Bradbury et al 1998).
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Prognosis following non-ruptured repair:- Surgical mortality in individual case
series ofasymptomatic elective AAA repair has been reported to be as low as 1-5%
(Hollier and Wisselink 1996). The UKSAT showed the 30-day operative mortality in
4-5.5cm AAA to be 5.8% (The UK Small AAA Trial Participants 1998). In Edinburgh,
over a 21-year period, the operative mortality was similar at 6.1% for asymptomatic
elective repair and 5.8% for symptomatic elective repair (Bradbury et al 1998). In
contrast, patients operated as an emergency have a 14-37% mortality rate (Bradbury et
al 1998). Patients who survive elective AAA repair return to a (near) normal life
expectancy. This is partly because high-risk patients with major cardiac disease are, in
general, not offered (or do not survive) surgery. After repair of ruptured AAA, the
long-term survival also approaches normality, again because the very high-risk patients
are not operated or die in the early post-operative period (van Ramshorst et al 1990).
1.2.4 Risk factors for AAA
AAA and atherosclerosis frequently co-exist in the same patient and appear to share
common risk factors:
Smoking:- Tobacco is the major 'environmental' agent implicated in AAA formation.
The association between smoking and aneurysmal disease appears to be stronger than
that between smoking and coronary heart disease (Hollier and Wisselink 1996).
Wilmink et al (1999a) suggested that smoking results in AAA elastolysis.
MacSweeney et al (1994a and b) suggested that smokers have higher AAA growth
rates than ex-smokers and that smoking increases the likelihood of death from AAA. It
is also apparent that heavy smokers who inhale deeply have the highest risk ofAAA
among current and ex-smokers (Franks et al 1996, Brown and Powell 1999).
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Hyperlipidaemia:- It has been suggested that hyperlipidaemia, leading to
atheromatous plaque deposition, may be associated with AAA progression, dissection
and rupture (Hollier and Wisselink, 1996). However, other population-based studies
have not confirmed this (Wilmink and Quick 1998). Furthermore, Limet et al (1998)
reported that monkeys fed an atherogenic diet failed to develop AAA.
Hypertension: - Hypertension has also been shown to be related to increased AAA
expansion and rupture (Hollier and Wisselink 1996, Stonebridge and Ruckley 1996).
Over 40% ofAAA patients are hypertensive (Hollier and Wisselink 1996), as are 70%
ofdissecting AAA patients (Millis et al 1992). Cronenwett (1996) suggested that
hypertension is amajor risk factor for AAA rupture. Diastolic hypertension may be
associated with a 3 to 4-fold increase in the risk ofdeveloping an AAA (Franks et al
1996). The role ofhypertension in aneurysm development, progression and rupture is
complex and not clearly understood. However, since AAA growth depends on the
intrinsic strength of the aortic wall and the pressure exerted upon it by the flowing
blood, hypertension is an obvious risk factor for AAA development and progression.
Gender: - AAA prevalence is higher in males. Despite this, rupture risk appears to be
as much as three times higher in females than in males (Brown and Powell 1999).
Age: - Advancing age itself is an important risk factor, the incidence being higher in
those over 60 years (Hollier and Wisselink 1996). However, 25% of the population
over 60 years of age have age-related aortic expansion as opposed to true AAA
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development (Grimshaw and Thompson 1997). The peak prevalence of rupture is
between 70 and 75 years of age (Grimshaw and Thompson 1997).
Genes: - There is a familial tendency to AAA, with around 30% ofbrothers and 5% of
sisters being affected (Bengtsson et al 1989). Limet et al (1998) found that male
patients with familial AAA were significantly younger at diagnosis and at rupture, and
had a significantly higher rupture rate (32%) than those with sporadic AAA. Studies of
genetic variations in AAA disease have so far produced contradictory evidence of
possible pathways (Cohen et al 1990, Majumber et al 1991, Powell et al 1993,
Ramsbottom et al 1994, Elzouki and Eriksson 1994, Verloes et al 1995). Inheritance of
AAA disease may be multifactorial; the result of a complex interaction between
environmental factors and genetic susceptibility. Despite familial clustering and the
investigation of several genes, the genetic basis ofAAA formation remains obscure
(Wills etal 1996a).
1.2.5 The role of atherosclerosis
Although atherosclerosis and aneurysm commonly co-exist, the former is thought to be
an associated factor rather than the cause ofaneurysm formation. The two diseases
may have the above risk factors in common, however, the following arguments suggest
that AAA and atherosclerotic occlusive disease are distinct and separate conditions
(Limet et al 1998).
• There are distinct pathological differences between the two diseases. For example,
AAA morphology shows marked attenuation of the media compared with the well-
developed media in aorto-occlusive disease.
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• Experimental atherogenic models have not consistently produced AAA
• Evidence suggests a genetic predisposition to AAA
• Specific alterations of collagen and elastin occur in AAA but not in atherosclerosis
• Inflammatory infiltrate (T and B-lymphocytes, mast cells and macrophages) is
present in AAA wall, predominantly in the media and at the medial-adventitial.
Junction (Satta et al 1998)
• Enzymatic activation leads to proteolysis by matrix metalloproteinases (MMP's) in
AAA
1.3 Surgical treatment
Open AAA repair is one of the commonest procedures carried out by vascular
surgeons. There are several operative approaches, but all involve clamping the neck of
the aneurysm and the iliac arteries. The sac is then opened and the laminated thrombus
removed. Bleeding lumbar arteries are suture ligated and a prosthetic graft inserted.
The sac is then closed over the graft.
1.3.1 Risk-benefits of surgical repair
The decision to operate on an AAA involves weighing the risk of rupture against the
risk of surgery for each individual patient. Important factors include:
i) AAA diameter
ii) The presence of symptoms
iii) The presence of concomitant disease, notably cardiac, respiratory and
renal disorders.
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The UKSAT (The UKSAT Participants 1998) has recommended that ultrasonographic
surveillance ofAAA <5.5cm in diameter is safe and that early surgical repair of these
AAA does not provide a long-term improvement in survival. Mortality following repair
ofAAA with diameters of4-5.5cm was not improved at 2, 4 and 6 years when
compared with the surveillance group (The UKSAT Participants 1998).
1.4 Pathophysiology of AAA
1.4.1 Normal aortic wall
The normal aorta is an elastic artery comprising three layers (Figure 1.7):
Intima:- The intima is the innermost layer comprising a single layer of endothelial
cells supported by elastin-rich collagenous tissue (Burkitt et al 1993). The internal
elastic lamina separates the intima from the media. The subendothelium comprises
fibroblasts and myointimal cells. With increasing age, the myointimal cells accumulate
lipids and the intima progressively thickens.
Media:- The media comprises concentric layers of fenestrated sheets of elastic
lamellae and circumferentially oriented collagen fibres. Each layer of collagen runs
alongside a network of fine elastin fibres with a layer of smooth muscle cells (SMC)
compacted between adjacent elastic lamellae (Wills et al 1996a). The SMC in the
media are responsible for the mechanical properties of the aorta and for the production
of the extracellular matrix (He and Roach 1994), while the close association ofelastin,
collagen and SMC provides the viscoelastic properties. The extracellular matrix
contains microfibrillar proteins that are closely associated with the medial elastic
lamellae.
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Adventitial- The adventitia comprises collagen, scattered elastin fibres, fibroblasts
that synthesise extracellular matrix proteins, and inflammatory cells (Wills et al
1996a). There is a network ofvasa vasora (relatively scant in the infra-renal aorta in
comparison with that of the thoracic aorta) which penetrate the outer half of the media.
[Details of elastin and collagen within the AAA wall are described in Sections 1.4.3
and 1.4.4].
Figure 1.7. Micrograph of the normal aorta on the left including the intima (I), the
media (M) and the adventitia (A) containing vasa vasorum (V). The image on the right
shows the concentric fenestrated sheets of elastin (black) separated by collagenous
tissue (red) and smooth muscle cells (yellow) in the media (Young and Heath 2000).
Elastic Van Gieson x33 Elastic Van Gieson x320
1.4.2 The aneurysmal aortic wall
Intima:- The intima becomes thickened because of aggregated myointimal cells that
have taken up lipid (Figure 1.8). Laminated thrombus is deposited on the intimal
surface. There is an increased volume of disorganised collagen and elastin and the
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internal elastic lamina is variably destroyed making it difficult to distinguish the
intima from the media (Limet et al 1998).
Media:- The media becomes attenuated due to the loss of supporting elastic tissue,
atrophy of smooth muscle cells and progressive medial fibrosis. The medial lamellar
units become disorganised and damaged and the elastin fibres become fragmented
(Wills et al 1996b, Ghorpade and Baxter 1996). Eventually the medial fibrous tissue
stretches because of the loss of elastic recoil and the artery dilates (Figures 1.10 and
1.11).
Adventitial- In order to maintain its original thickness, the circumferential area of the
adventitia increases. This involves the synthesis and accumulation ofmatrix proteins
such as fibrillin (Halloran and Baxter 1995, Wills et al 1996a).
Figure 1.8. Early aneurysmal changes in the aorta; (In) represents thickening of the
intima, (M) shows the media which has not yet undergone degeneration or attenuation
(Burkitt et al 1996)
In
.-v-, ,
Haematoxylin and eosin, low power.
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Figure 1.9. Photomicrograph of the AAA wall; (M) shows medial infiltration by
cholesterol deposits and disruption of the lamellar units, and (A) the adventitial
thickening (Courtesy ofDr K McLaren, Dept. Pathology, University of Edinburgh).
Haematoxylin and eosin, high power.
1.4.3 The role of collagen and elastin in the non-aneurysmal aorta
Collagen and elastin have quite distinct mechanical roles in the aorta. Elastin expands
by 50-70% of its original length and bears most of the stress at low pressures. It also
allows stress to be distributed uniformly throughout the wall and maintains the
equilibrium between mural haemodynamic stress and the resultant deformation.
Collagen expands by only 4% of its original length. However, it is coiled in such a way
that it allows elastin to stretch in response to the cardiac cycle and provides tensile
strength at high pressures, thus preventing over-distension (MacSweeney ei al 1994a).
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1.4.4 Collagen and elastin in AAA
Aneurysmal formation and expansion occur in response to the degradation and
remodelling of elastin and collagen fibres (Figure 1.10). These changes are the result of
increased proteolytic activity consequent upon macrophage and lymphocyte infiltration
of the AAA wall (Anidjar et al 1994, Halloran and Baxter 1995, Lopez-Candales et al
1997). There is an increase in total protein, microfibrillar protein (possibly fibrillin)
and collagen content but a reduction in elastin concentration and medial SMC (Sumner
et al 1970, He and Roach 1994, Gandhi et al 1994, Wills et al 1996a). The result is a
relative imbalance in the structural proteins.
Figure 1.10. Photomicrograph showing breakdown ofelastin; the concentric layers of
elastin are fragmented (black), (Courtesy ofDr K McLaren, Dept. Pathology,
University of Edinburgh).
Elastin Van Gieson, High Power
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Elastin degeneration:- Elastin degeneration appears to occur early in AAA
development (Dobrin et al 1984, White and Mazzacco 1996, Limet et al 1998).
Compared with the non-aneurysmal aorta, the volume fractions of both elastin and
SMC in AAA are decreased considerably (90%) (He and Roach 1994, Lopez-Candales
et al 1997). Total elastin concentration of the aneurysmal inffarenal aorta has been
reported to be only 5-8% compared with the 15-35% found in age matched, non-
aneurysmal controls (Powell and Greenhalgh 1989). Although the total elastin content
of the aorta has been shown to increase, elastin concentration decreases because of the
increased total protein content of the thickened aortic wall (Baxter et al 1994, Minion
et al 1994, Sumner et al 1970).
There is disagreement among authors as to the cause of the reduced elastin
concentration. Elastin gene expression is unaltered in AAA, whereas mRNA levels for
the collagen precursor, a 1-procollagen, are increased. This suggests that discordant
gene expression is responsible for the change in elastin and collagen concentration
(Mesh et al 1992). Other authors suggest that selective degradation of elastin in the
aneurysmal media would result in an apparent increase in collagen concentration
(Menashi et al 1987). Whatever the mechanism, it would appear that elastin may not
actually be lost but simply altered and redistributed over a larger area (Halloran and
Baxter, 1995).
The rate ofelastin degradation depends upon the balance between elastases and their
inhibitors (anti-proteases). Cohen et al (1987) found aortic wall elastase to be
significantly higher in patients with ruptured AAA than in those undergoing elective
repair and higher still than those with aortic occlusive disease. Neutrophil elastase is
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modified by the major protease inhibitor alphai-antitrypsin, forming elastase alphai-
antitrypsin complexes. Increased serum-elastin-peptide (SEP) concentration indicates
elastolysis (Sata et al 1998, Rao et al 1996) and has been suggested as a method of
monitoring the degradation ofelastin (Lindholt et al 1997).
Collagen synthesis and lysis:- Collagen types I and III predominate within the aortic
wall. Type III providing most of the walls tensile strength. It has been hypothesised that
an increase in proteolytic (MMP-9) activity in AAA leads to collagen destruction and,
consequently, allows aneurysm growth and rupture (McMillan et al 1997). However,
there is also an increase in collagen metabolism that involves a complex remodelling
process. During this process, neosynthesis of collagen fibres and thickening of the intimal
and advential layers compensate for the haemodynamic disequilibrium caused by
elastolysis and collagenolysis, avoiding rupture at this stage.
The aminoterminal propeptide of type III procollagen (PIIINP) is released into the
extracellular fluid (Prockop et al 1979) and is measurable in the serum. Satta et al (1995)
demonstrated an apparent increase in PIIINP in patients with AAA compared with
controls and suggested that this may be due to a combination of both enhanced synthesis
and enhanced degradation of collagen. Indeed, volume fractions of collagen and ground
substance are increased by approximately 80% in AAA (He and Roach 1994). Treska and
Topolcan (2000) found AAA wall PIIINP to be significantly higher in larger AAA.
However, this newly formed collagen may be weaker and more prone to proteolytic
degradation (Sakalihasan et al 1993). Subsequently, inflammatory infiltrates,
lymphocytes and macrophages cause dissociation of the collagen fibres. The loss of
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tensile strength and thinning of the aortic wall leads to expansion of the aorta until
eventually rupture may occur.
1.4.5 Matrix metalloproteinases
Matrix metalloproteinases (MMPs) are a family of zinc-based enzymes that selectively
degrade the extracellular matrix of the aortic wall (Table 1.4). Endogenous tissue
inhibitors ofmetalloproteinases (TIMPs) inhibit the activity of these MMPs. It is now
accepted that increased elastase, collagenase and gelatinase activity plays a central role
in aortic wall degeneration and AAA formation (Wills et al 1996a).
The MMPs present in elevated levels in AAAs have a synergistic effect stimulating the
initiation and maintenance of extracellular matrix degradation of the media. MMP-9
can degrade elastin and denatured collagen, and facilitates the action of interstitial
collagenase on collagen types I and III. Active forms ofMMP-3 and plasmin lead to
activation ofMMPs -1 and -9, which in turn degrade elastin, fibrillar collagens and
other matrix components (Vine and Powell 1991, Newman et al 1994a, Newman et al
1994b). The actions of the MMPs involved in AAA formation are tabulated in Table
1.4.
27
Table 1.4: Matrix metalloproteinases and their endogenous enzyme inhibitors (Thompson
and Parks 1996).















Smooth muscle cells Proteoglycans, collagen types
IV, V, IX, X
92-kDa Gelatinase
(MMP-9)
Macrophages Collagen types IV, V, VII, X,
elastin
1.4.6 Inflammation
Inflammatory infiltrate is present in varying degrees in most AAA (Newman et al 1994c,
Freestone et al 1995). T- and B- lymphocytes and macrophages are the predominant
inflammatory cells found in the walls ofAAA (Freestone et al 1995, Satta et al 1998) and
are concentrated around the vasa vasorum at the medial - adventitial junction. These cells
produce MMP-1, -2, and -9, which act specifically on elastin and collagen (Wills et al
1996b). Satta et al (1998) found that loss of elastin was related to the quantity of
inflammatory cells present in the wall.
The lymphocytes and macrophages also activate resident mesenchymal cells by
cytokinetic control mechanisms (Wills et al 1996a). Many cytokines [e.g. tumour
necrosis factor-a (TNF-a), interleukin (IL)-ip, -6 and -8, monocyte chemoattractant
protein-1 (MCP-1)] with pleiotropic and often incompletely defined affects are involved.
However, the key processes appear to be upregulation ofadhesion molecules, activation
of proteases and the eventual destruction of collagen and elastin.
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1.4.7 Haemodynamic influences
Aneurysms occur most frequently in the abdominal aorta where there are unique
haemodynamic conditions (Figure 1.11). As the aorta descends from the thorax to the
abdomen, it tapers and becomes less distensible. This results in increased pulse
pressure that is highest in the infrarenal aorta. Pressure waves are reflected from the
aortic bifurcation further increasing pressure in the infrarenal aorta. The reflected
waves also result in lower, and even negative, shear stress at the aortic wall. Low shear
stress promotes atherosclerotic plaque formation because of stagnant blood flow
(Sumner 1995). Model studies ofAAA have suggested that laminar blood flow may
predominate in smaller AAA but that as the aneurysm sac dilates this may become
turbulent, which in turn may increase shear stress (Asbury et al 1995). Whether the
pressure acting on the aortic wall is affected by the presence, extent and physical
properties of the mural thrombus lining the sac remains to be thoroughly investigated;
model studies suggest that intraluminal thrombus may reduce wall stress (Mower et al
1997), however, human studies (Schurink et al 2000) have failed to support this.
Figure 1.11. Haemodynamic influences in the progression ofAAA.
Reflected waves
from bifurcation
Aortic dilatation Laminar an<aturbulent flow
Increased pulse pressure
Small AAA -I shear stress
Large AAA T shear stress
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1.4.8 Pathophysiological sequence
The complexity of the process of aneurysm formation is evident. The precise
mechanisms behind the proteolytic activity remain to be clarified although the overall
sequence ofevents has become more apparent in recent years (Figure 1.12).
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1.5.1 Definition of normal blood pressure and hypertension
Peak systolic arterial blood pressure is produced by the transmission of left ventricular
systolic pressure. Vascular tone and the integrity of the aortic valve maintain diastolic
pressure. Normal blood pressure in a resting young adult does not usually exceed
140mmHg in systole or 85mmHg in diastole (Camm 1998). In the elderly,
independently of disease, ageing produces rigidity of the vessels that increases systolic
pressure to a greater extent than diastolic pressure. In fact, over the age of65 years,
diastolic pressure may even begin to fall (Camm 1998). There is wide variation in
'normal' blood pressure and, indeed, within each individual, BP varies in response to
environmental factors such as physical exertion, stress and pain.
Essential hypertension is defined as a sustained high blood pressure not attributable to
a specific cause. In recently published guidelines, the British Hypertension Society
(Ramsay et al 1999) recommended that systolic pressure of>140mmHg and diastolic
pressure of>90mmHg be considered as hypertension.
1.5.2 Pressure measurement
i. Sphygmomanometry is by far the most acceptable form ofmeasurement to the
patient and the easiest for the clinician to carry out. Automated
sphygmomanometry is now accepted as a convenient form ofmeasurement
since mercury and aneroid manometers require frequent calibration.
ii. Blood pressure can be measured by inserting a cannula into an artery allowing
continuous monitoring. This is the 'gold standard' for BP monitoring. However,
it is invasive and therefore not acceptable in the routine follow-up of subjects.
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1.5.3 Age and sex differences
Systolic pressure in Western countries increases with age until the sixth decade in
females and the seventh decade in males. The relative increase in systolic pressure is
greater in males than in females until 25 years of age. Between 45 and 60 years of age,
acceleration in the rise of systolic pressure in females leads to female systolic pressure
reaching the same level as that in males. Diastolic pressure rises in both sexes until 70
years when it begins to fall (Swales 1996, Starr et al 1998).
1.5.4 Hypertension and distensibility
The aorta and other large elastic arteries distend during systole, storing blood volume
and potential energy. This energy is released during diastole due to elastic recoil of the
arterial wall. The amount of energy stored depends on the degree of distension and the
initial diameter of the vessel. The response of the arterial wall to blood pressure is
described in terms of its compliance and distensibility (the difference between
distensibility and compliance is described in Section 2.5). In established hypertension,
distensibility and compliance of the larger elastic arteries is reduced in relation to that
ofnormotensive individuals (Reneman and Hoeks 1995).
1.6 Questions arising from current epidemiological knowledge
It is apparent that the incidence ofAAA is rising in Western countries and in spite of
major advances in diagnosis, surgical intervention, and anaesthetic technique, the
mortality rate for rupture remains unacceptably high. In contrast, elective repair in a
specialist unit carries a much lower mortality rate. The question, therefore, is how can
rupture be more accurately predicted in order to reduce mortality?
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AAA wall degeneration is becoming more clearly understood and it would appear that
a non-invasive method ofmeasuring this process might enhance the predictive ability
of diameter and expansion rate (the current measures of rupture risk). The use of a non¬
invasive tool would allow frequent outpatient follow-up. Rupture occurs when the
stress within the wall exceeds the tensile strength of the wall material. This is measured
by arterial wall compliance and, to a lesser degree, distensibility. Distensibility can be
measured non-invasively and so this study aims to test whether non-invasive
measurement ofAAA wall distensibility provides clinically relevant rupture risk
information.
The relationships between AAA diameter, expansion, distensibility and rupture are, at
present, not known. This study aims to provide this knowledge by:
i- describing the range ofdistensibility in a population of subjects with AAA;
ii- describing the relationships between distensibility, diameter and rupture.
The haemodynamic relationships between blood pressure, AAA diameter and arterial
morphology are complex and no model of this yet exists. It is not possible to measure
blood pressure within the AAA non-invasively and so the question arises as to whether
brachial pressure could be used instead in the measurement ofAAA distensibility.
Atherosclerosis very often occurs in combination with AAA. Although it does not
appear to be causally related, the effect of the presence of atherosclerosis on the
relationships between blood pressure, diameter and wall distensibility has not been
investigated in AAA. This study aims to address the question ofwhether the presence
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ofatherosclerosis compromises AAA wall distensibility and consequently affects the
risk of rupture.
The specific aims and objectives are listed in Chapter 3.
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Chapter 2. Physics Background
2.1 Introduction
A description of the pathophysiology of aneurysm formation allows an understanding of
aneurysm disease progression. It does not in itself lead to an understanding of the rupture
process. As described in section 1.6, this thesis aims to assess the use of arterial wall
distensibility in rupture risk assessment. This chapter reviews the physics principles
necessary to understand the measurement of the mechanical behaviour of aneurysms
undertaken in this study. The areas covered will include consideration of the aneurysm
wall properties, of blood pressure and of the principles of the ultrasound instrument that
will be used for measurement.
The aorta is a compliant artery: that is, it changes diameter (and length) as a result of
changes in blood pressure (Figure 2.1). The principal arterial components determining the
compliance of the artery are elastin and collagen (Millis et al 1992, MacSweeney et al
1994). Their respective roles are discussed in chapter 1.4. Ofparticular relevance to this
thesis is the observation that the elastin/collagen content and concentrations change
during AAA growth (He and Roach 1994, White and Mazzaco 1996, Limet et al 1998,
Sata et al 1998), and that the resulting changes in the physical properties of the artery
may be crucial in determining whether or not aneurysms grow and/or rupture. The
following subsections explain the concept of compliance, distensibility and elasticity, and
demonstrate how distensibility can be calculated from changes in the artery diameter and
blood pressure.
36
Figure 2.1. Arterial diameter and wall thickness changes in response to changes in
pressure produced by the cardiac cycle. Typical diastolic pressure is 80mmHg: systolic
pressure is 120mmHg
2.2 Physical / mechanical properties of aortic wall: definitions
15mm 18mm 15mm
Although this thesis is principally a clinical work, it is necessary to define the physical
terms as they are used in this thesis.
Elasticity - The ability of a substance to regain its original form once a deforming force
has been removed.
Stress - The force producing the deformation.
Strain - The ratio of the deformation to the original form
Compliance - The absolute change in arterial volume for a given change in pressure
(Reneman et al 1996).
Distensibility - The relative change in volume for a given change in pressure (Reneman
etal 1996).
Pressure-strain elastic modulus - the ratio of stress to strain (Peterson 1960).
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Stiffness - The log of the stress: strain ratio that reduces pressure dependence (Hayashi
1980).
Pulse wave velocity - the average speed of the pressure wave travelling along a
length ofartery not at a localised point.
2.2.1 Stress
Stress (S) is the intensity of a force (F) acting on a given plane and, if it is distributed
evenly over a given area (A), is calculated as follows;
S = F/A (Nm2)
2.2.2 Strain
Strain is the change in dimension of the artery (diameter, area or volume) under
extension (stress). A material in which the change in dimension is uniform in all three
directions is said to be isotropic. However, since the elastic properties of the three
distinct layers within the arterial wall are different, the arterial wall is anisotropic. The
difficulties arising in the measurement ofarterial strain have led to the simplified
models of stress-strain relations. The relationship between stress and strain is expressed
as an elastic modulus.
2.3 Indices of Compliance and Distensibility
2.3.1 Young's modulus
The ratio of stress (force per unit area) to strain (fractional deformation) is referred to as
Young's modulus (E). For some materials such as steel or rubber, over a limited range of
stress, E is constant and is a linear relation. The artery, however, is not homogeneous and
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its stress-strain behaviour is not linear (Figure 2.2). The relationship between stress and
strain is seen in Figure 2.2 to be curved, with a greater change in diameter at lower
pressures. The hysteresis of the pressure-diameter curve is a result of the pressure leading
the change in diameter during systole (the upward curve) and the energy being stored and
released slowly during diastole (the downward curve). This curve flattens with age. The
'incremental Young's modulus' (Sumner et al 1970) refers to the ratio of the change in
stress to the change in strain when the curve is non-linear.
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Figure 2.2 The hysteresis curve of change in pressure and the resultant change in
diameter (modified from Lanne and Bergentz 1995).
2.3.2 Compliance and distensibilitv
The terms compliance and distensibility are often used interchangeably to describe the
generic behaviour of arteries in response to change in blood pressure. However, it is
necessary to review the use of different quantities related to the elastic behaviour of
arteries, and to specify which quantities and terms will be used in this paper.
The volume of blood within a segment ofartery increases as a result of an increase in
pressure. The change in dimensions can be expressed by considering the volume
change 8V, the cross sectional area change 5A, or the diameter change 8d. The indices
that will be discussed are categorised by Hayashi (1980) as the 'structural stiffness'.
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Structural stiffness:- These indices are related to the change in dimensions of the
artery wall with a change in pressure. The term compliance (C) usually refers to the
change in volume (8V) of the blood contained within a segment ofartery in which
there is a pressure change (5P) i.e. C=8V/8P. The term distensibility (D) usually refers
to the fractional change in volume for a pressure change (8P) i.e. D=[8V/V]/ 8P.
In this thesis a variant of the distensibility index has been used. This is called the
pressure-strain elastic modulus, E(p), and was introduced by Peterson et al (1960).
Ep = 8P Ep = K fP systolic - P diastolic!
(8d/d) ^ [(D systolic-D diastolic)/ D diastolic]
This term was introduced as a means of comparing arterial data for which the arterial
wall thickness is not known (Peterson et al 1960). This is applicable in this study as
the wall thickness of the AAA cannot be measured using ultrasound imaging. Ep has
been used by several workers using ultrasound to measure the elastic behaviour of
arteries (Sumner et al 1970, Sonesson et al 1993). A modification of this term was
proposed by Hayashi (1980) in recognition of the fact that the pressure-diameter
relationship of arteries is not linear. He introduced the stiffness index, (P), which was
modified by Kawasaki et al (1987).
P = lnfPsystolic/Pdiastolic)
[(D systolic-D diastolic)/ D diastolic]
The distinction between these indices can be clarified by noting that if the Young's
modulus (stress: strain) of the artery remains constant, as the wall thickness increases
so the C, D, Ep and p all change in value. As wall thickness increases, C and D
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decrease in value while Ep and P increase in value. In this respect Ep and p are both
stiffness indices, the inverse ofdistensibility.
In this thesis the terms 'elasticity' and 'distensibility' are used to describe the generic
behaviour ofarteries, and the terms 'pressure-strain elastic modulus' and 'stiffness'
are used as defined above. The term compliance will not be used. For a more detailed
discussion of these concepts the reader is referred to two reviews (Loagun and
Gosling 1982, Lanne and Bergentz 1995).
2.3.3 Pulse wave velocity
Pulse wave velocity (PWV) is the velocity with which a pressure pulse is propagated
along an artery. It is proportional to the elastic modulus of the arterial wall and can
determine the average value of arterial elasticity over a length of the arterial tree. The
less elastic an artery is, the higher the PWV (Sumner 1995). Calcification and
increased wall thickness also increase PWV. The distance between the sites at which
measurements are made determines the length of artery over which distensibility is
averaged; for example, to measure the elasticity of the aorta, PWV measurements are
taken from the carotid and femoral arteries. However, PWV does not provide an
elasticity value for specific points and so for the purpose of this study, has been
deemed less useful than the pressure-strain elastic modulus and stiffness in assessing
AAA wall distensibility. It is of use in determining the central pressure non-
invasively which will be discussed in Chapter 6.
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2.4 Blood pressure
The indices ofdistensibility used in this thesis require the measurement of the systolic
and diastolic blood pressures at the site of the aneurysm. To perform this measurement
would require insertion of a pressure transducer into the vessel, which is not justifiable
for repeated measurements on patients. Instead measurement of the systolic and diastolic
pressure at the brachial artery was performed. Systolic pressure increases along the
arterial tree from the aorta to the peripheral arteries by 10-35 mmHg (Nichols and
O'Rourke 1998, Pauca et al 1992). It was acknowledged that non-invasive measurement
ofbrachial pressure caused a systematic error in the determination ofaortic pressure and
distensibility (Hansen et al 1993). However, that work compared invasive brachial with
non-invasive brachial pressures instead of central and brachial pressures. It was also
performed on young, non-AAA volunteers. The situation with regard to older patients
with AAA had never been investigated. It has become clear that there is a difference
between central and peripheral pressure, which in some patients may be of a magnitude
that could affect the accuracy ofaortic distensibility measured using brachial pressure. To
address this problem a recently developed instrument, which enables central pressure to
be calculated from non-invasive measurements ofperipheral blood pressure, was used.
This is discussed in section 2.5.4 of this thesis. The following section describes the
physics of blood flow with respect to blood pressure.
2.4.1 Reflected waves
Within the arterial system there are two waveforms relevant to this study; the pressure
wave and the flow wave. These waves are reflected wherever there is a discontinuity
within the system; branching, changes in wall distensibility, stenoses and dilatations.
Nichols and O'Rourke (1998) suggest that the shape ofpressure and flow waves are
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dramatically different because of reflected waves. It can be seen from Figure 2.3 that the
peak of the flow wave occurs at the first dichrotic notch and that pressure continues to
rise even after flow begins to decrease.
Figure 2.3. Ascending aortic pressure (top) and blood flow velocity (bottom) waves.
Time (ms) 1000
A portion of the left ventricular stroke volume is stored in the compliant aorta during
systole and then propelled distally by elastic recoil during diastole. When this surge of
blood encounters the high resistance imposed by the arterioles, part is transmitted into the
capillaries and part is reflected back up the arterial tree. The magnitude of the reflected
wave relative to that of the incident (forward going) wave is determined by the peripheral
resistance, being greatest when the vascular bed is constricted. As the reflected wave
travels back up the artery, it subtracts from the forward flow wave but adds to the
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forward pressure wave (Sumner 1995). The result is that the amplitude of the pressure
wave increases while that of the flow wave decreases as they travel towards the periphery
(Nichols and O'Rourke, 1998). It is the additive effect of reflected waves on the pressure
wave that results in systolic amplification and reduced diastolic pressure from central
arteries to peripheral arteries (Figure 2.4).
Figure 2.4. Pressure and pulse contours in a normal subject.
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2.5 Methods of distensibility and diameter measurement
2.5.1 Available methods ofmeasurement
There are several methods ofmeasuring arterial wall distensibility but this study aimed to
look at the aorta in vivo using non-invasive methods. This limited the choice of
technique. As discussed above, PWV does not provide information on local arterial
distensibility, which was a prerequisite of this study. MRI or ultrasound can be used to
measure the fractional change in diameter in response to change in pressure. MRI
however, is costly for routine follow-up.
For this study a non-invasive method ofmeasurement of the elastic properties of the
aneurysm was needed. B-mode ultrasonography with phase-locked loop echo-tracking
software appeared to be the most appropriate method to use. The software could be
incorporated within a portable B-mode scanner and it was relatively simple to learn and
use on a routine basis. The study subjects were familiar with the ultrasonic component of
this technology and it provided a non-invasive method ofdistensibility and diameter
measurement. Previous work reported that the results were reproducible (Hansen et al
1993). The equipment is described in detail below.
2.5.2 B-mode ultrasound technology
Ultrasound technology provides detailed cross-sectional images ofanatomy visualised in
real time. Ultrasound involves the emission of very high frequency sound waves that
travel through tissue and are reflected back to the probe. In this thesis, a linear array
transducer has been used with the Diamove equipment (section 2.5.3). This type of
transducer contains a row of crystal elements which are fired in groups from one side of
the transducer to the other allowing the image to be built up line by line (Figure 2.5). The
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focused beam of sound transmitted into the tissues is reflected strongly from the
boundaries between tissues possessing differing impedance (the speed of sound wave
transmission). The depth of the tissue is determined automatically from the time interval
between the outgoing ultrasound pulse and the reflected echo. The further away the tissue
is, or the more tissue the wave has to travel through, the smaller the reflected wave. The
resulting image is a cross-section of the anatomical structures showing the depth and
indicating the structure of the differing tissues by means of a grey scale image (Figure
2.6). This is called a 'brightness' mode or B-mode image.
Attenuation increases linearly with the frequency of the waveformsa. This means that as
the frequency of the sound waves increases so does the attenuation (wavelength
decreases). For deep structures this does cause some limitation as there will be a depth
beyond which the transducer cannot differentiate between the small, reflected waves and
electronic 'noise'. A further difficulty is that the ability to distinguish spatial detail is
reduced as frequency decreases. For the required depth, the highest frequency possible is
used in order to odtain maximum detail. In the case of the abdominal aorta, the optimal
frequency is 3.5MHz. Ultrasonic waves can only travel through fluid so the air gap














































Figure 2.6. Transverse B-mode ultrasound image of the anteroposterior view of a
4.3 cm AAA.
2.5.3 Echo-tracking
The echo-tracking equipment has been used and described previously. (Lanne and
Bergentz 1995). An echo-tracking device (Diamove, Teltec AB, Sweden) is
interfaced with a B-mode ultrasound scanner (EUB- 240 Hitachi, Japan) (Figure
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2.7). A 3.5MHz linear array transducer provides optimal resolution at the depth of
the abdominal aorta. An echo-tracking phase-locked loop circuit restores the
position of two electronic gates relative to the moving echoes from the anterior
and posterior vessel walls. This dual tracking is carried out simultaneously and
allows instantaneous calculation of the differences in vessel diameter. The
theoretical minimum detectable motion that can be detected is 8pm.
Data acquisition and analysis using the Diamove softeware is carried out by a
Pentium 24X personal computer (DCS, Scotland) interfaced with the ultrasonic
echo-tracking device. The pressure-diameter curve is registered on the
computer in real time and at least three consecutive waves are analysed. This
enables the observer to visualise and monitor the quality of the waves as they
are being measured (Figure 2.8).
50
Figure 2.7. The Diamove ultrasonic echo-tracking equipment: A, the ultrasound
scanner interfaced with echo-tracking software; and B, the computer with the
displaying the pressure diameter waveform produced by the software.
The transducer is placed over the AAA to obtain a longitudinal section; this view
allows visualisation of the longitudinal axis of the aneurysm avoiding
measurement ofoblique angles across the aneurysm which may occur using the
transverse view. The anterior and posterior vessel walls are echo-tracked after
initial placement of a cursor within the vessel at the point ofmaximal antero¬
posterior (AP) diameter (Figure 2.6). The observer controls the length of the
cursor to over-ride thrombus or wave refraction noise and lock onto the vessel
wall (within the limits of B-mode ultrasonography).
The Diamove software automatically identifies the start and end of each cardiac
cycle and using at least three consecutive waves can calculate an average
waveform (Figures 2.8 and 2.9). Brachial artery pressure is entered and the
software calculates Ep and p using the equations discussed above. The
reproducibility of the Diamove equipment and the use ofbrachial pressure instead
of aortic pressure will be discussed more fully in Chapters 5 and 6.
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Figure 2.9. The average pressure-diameter waveform from the data collected
over 7 cardiac cycles, The insert (top right) shows diastolic and systolic
pressure, pulse pressure, minimum, maximum and mean diameter, diameter
change, Ep and p.
Time (seconds)
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2.5.3.i Echo-tracking data quality
The quality of the waves in general is determined by the following criteria: the
waves are on a level plane; the amplitude ofeach wave is equal; there are no
irregularities in rhythm and the wave has a relatively smooth, dichrotic curve
(Figure 2.8). Usable data requires that at least three consecutive waves meet these
criteria.
2.5.4 Sphygmocardiography
Sphygmocardiography involves the derivation of the central aortic pressure
waveform from recordings ofperipheral pulse pressure waveforms. Essentially
the peripheral pressure waveform is measured and the central pressure
waveform is calculated using a mathematical technique called transfer function
analysis. It is not possible to describe this in detail in this thesis but the
principles are described in detail by Nichols and O'Rourke (1998).
The pressure waveforms are obtained non-invasively at various peripheral sites
using a technique called applanation tonometry. This technique uses a small
transducer to flatten the wall of an artery, at which point tangential pressures
are eliminated and the sensor is exposed to the pressure within the artery
(Figure 2.10).
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Figure 2.10. Applanation tonometry uses a tonometer to flatten the arterial
wall so eliminating tangential pressures and leaving the transducer exposed to
the full extent of intra-arterial pressure.
In order to calibrate peripheral pressure pulse waveforms, the systolic and
diastolic pressures are set using brachial sphygmomanometry. When using the
radial artery the effect ofpressure wave amplification between the brachial and
radial arteries is ignored; Nichols and O'Rourke (1998) suggest that only a
minimal error results. When measuring from the carotid artery the pressure wave
amplification is too great to allow use of the brachial pressure alone. A transfer
function is applied in this case.
The software calculates two parameters of the waves' variability allowing the
observer to accept the waveform according to pre-stated levels of acceptable
transducer
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variability; namely wave amplitude >100 mV, standard deviation of systolic
and diastolic peak <5%. The validation of the Sphygmocor has been carried
out by its developers and found to be acceptable (O'Rourke et al 1995). The
reproducibility of the SphygmoCor technique in pulse wave analysis and the
measurement of central pressure has been assessed independently (Wilkinson
et al 1998). This technology will be further discussed in Chapter 6.
2.6 Questions arising from physics review
Pressure-strain elastic modulus (Ep) and stiffness (P) index have previously
been used to measure arterial distensibility. Ultrasonic echo-tracking has been
validated in the measurement of distensibility and a commercially available
echo-tracker (Diamove, Teltec, Sweden) was used. However, the variability of
this technology has not been tested in AAA subjects, nor has this technology
been used to measure diameter in a follow-up setting. This study aimed to test
these points in terms of both inter and intra-observer variability. This would
also allow recommendations to be made regarding its use as a follow-up tool
as well as quantifying the reliability of the data collected.
As discussed in Chapter 1.6, the error involved in using brachial as opposed to
central pressure in the derivation ofAAA Ep and P will be quantified for the
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first time in this study. More specific details of the aims and objectives of this




Section 1.6 described the gaps in the current knowledge ofAAA dynamics,
distensibility and rupture risk. Section 2.6 described the gaps in the current
understanding ofdistensibility and its measurement. The following aims and
objectives are intended to address these areas:
3.2 Aims
3.2.1 To investigate whether data derived from the Diamove ultrasonic
echo-tracker are a reproducible method ofmonitoring AAA
expansion and distensibility.
3.2.2 To investigate whether AAA wall distensibility is related to rupture
risk.
3.3 Objectives
3.3.1 To test the variability of the ultrasonic echo-tracking equipment in
the measurement ofAAA wall diameter and distensibility.
3.3.2 To test the effect ofusing brachial pressure as opposed to derived
central pressure in distensibility measurement.
58
3.3.3 To describe the range of values of aortic wall distensibility using
Ep and (3 in a population with AAA of 3.0cm anteroposterior
diameter or more.
3.3.4 To describe the natural history of AAA wall distensibility, as
measured by Ep and (3.
3.3.5 To test the hypothesis that wall distensibility (Ep and P) is related to
risk of rupture ofAAA and to describe this relationship.
3.3.6 To assess whether smoking, concomitant vascular disease or
medication influence AAA size, growth or distensibility.
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Chapter 4. Patients and methods
4.1 Introduction
The methodology utilised in the measurement ofarterial wall compliance has
been discussed in detail in the physics introduction (Chapter 2). The method of
patient recruitment, data collection and data analysis will now be discussed.
4.2 Patient recruitment
4.2.1 Numbers
The pilot study data (Appendix III) on diameter and distensibility were not
normally distributed and so non-parametric sample size calculations, based on
the Mann-Whitney U test (Noether 1987) were carried out. This method
required the proportion of ruptures (incidence at 7 months in the pilot study
was estimated to be 6%) and the relative risk of rupture (not directly available
for distensibility from the pilot study data). A relative risk of rupture of 2 was
assumed for maximum diameters greater than the median size when compared
with maximum diameters less than the median.
211 patients were required for 90% power, testing at the 5% significance level,
to compare differences in maximum diameter between the rupture and the
non-rupture groups. This was based on the assumption that 90% ofpatients
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would produce usable data. Because so little was known about distensibility
and AAA rupture at the outset of this study, it had to be assumed that
differences in distensibility would be apparent between rupture and non-
rupture groups.
In retrospect, the anticipated rupture rate was rather high. In this study, 216
subjects were recruited, 210 produced usable data and 28 ruptures occurred.
The relative risk of rupture for initial diameters greater than the median was
1.96, which meant that 80% power was achieved. A power calculation was
carried out retrospectively for distensibility and found to be 71% at the 5%
significance level.
4.2.2 Subjects
Subjects with diagnosed AAA who were attending the vascular outpatient
clinic at the Royal Infirmary ofEdinburgh under the care ofProfessor CV
Ruckley, Mr JA Murie, Mr AMcL Jenkins and Mr AW Bradbury were invited
to participate. Patients were also recruited from:
Ninewells Hospital, Dundee; Mr P McCollum and Mr P Stonebridge
Aberdeen Royal Infirmary; Mr J Engeset and Mr G Cooper
Queen Margaret Hospital, Dunfermline; Ms A Howd
Gartnavel General Hospital, Glasgow; Mr AJ McKay
Freeman Hospital, Newcastle; Mr M Wyatt
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Patients with an ultrasound-diagnosed AAA of 3.0 cm or more in antero¬
posterior diameter were included. It should be noted, however, that the
equipment has a variability of 5% in the measurement of static AAA diameter
(Hansen et al 1993), which resulted in one AAA of2.9cm at baseline being
included. Males and females ofany age were invited to attend.
4.3 Follow-up
Follow-up was initially carried out every three months. However, it became
apparent that a large number of these elderly subjects were attending several
different clinics, often from a considerable distance. The follow-up interval
was, therefore, changed to six-months after the study had run for two years.
All subjects were followed up for a minimum of 18 months with the exception
of those who died, those whose AAA ruptured or were operated, or those in
whom no usable wave could be collected. Details of follow-up are given in
Chapter 7.
Patients who were unable to hold their breath for a minimum of 5 seconds or
those with any type of cardiac dysrhythmia preventing three consecutive
usable waves (see definition in Chapter 2) being produced, were deemed
'unfit' for this study. These patients were recruited to avoid selection bias but




Ethics committee approval was given for this study and informed written
consent obtained from each patient prior to commencement. A
questionnaire was devised which included standardised World Health
Organisation (WHO) questions on claudication, angina and smoking
history. Family history ofAAA, past medical and drug history were also
collected.
At initial assessment the questionnaire was completed. The data collected
included:
Measured variables: systolic blood pressure (SBP)
diastolic blood pressure (DBP)
anteroposterior AAA diameter (Dmax)
pulse wave velocity (PWV)
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Derived variables:
pulse pressure (PP) SBP - DBP
mean arterial pressure (MAP) DBP + 1/3 (SBP - DBP)
central pressure See Chapter 2.5.4
diameter change Systolic Dmax -Diastolic Dmax
pressure-strain elastic modulus (Ep) See Chapter 2.3.2




The Rose/WHO questionnaire (Rose et al 1977) and the Edinburgh
Claudication Questionnaire (Leng and Fowkes 1992) were used to identify
subjects with intermittent claudication and angina (Appendix 1). These
questionnaires have been widely recognised as reliable methods of identifying
angina and claudication with a high level of sensitivity and specificity (Rose et
al 1977, Leng and Fowkes 1992). The claudication and angina sections of the
combined questionnaire were graded. Grades 1 and 2 were defined as:
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Claudication - Grade 1, leg pain does not occur at an ordinary walking
pace on the level.
Grade 2, leg pain does occur at an ordinary walking
pace on the level.
Angina - Grade 1, chest pain does not occur at an ordinary
walking pace on the level.
Grade 2, chest pain occurs at an ordinary walking pace
on the level.
Outcome measures - rupture ofAAA (RAAA)
emergency operation for rupture
repair of symptomatic AAA
repair ofasymptomatic AAA
death from RAAA
death from other causes
This information was collected from medical records and/or death certificates.
Following an outcome event, the patient was no longer followed-up.
4.4.2 Clinical data
The clinical measurement data collected are listed in section 4.4.1. Two
recordings of the pressure-diameter wave over 4-1 Is were collected on each
patient, during each session, with brachial artery pressure measured each time.
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The 'best' of the two pressure-diameter traces was selected for analysis on
the basis of the following criteria:
1) The maximum diameter measurements were within 2mm of the
estimated value (estimated diameter being taken from a static image of
systolic diameter), or 5% if the aneurysm was less than 4cm wide;
2) At least three consecutive cardiac cycles producing uniform waves were
available for analysis;
3) Any obvious arrhythmias were excluded.
4.4.3 Blood pressure measurement
Measurement was carried out with the patient in the supine position with the
arm resting horizontally on the bed at the patient's side. Blood pressure was
measured from the brachial artery in the right arm (Fowkes et al 1991) using,
initially, a hand held sphygmomanometer (years 1 and 2 of the study) and
subsequently an automated sphygmomanometer (model 711, Omron Healthcare
GmbH, Hamburg) (Figure 4.1) (years 3-5). The cuffwas wrapped around the
upper arm and inflated until the brachial artery was occluded. Systolic pressure
was taken as the pressure where the first Korotkoff sounds (phase 1) were
detected while cuffpressure was reduced. Diastolic pressure was taken as the
pressure where the final Korotkoff sounds (phase 5) disappeared (Camm et al
1998).
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Figure 4.1. Blood pressure measurement from the brachial artery using an
automated sphygmomanometer.
Hypertension: Although the questionnaire collected information on treatment
for hypertension, this was not used in the analysis to define the presence of
hypertension. A separate variable recording the presence of hypertension at
each follow-up was derived from measured blood pressure data according to
the definition (Ramsay et al 1999): diastolic BP > 90mmHg, systolic BP >
140mmHg.
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4.5 Data collection failure
The patient was not invited back if they were deemed too frail to attend (e.g.
unable to mobilise onto the bed or dementia prevented complete understanding
of the visit). However, if they were fit enough to attend but were unable to
produce usable data, they were invited back because correct use of the
equipment requires a degree ofpractice/expertise. It was thought that for some
subjects, anxiety regarding the examination and extraneous circumstances on
the day ofappointment might have affected compliance data collection. If no
data were collected at two consecutive appointments it was deemed
unnecessary to invite the patient back.
Family and drug history data could not be collected in two subjects because
of dysphasia and poor memory. In 10 subjects, the angina data was deemed
'missing' according to the Rose/WHO (Rose et al 1977) guidelines because
the subjects could not answer question 12.07 (Appendix 1) on the location
of chest pain. Claudication status could not be evaluated because 5 subjects
did not walk or exercise in a way that would have elicited the symptoms
used by the questionnaire.
Measurement of the mechanical properties of the aorta in vivo was problematic
for several reasons:
1) The position of the aorta deep within the abdominal cavity makes visualisation
difficult, especially in overweight subjects.
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2) The aorta cannot be palpated as easily as a more peripheral artery, for example
the femoral artery.
3) As the main arterial route from the heart, it is not easily possible to excise the
aorta or insert probes inside it without potentially serious side effects.
4) Palpation and visualisation of the aorta may require a degree ofpressure to be
applied to the probe especially in the overweight subject. However, the
examination procedure should not exert any pressure upon the arterial wall
because this may limit wall movement.
4.6 Data analysis
All clinical measurement data with the exception of age, were found to be
skewed, so non-parametric statistical tests have been used. The skewed data
were logarithmically transformed to the natural log when there was no non-
parametric test available. Data analysis was carried out using SAS 6.12 and
SPSS version 10 (SPSS® 1999, SAS/STAT 1988). Statistical guidance was
provided by Ms AJ Lee of the Medical Statistics Unit, and Dr AJ Lee of the
Wolfson Unit for the Prevention ofPeripheral Vascular Disease, University of
Edinburgh. The Cox proportional hazard model was carried out by Ms AJ Lee.
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4.6.1 Univariate analyses
Univariate analyses involved the following methods:
■ Mann-Whitney U test for the comparison of two independent groups.
■ Kruskal-Wallis test for the comparison ofmore than two independent
groups.
■ Spearman's rank correlation for the measure ofassociation between two
variables.
■ Wilcoxon's signed rank test for the comparison ofpaired data.
4.6.2 Cox proportional hazard model and survival analyses
Since the univariate analyses showed few significant relationships between
baseline or final follow-up distensibility and risk of rupture, it was possible
that the absolute value ofEp and p was less important than the relative change
in either variable over time. To investigate whether a marked change in
distensibility occurred prior to rupture, the statistical models had to take
account of changes in each variable over time. The Cox proportional hazard
model took account of time-dependent changes in the variables.
Multivariate analysis (Cox proportional hazard model) also enables
investigation of the effect ofeach variable in relation to the effects of the other
variables, i.e. one variable could be adjusted for all the other variables. The
main aim of this study was to discover whether Ep and p had a significant
impact on risk of rupture. There were five possible outcomes: 1) rupture with
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no attempted repair, 2) elective, asymptomatic surgical repair, 3) emergency
or symptomatic repair, 4) intact AAA (patients were alive and had intact AAA
by the end of the study) and 5) death from other causes. Sections 4.4.1 and 2
show that there were a large number of time-dependent and non time-
dependent variables which may impact upon these outcomes
The Cox proportional hazard model is a commonly used survival analysis
method, which is similar to multiple regression. It allows the assessment of the
effect of several independent variables (age, sex, blood pressure, diameter,
distensibility, risk factors, co-morbidity, smoking and drug history) on a
dependent variable (time to rupture). While other survival analysis methods
assume a parametric distribution for survival time, the Cox proportional
hazard model does not assume any particular distribution and so has been
chosen for these, mostly non-parametric, data. The details of the Cox model
will be described more frilly in Chapter 11, where the results of this analysis
are presented.
Within the rupture group, the time from baseline to rupture varied widely. To
assess the characteristics of the rupture group, 'time to rupture' was used as
the dependent variable in the multivariate analyses and can be interpreted as
risk of rupture at any given point in time. This type of survival analysis uses
'time to an event' as the dependent variable, so-called because often the event
of importance is death. However, the 'event' of interest does not need to be
71
death and in this analysis was rupture. It is also the case in survival analysis
that many patients do not undergo the 'event' by the end of the study. Other
multivariate methods of survival analysis would exclude this data. However,
these subjects contribute important information to this study since they have
not ruptured within time (t), the length of the study, and so the Cox model uses
these data.
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Chapter 5. Variability of the measurements derived
using the Ultrasonic Echotracker
5.1 Introduction
Measurement of aortic distensibility using an echo-tracking device (Diamove,
Teltec AB, Sweden) is reproducible in healthy, non-aneurysmal subjects
(Hansen et al 1993). However, this may not be true in patients with AAA
because of cardiorespiratory co-morbidity, obesity and variable aneurysm
morphology. Before the relationship between aortic distensibility, future
growth and rupture can be investigated, it is essential to quantify the
reproducibility of this method.
5.2 Aims
The aim of this study, therefore, was to examine for the first time, the intra-
and inter-observer variability associated with the commercial ultrasonic phase-
locked echo tracker used in the measurement ofAAA distensibility.
5.3 Additional methodology
The use of the echo-tracking ultrasound system has been discussed in detail in
Chapter 2.5.3 and 4.4, the blood pressure technique has been discussed in
Chapter 4.4.
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Observer A underwent 5 months of training in the Departments ofRadiology
and Vascular Surgery at the University ofEdinburgh. Observer B received
two months of training in the Department ofVascular Surgery at the
University ofEdinburgh prior to commencing the study. Observers were blind
to Dmax, Ep and p as these variables were only shown on the computer screen
once analysis had been carried out at the end of the study. The observers




Observer A performed two sets ofAAA distensibility measurements during
two sessions 30-60 minutes apart, on each of 14 patients during a single visit
to the Vascular Studies Unit (VSU).
Study 2:- Inter-observer variability
Observers A and B performed two AAA distensibility measurements on a
further 23 patients during each of two visits to the VSU two weeks apart.
5.3.2 Statistical methods
Data were analysed using the statistical package SPSS-X (SPSS-X 1986).
Statistical advice was provided by Dr AJ Lee. Medians of the variables in
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studies 1 and 2 were compared using the Wilcoxon signed rank test to check
for systematic bias between the sessions and observers. The coefficient of
variation expresses the standard deviation (SD) of a single set of
measurements as a percentage of the sample mean. However, in this study, the
aim was to express the degree ofvariability between two sets ofmeasured
data. For that reason Bland and Altman's (1986) coefficient ofvariation of
method error (CVME) was used.
5.4 Results
5.4.1 Study 1: Intra-observer variability
Table 5.1 shows the median and interquartile range of the variables measured
by observer A during sessions 1 and 2. There were no statistically significant
differences between the first and second sessions with regard to the
distributions of any of the distensibility measurements (Figure 5.1). The intra-
observer CVME for observer A's measurements were low for the directly
measured variables: systolic BP 7.3%, diastolic BP 5.4% and Dmax 2.6%. The
intra-observer CVME of the derived variables were higher: Ep 21.2%, p 17.6%
and diameter change (Dch) 18.2%. Figures 5.2 and 5.3 show the Bland-
Altman plots of the intra-observer differences in Ep and P measured by
observer A.
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Figure 5.1. Intra-observer differences
measurement.
for diameter and distensibility
Measurements:12 12
Wilcoxon signed rank test
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Figure 5.2. Bland and Altman plot of intra-observer differences in Ep measured by
observer A at two sessions 30 -60 minutes apart.
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Figure 5.3. Bland-Altman plot of intra-observer differences in p measured by
observer A at two sessions 30-60 minutes apart.
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5.4.2 Study 2: Inter-observer variability
Table 5.2 shows the median and interquartile range ofeach variable obtained
by observers A and B at each visit. Significant inter-observer differences were
only found with regard to Dmax at visit 1 (p< 0.05) and diastolic BP at visit 2
(p<0.05). Figures 5.4 and 5.5 show the Bland and Altman plots of the inter-
observer differences in Ep and P at visit 1.
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Figure 5.4. Bland-Altman plot of the inter-observer difference in Ep between





























Figure 5.4. Bland-Altman plot of the inter-observer difference in p between observers






































































































































































































































All variables reached a high (r >0.5) and significant (p<0.05) degree of intra-
and inter-observer correlation (Table 5.3). Intra- and inter-observer
measurement ofDmax demonstrated a significant degree of correlation (r >
0.96 and r > 0.94 respectively). CVME for intra- and inter-observer variation
was < 10% for the variables directly measured by the observers (diastolic BP,
systolic BP and Dmax) and <35% for the mathematically derived parameters
(pulse pressure, Ep, P) (Table 5.4). However, CVME is a parametric test and
none of these data were normally distributed. To address this, the values were
subsequently log transformed before calculating the CVME. For example; p in
Table 5.4 became; for observer A 10.2%; observer B 8.6%; visit 1 6.6%; visit
2 10.2%. This is not the correct usage of this parametric test and so we have







































































































































































































































































• There were no significant differences in intra-observer measurement ofany of the
variables.
• There were no significant and consistent differences in inter-observer
measurement ofany of the variables (diastolic BP differed at visit 2 but not visit 1
and Dmax at visit 1 but not 2), the Bland -Altman plots reflect these findings.
• Intra- and inter-observer CVME for directly measured variables were low (<10%)
while CVME for the derived variables were higher (<21% for observer A, study
1).
• The CVME is a parametric test. However, when these skewed data were
logarithmically transformed to normality, intra-observer CVME for p was 10.2%
and 8.6% for observers A and B respectively.
5.6 Discussion
There were no statistically significant differences in intra-observer measurement of
any of the distensibility variables. Significant inter-observer differences were only
found in DBP at visit 2 and Dmax at visit 1. Intra- and inter-observer CVME for
directly measured variables were low (<10%) while CVME for the derived variables
were higher (<21% for observer A in study 1 but up to 35% in study 2).
Variability of the Diamove echo-tracking device has not previously been reported in
patients with AAA. However, present data were comparable with those obtained in a
previous methodological study (Hansen et al 1993) using healthy subjects with
normal aortas (Table 5.5). A third study also investigated aortic distensibility in 4
young (age <35 years), non-aneurysmal subjects (Lanne et al 1992) and reported on 4
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distensibility measurements from each subject during one visit. These authors (Lanne
et al 1992) expressed their methodological error for Ep and (3 in terms of SD. SD was
not appropriate for the analysis of this group ofAAA subjects because distensibility
measurements were not normally distributed and were highly variable. Lanne et aT s
(1992) results were, therefore, less comparable with the present findings than those of
Hansen et al (1993). The present study was also unique in that measurements were
taken in two distinct sessions up to 2 weeks apart.
Blood pressure and maximum aortic diameter were the two variables directly
measured by the observers and, therefore, the only variables that were prone to
observer bias. The low CVME for these variables indicated that this echo-tracking
equipment could be reliably used in the follow-up ofAAA maximal diameter. There
may, however, have been some random error in the values calculated for Ep and p
because these are derived values and were not directly measured. The use ofbrachial
artery pressure rather than central aortic pressure is likely to have biased calculation
ofEp and p and this will be discussed in Chapter 6. However, the error will have been
systematic, affecting all patients approximately equally. Invasive measurement of
aortic pressure is not practicable for routine distensibility follow-up. Most previous
studies using Doppler phase-locked loop echo-tracking have assumed that brachial
blood pressure is consistently related to aortic pressure (Hayashi 1980, Hansen et al
1993, Lehmann et al 1993, Lanne et al 1992).
The high CVME ofboth Ep and p must be viewed in the context of the wide range of
distensibility observed in this particular study group (Table 5.1). For example, Ep
varied by a factor of 12.75 (0.74 to 9.44 105Nm"2) and P varied by a factor of 12.0
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(5.6 to 66.8 a.u.). It should also be noted that, with the exception of blood pressure,
the variables measured were all skewed to the right. Because there is no non-
parametric equivalent of the CVME, the effect of this skewness on the values of
CVME cannot be ascertained. However, if a logarithmic transformation had been
applied to the data before the CVME was calculated, the resultant CVME would have
been substantially reduced. For example, the non-transformed CVME for observer A's
intra-observer stiffness was 32% and for observer B, 25.6%. After transformation
these CVME were 10.2% and 8.6% respectively. Using the CVME calculated from
transformed data does not allow direct comparison ofvariability with previous
studies. However, it does suggest that the Bland and Altman (1986) test for CVME is
not applicable to skewed data. More importantly for this study, it also suggests that
the high level of variation was in fact due to the large variation ofEp and P within the
study population rather than due to the technique. The diameter and distensibility
variations, which were observed between visits in study 2, may also have reflected a
certain degree of real variation in AAA wall distensibility over time.
When the raw data were examined, there were two particular subjects in whom
markedly different diameters were measured. These patients were difficult to scan
because ofobesity and cardiorespiratory disease. These subjects were not removed
from the study because it would have biased assessment of reproducibility.
Nevertheless, approximately 10% of subjects could not be satisfactorily scanned
because of the factors mentioned above. Excluding such patients would have
increased the apparent reproducibility of the technique.
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The longitudinal view of the AAA allowed a true anteroposterior measurement to be
made perpendicular to the long axis of the aneurysm. Three distensibility
measurements were made at each examination. Each was slightly different due to
slightly differing blood pressure and due to the cursors inevitably locking onto
different layers of the wall. Slight changes in the angle of the probe may also have
increased the variability of diameter change but this was not investigated specifically
in this study.
The echo-tracking technique involves placing the cursors onto the echoes of the
anterior and posterior walls while the vessel wall is moving with each cardiac cycle.
Tracking of the same points within the wall structure is difficult because the quality of
the B-mode imaging does not allow easy differentiation between thrombus,
calcification, intima and media. It is likely that improvement in the image quality and
echo-tracking technology will reduce the effect of these factors on reproducibility.
The learning curve associated with echo-tracking distensibility measurement was
steep for observer A who had no previous experience of ultrasonic scanning.
However, intensive training by radiology staff in the recognition of abdominal
structures and variations in AAA wall morphology meant that the curve levelled off
after about three months. At this point the observer A's measurements were within
2mm of those reported by the ultrasound department. Observer B was subsequently
taught the technique by observer A. This may have introduced some systematic bias
into the study, although observer B had previous experience scanning AAA so
reducing the learning curve considerably. At the time of the study, observer A had
two years ofexperience with the equipment while observer B had three months
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experience. It was not possible to provide a longer training period. This may also have
contributed to the intra-observer CVME (Table 5.4).
There are many factors that might influence AAA distensibility, for example blood
pressure, AAA geometry and thrombus content. As such, it is perhaps unsurprising
that the CVME were high. However, the following selection criteria can be used to
minimise variability:- 1) the maximum diameter measurements should be within 2mm
of the estimated value, or 5% if the aneurysm is less than 4 cm wide; 2) at least three
consecutive cardiac cycles producing uniform waves should be selected for analysis
and; 3) obvious arrhythmias should be excluded. It is recommended that both intra-
and inter-observer variability should be measured, albeit in a small number of
subjects, in any study ofdistensibility. Variability should be reassessed regularly.
5.7 Conclusions
These results suggest that the Diamove echo-tracking technique is a reliable method
ofmeasuring AAA diameter (to within 2-3.5% of the 'true' value), and pulsatile
diameter change enabling calculation ofEp and p. The clinical utility of these
variables will be investigated in rest of this thesis.
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Chapter 6. Use of derived central pressure in the
measurement of aortic distensibilitv
6.1 Introduction
Poiseuille's law states that blood flow is directly proportional to the difference
between inflow (aortic) and outflow (peripheral) pressures (Berne and Levy, 1998).
Systolic pressure increases along the arterial tree from the aorta to the peripheral
arteries by 10-35 mmHg (Kroeker and Wood 1955, Rowell et al 1968, Pauca et al
1992) due to wave reflections and differences in vessel stiffness. In contrast, diastolic
pressure and mean arterial pressure (MAP) fall by approximately 2mmHg (Kroeker
and Wood 1955, Rowell et al 1968, Pauca et al 1992), thus providing the pressure
gradient for forward flow ofblood. The net result is an increase in pulse pressure
towards the periphery. Use ofbrachial pressure as opposed to intra-AAA pressure
may alter the value obtained for distensibility by the Diamove system. Intra-aortic
pressure cannot be measured non-invasively and so a non-invasive technique for
deriving central pressure has been used to examine the effect of using brachial
pressure.
6.2 Aims
The aim of this study, therefore, was to compare AAA distensibility (Ep and P)




Central blood pressure may be estimated by means of pulse wave analysis (PWA,
Sphygmocor, SCOR; PWV Medical, Sydney, Australia) (O'Rourke and Gallagher
1996). Briefly, PWA uses a generalised transfer function (GTF) to convert a peripheral
arterial pressure waveform into a central (ascending aortic) arterial pressure waveform
and to calculate the augmentation index. Peripheral waveforms are recorded with high
fidelity by applanation tonometry. When the opposing external curved surfaces of a
vessel are flattened (applanated) by a tonometer until parallel, the contact pressure
between the two equals the intra-arterial pressure (Chapter 2, Figure 2.10). The
validation of sphygmocor will be discussed in more detail in Section 6.6.
An oscillometry pressure monitor (model 711, Omron Healthcare GmbH, Hamburg)
was used to measure right brachial pressure, and the Diamove to measure aortic Ep
and P, in 28 subjects (18 male, 10 female). PWA (SphygmoCor) was measured in the
right radial artery using a high fidelity micromanometer (SPC-301, Millar Instruments,
Texas, USA) (Wilkinson et al 1998a). After 20 sequential waveforms were collected,
an averaged peripheral and corresponding central waveform was generated (O'Rourke
1995).
The software calculates two parameters of the waves' variability, allowing the
observer to accept the waveform according to pre-stated levels of acceptable
variability; namely, wave amplitude >100 mV and the standard deviation of systolic
and diastolic peak <5%. The reproducibility of the SphygmoCor technique in pulse
wave analysis and the measurement of central pressure has been evaluated previously
(Wilkinson et al 1998a). Wilkinson et al (1998a) concluded that applanation
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tonometry using the radial artery produced clinically reproducible results and was, in
fact, more reproducible than some automated sphygmomanometers.
Distensibility, calculated as described in Chapter 2 using derived central pressure, is
referred to as Epc and pc. Distensibility calculated using brachial pressure is referred to
as Epb and pb. Statistical analysis was carried out using SPSS 8.0 (SPSS 8.0 1998).
Bland and Altman plots were used to measure the level of agreement between the two
methods ofblood pressure measurement because neither method is the gold standard
for aortic pressure measurement.
6.4 Results
The mean (range) age of the subjects was 74 (63-84) years and the median
[interquartile range (IQR)] AP diameter was 44 (40-51) mm. The median (IQR)
brachial pressures were systolic 144 (130-164) mmHg, diastolic 76 (71-86) mmHg.
The median (IQR) central pressures were systolic 140 (121-153) mmHg, diastolic 76
(72-86) mmHg. The amplification ratio (peripheral PP: central PP) was 1.1.
Derived central systolic pressure, pulse pressure and MAP were significantly lower
than the brachial equivalents (Table 6.1). There was no difference with regard to
diastolic pressure. The Wilcoxon signed rank test showed that median Ep and p were
significantly lower (p <0.01) when using central pressure rather than brachial













































































































*Wilcoxon signed rank test
Bland and Altman plots comparing the agreement between the two methods are
shown in Figures (6.2-5).
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Figure 6.2. Bland-Altman plot for repeated measures ofdiastolic pressure using




































Figure 6.3. Bland-Altman plot for repeated measures of systolic pressure using












































Figure 6.4. Bland-Altman plot for repeated measures ofpressure-strain elastic
















Figure 6.5. Bland-Altman plot for repeated measures of stiffness using brachial








In order to examine whether the difference in distensibility derived from central and
brachial pressures was confounded by age or AAA diameter, predicted log values for
central and brachial-derived distensibility adjusted for age and diameter were
calculated and compared. The differences between distensibility calculated using
brachial and derived central pressures remained significant (Wilcoxon signed rank
test, both p< 0.001). Median (IQR) Epb predicted from brachial pressure was 1.22
(1.08-1.45) 105Nm"2, and Epc predicted from central pressure was 1.11 (0.94-1.35)
105Nmf2. Similarly, pb predicted from brachial pressure was 3.18 (3.05-3.37), and pc
predicted from central pressure was 3.07 (2.94-3.32).
6.5 Summary
Use ofbrachial pressure as opposed to central aortic pressure significantly and
systematically overestimated Ep by 13% and p by 12% (based on the assumption that
Sphygmocor PWA accurately calculates central pressure). The systematic nature of
this error suggests that this overestimate is independent of the magnitude ofblood
pressure.
6.6 Discussion
This study compares the use ofnon-invasive brachial artery pressure and non¬
invasive, derived aortic pressure in the measurement ofAAA distensibility. Previous
work comparing invasive intra-aortic pressure and non-invasive brachial pressure in
the assessment of aortic distensibility suggested that using peripheral blood pressure
to calculate distensibility underestimates Ep and p by 25-30% (Imura et al 1986,
Sonesson et al 1994). These studies were performed on young volunteers with normal
aortas. The situation with regard to older patients with AAA might be expected to be
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different because of reduced pressure amplification between the aorta and the brachial
artery in the elderly.
Imura et al (1986), who compared invasive intra-aortic and non-invasive brachial
artery pressures, found that brachial systolic and diastolic pressures were higher, and
that brachial pulse pressure was lower, than in the aorta. Sonnesson et al (1994) also
compared invasive arterial pressure at the point of diameter measurement with
brachial sphygmomanometry pressure. However, these authors found brachial
systolic pressure to be the same or lower than in the aorta, brachial diastolic pressure
higher, and consequently brachial pulse pressure lower than in the aorta. Not only are
these findings difficult to explain physiologically, but they are also in contrast to the
majority of other data as described above and below (Kroeker and Wood 1955,
Rowell et al 1968, Pauca et al 1992). The most likely explanation may be that,
because the authors compared invasive aortic pressure measurement with
sphygmomanometrically determined brachial artery pressure, the error was dependent
on the method, rather than the site, ofmeasurement. Indeed, the inaccuracy of
sphygmomanometric blood pressure measurements has been previously reported
(Watson et al 1998).
As the pressure wave travels through the arterial tree from the large, elastic arteries to
the smaller, muscular vessels, the speed and amplitude of the wave increases because
of decreasing vessel distensibility. The pressure contour also becomes distorted: the
systolic portion is narrowed and elevated; the incisura is damped and eventually
disappears; a hump appears in its place in the diastolic portion. This damping of the
high frequency components of the pressure wave is attributed to the viscoelastic
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properties of the arterial wall. Reflection, vascular tapering and transmission velocity
enhance the peaking of the pressure wave. The result is that in the young there is a
pronounced difference in central and peripheral pressures, with systolic pressure
increasing distally whilst diastolic pressure remains essentially unchanged (Berne and
Levy 1998) (Figure 6.6).
Figure 6.6. Central arterial waveform (lower panel) and peripheral waveform (upper




Ageing of the arterial tree reduces vessel distensibility (increases stiffness) and
markedly reduces the difference between central and peripheral systolic pressure
while increasing pulse pressure, especially in the aorta. This is because stiffer arteries
transmit the pressure wave at a higher velocity i.e. pulse wave velocity is increased.
The result is that a larger than normal reflected pressure wave returns to the heart
earlier, augmenting late systolic peak pressure (Kroeker and Wood 1955). Thus, while
age increases aortic systolic pressure, peripheral systolic pressure is much less
affected, so the gradient between central and peripheral systolic pressure is reduced
Pauca et al (1992). Pauca et al (1992) examined a group of subjects aged 48-77
(median 61) years and found the difference between radial systolic pressure and
ascending aortic systolic pressure to be an increase of 12 mmHg, diastolic decreased
by 1 mmHg. In the present study, the median brachial-central pressure difference was
7 mmHg for systolic pressure and there was no significant difference in diastolic
pressure. The lower difference in systolic pressure and the amplification ratio
(peripheral pulse pressure: central pulse pressure) of 1.1 reflects the older age ofour
study population (68-84, median 74 years).
Abdominal aortic pressure remains difficult to measure non-invasively at present. The
PWA derived ascending aortic pressure is the closest approximation available and may
be considerably closer than brachial artery pressure. However, validation of
Sphygmocor is currently being debated. Validation of the use of a GTF has been
carried out by previous workers using similar, but not the same, technology
(Karamanoglu et al 1993, Chen et al 1996, Chen et al 1997, Fetics et al 1999).
Karamanolglu et al (1993) and Fetics et al (1999) used the same GTF as that used by
Sphygmocor, while Chen et al (1996) and (1997) used a different GTF. These studies
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compared invasive ascending aortic pressures with radial tonometric pressures and
showed that when a GTF was applied to radial pressures the reconstructed central
pressure waveform was clinically accurate for systolic and pulse pressures. Although
work carried out by the developers and published as an abstract suggested that
'...ascending aortic augmentation [could] be determined to a reasonable approximation
from the radial artery pulse using a generalised transfer function' (O'Rourke et al
1995), validation of the Sphygmocor system has not yet been independently carried out
and published. O'Rourke et al (1995) did not publish a clear description of the method
used.
In spite of this, several independent studies have now been carried out assessing the
reproducibility of the Sphygmocor device and using it (and its GTF) as a 'validated'
blood pressure measurement tool (Wilkinson et al 1998a, Seibenhofer et al 1999,
Brown 1999, Covic et al 2000, Segers et al 2000, Segers et al 2001). The general
consensus would appear to be that although individualised transfer functions may
provide more accurate derived central pressure wave contours, a GTF is adequate. In
response to these publications, one author has raised concerns regarding the paucity of
published evidence of the validity of the Sphygmocor device and the GTF it uses to
derive aortic arch pressure from radial pressure (Lehmann ED 2000, Lehmann ED
2001a, Lehmann ED 2001b, Lehmann ED 2001c).
It is beyond the scope of this thesis to investigate the validity of the Sphygmocor PWA
device but the concerns raised by Lehemann (2000, 2001a,b,c) should be
acknowledged. The aim of this chapter was to investigate the error caused by use of
non-invasive brachial pressure instead of invasive intra-AAA pressure in the
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calculation ofEp and p. Invasive intra-AAA pressure measurement was, however, not
an option and the only non-invasive method of aortic pressure measurement available
to this author at the time of study was the Sphygmocor PWA device.
The principal finding of the study, based on the assumption that Sphygmocor PWA
accurately calculates central pressure, was that use ofbrachial pressure as opposed to
central aortic pressure may have significantly increased Ep by 13% and P by 12%.
The error was a systematic overestimate ofEp and P and as such will not affect
comparisons between subjects or over time. The systematic nature of these findings
suggests that this overestimate is independent of the magnitude ofblood pressure and
therefore applies to all subjects of comparable ages regardless of the presence of
hyper- or hypotension. The importance of these findings is that this non-invasive
method of aortic wall distensibility measurement (Diamove) can be used successfully
in the clinical setting in conjunction with brachial sphygmomanometry.
Previous findings of this group (Wilson et al 1998, Wilson et al 2001) suggest that
routine follow-up ofdistensibility and diameter could provide a greater understanding
ofAAA wall degeneration than diameter alone. If this is the case then the systematic
nature of the error should not bias the measurements because it is likely to be the
change in the measurements over time that provides the important information and
not the absolute values. However, a study comparing distensibility calculated using
invasive aortic pressure at the site of the AAA with that using derived central
pressures and with non-invasive brachial pressures may provide more accurate data.
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6.7 Conclusions
The overestimate ofEp and p is viewed to be small and therefore acceptable
clinically. The linearity of the relationship between central and peripherally derived
distensibility shows that the error is a systematic overestimate. However, since the
discrepancy between central and peripheral systolic pressure (i.e. pressure
amplification) is age-dependent, greater differences between Epb/pb and Epc/pc may
occur in younger individuals, and care must be exercised when comparing measures
ofdistensibility based on peripheral blood pressure measurements between age
groups. The validity of the Sphygmocor may require more rigorous study.
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Chapter 7. Follow-up and endpoints of interest of the study
population
7.1 Introduction
This chapter describes patient follow-up and the outcome events leading to the
cessation of follow-up. Further details of the numbers ofpatients in each part of the
analysis are given in Appendix III.
7.2 Study population
The collection of compliance data is shown in Figure 7.1. Data could not be collected
on 6 patients; three due to obesity and shortness of breath, and three due to cardiac
arrhythmia (see Chapter 4). The first data set was collected at baseline in 193 patients;
in another 17 patients, the first data set set was collected at a later visit, thus the total
number of patients with usable data collected at baseline or at any subsequent visit
was 210 (Appendix III).
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Figure 7.1. Data collection in the study population as a whole.
216 subjects
Compliance measurements achieved No compliance measurements
210 (97%) achieved 6 (3%)
Male 163 (78%) Female 47 (22%)
Baseline Follow-up Baseline Follow-up
152(93%) 11(7%) 41(87%) 6(13%)
Baseline - data were successfully collected at baseline appointment n = 193
Follow-up - data were successfully collected at a subsequent follow-up appointment n = 17
7.3 Length of follow-up
For logistical reasons, as the number ofpatients in the study grew, the follow-up
interval was reduced from three to six months. At the end of the study, 164 (76%) of
the study population had at least two compliance data sets, 102 (47%) at least four,
and 71 (33%) had at least five (Figure 7.3).
Figure 7.3: Length of follow-up ofpatients on whom usable waves were achieved at
any time.
210 patients with measured data
at baseline or subsequently
One data-set only 6 months 12 months 18 months
(no follow-up) follow-up follow-up follow-up
46(22%) 140(67%) 114(54%) 87(41%)
>





Follow-up was discontinued when the AAA ruptured or was repaired, when the
patient died, could no longer produce compliance data, or no longer wished to attend.
Cause ofdeath was collected by means ofhospital records and Central Registry
notification.
Death ended follow-up for 49 patients during the study. 28 patients suffered ruptured
AAA, ofwhom 24 died (Table 7.1, Figures 7.4 and 5). During the study, AAA in 17
(10%) male patients ruptured compared with 11 (23%) in the female patients (Figure
7.6). Although there were more females than males in the rupture group (x2 p<0.04)
there were more males than females in the asymptomatic elective group (x2 p<0.03).
The proportions ofmales and females in the intact AAA and symptomatic groups
were not significantly different (Figures 7.7 and 7.8). It should be noted that the AAA
that had not been operated on and had not ruptured by the end of the study have been
described throughout as 'intact AAA'.
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Figure 7.4: Flow chart of age, sex and outcome measures in 210 subjects who
































Table 7.1: Numbers ofpatients for whom follow-up was discontinued and the reasons.
Reason Total F-up 1 F-up 2 F-up 3 F-up 4 F-up 5+
Deceased 49 9 9 13 7 11
Surgery 66 20 11 11 10 14
Refusal 5 1 1 2 0 1
No waves 3 0 0 2 0 1
Unfit 12 0 5 1 3 3
End of 74 0 1 5 16 52
study
Unknown 1 0 0 0 0 1











































































• 216 subjects were recruited, ofwhich 210 produced usable data.
• 193 (89%) produced usable data at baseline and a further 17 (8%) produced usable
data at subsequent follow-up appointments.
• Failure to produce usable data was due to obesity, cardio-respiratory disease and
arrhythmia; it was unrelated to gender.
• Ofthose who produced usable data, 54% were followed for 12 months and 36%
of subjects were followed for more than 18 months.
• 63% ofAAA ruptures occurred in males.
• AAA rupture occurred in a significantly higher proportion of females than males
(23% and 10% respectively).
7.6 Conclusions
In approximately 3% of subjects, distensibility measurement may not be possible.
Females in this study population were more likely to suffer ruptured AAA.
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Chapter 8. Baseline statistics
8.1 Introduction
This chapter describes the baseline demographics and variables. Further details of the
numbers ofpatients in each part of the analysis are given in Appendix III.
8.2. Baseline data
8.2.1 Clinical data
Baseline variables (Table 8.1), with the exception of age, were skewed and so non-
parametric statistical methods have been used. Baseline blood pressure was obtained
in 194 patients and baseline diameter and distensibility data in 193 (Chapter 7 and
Appendix III).
Table 8. 1: Median and interquartile range (IQR) of the variables measured on 193
subjects (152 males: 41 females) who produced usable data at baseline.
Variable Median (IQR) Data points
Age (years) 72 (68-77) 210
DBP (mmHg) 80 (72-90) 194
SBP (mmHg) 140 (130-160) 194
PP (mmHg) 60 (50-75) 194
MAP (mmHg) 102 (93-111) 194
Dmax (mm) 47.9 (41.0-53.7) 193
Ep (105Nm"2) 2.91 (1.99-4.37) 193
P (a.u.) 19.4 (14.4-29.4) 193
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8.2 Univariate analyses of baseline data
8.2.1 Correlations between variables at baseline













































































8.3 Univariate analysis of baseline data by gender
8.3.1 Comparison of baseline data by gender
There was a trend towards increased AAA distensibility in women (Table 8.3).
Table 8.3. A comparison ofmedian (IQR) measurements in 152 males and 41







Age (years*) 73 (68-77) 72 (68-77) 0.94
DBP (mmHg*) 80 (74-90) 80 (60-122) 0.70
SBP (mmHg*) 140(102-210) 148 (100-212) 0.67
PP (mmHg*) 60(20-130) 64(18-112) 0.56
MAP (mmHg*) 103 (93-112) 102 (93-110) 0.89
Dmax (mm) 49 (42-54) 44 (40-54) 0.20
Ep (105Nm"2) 3.03 (2.08-4.55) 2.37(1.91-3.31) 0.07
P (a.u.) 20.7 (14.8-29.6) 17.0(12.7-24.6) 0.06
* 42 females had age and blood pressure data.
8.3.2 Relationships between baseline variables analysed by gender











































































































8.4 Univariate analysis of baseline data by outcome
8.4.1 Comparison of baseline data bv outcome
Some baseline variables and their interrelationships were related to outcome























































































































































































































































■ AAA diameter was significantly related to age, diastolic pressure, MAP and
distensibility at baseline in the group as a whole.
■ There were no significant gender-dependent differences in any of the variables
although distensibility tended toward being higher in females.
■ The relationships between the variables were different between the genders.
■ Age and diameter were both greater in the rupture group compared with the intact
AAA group.
8.6 Discussion
At baseline, there was a significant inverse relationship between distensibility and
diameter, and diameter increased with age. Although AAA diameters were similar in
males and females, AAA in females were more likely to rupture. AAA that ruptured
were larger, and found in older patients, at baseline. Larger AAA tended to be less
distensible. The relationships between distensibility and blood pressure were different
in the rupture and intact groups. The median (IQR) time between baseline data and the
outcomes of interest was 20 (9-30) months. In order to examine the relationships
between these variable closer to the time of rupture, the data collected closer to the
time of rupture have been analysed in the following chapter.
8.8 Conclusions
AAA in females ruptured more frequently than in males of the same age, blood
pressure and AAA diameter. The AAA that ruptured, or were more likely to rupture
(female AAA), exhibited different dynamic relations between diameter and
distensibility compared with AAA that remained intact. Baseline data may not
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accurately represent AAA dynamics at the time of rupture because of the time elapsed
between baseline and outcome.
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Chapter 9. Descriptive statistics for last follow-up data
9.1 Introduction
210 patients produced usable data prior to an outcome of interest (see Appendix III).
The median (IQR) time difference between baseline data and the outcome of interest
was 20 (9-30) months. Baseline data may not reflect wall structure and distensibility
immediately prior to AAA rupture, so data measured at the last follow-up prior to the
outcome event have been analysed in the same way.
9.2 Data collected at last follow-up
9.2.1 Descriptive statistics of last follow-up data
The median (IQR) time difference between last data collection and outcome for the
rupture group was 102 (62-268) days [3.5 (2-9) months], for the asymptomatic AAA
repair group it was 51 (13-90) days or 2 (0.4-3) months, and for the symptomatic repair
group it was 116 (78-265) days or 3.9 (2.6-8.8) months. In patients undergoing elective
repair the arranged admission allowed final measurement a few days before the
operation in many cases. The Wilcoxon signed rank test was used to compare baseline
and last follow-up data (BP, Dmax, Ep, P) on the 154 subjects who had both data sets.
Compared to the baseline data, SBP, PP and MAP were not significantly different
(p=0.53, p=0.47, p=0.11 respectively). However, DBP (p=0.04), Dmax, Ep and p had
each increased significantly (Figures 9.1-3).
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DBP (mmHg) 82 (74-90)
SBP (mmHg) 145 (130-161)
PP (mmHg) 61 (48-77)
MAP (mmHg) 103 (94-113)
Dmax (mm) 51.5 (45-59)
Ep (105Nm"2) 3.4 (2.3-4.7)
P (a.u.) 22.2 (15.9-30.6)
Figure 9.1 Comparison of median (IQR) of diameter at baseline and last follow-up in










Bars represent the median and the IQR of diameter. Wilcoxon signed rank test on paired data sets.
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Figure 9.2. Comparison ofmedian (IQR) of Ep at baseline and last follow-up on 154









Bars represent the median and the IQR of Ep. Wilcoxon signed rank test on paired data sets.
Figure 9.3. Comparison of median (IQR) of p at baseline and last follow-up on 154









Bars represent the median and the IQR of p. Wilcoxon signed rank test on paired data sets.
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9.2.2 Correlations between variables at last follow-up
At last follow-up Ep and P were not related to maximum diameter in the group as a
whole. This is in contrast to the significant correlations found between these variables























































































9.3 Last follow-up data analysed by gender
9.3.1 Differences in last follow-up data by gender
There were no statistically significant differences between male and female subjects
with regard to any of the variables at last follow-up. However, there was a trend
toward female patients having more distensible AAA.
9.3.2 Relationships between the variables within each gender
In male patients at last follow-up, maximal AAA diameter was no longer
significantly correlated with Ep or (3. There remained no significant relationship
between diameter and Ep or (3 at last follow-up in females.
9.4 Last follow-up data by outcome
9.4.1 Last follow-up data by outcome
At last follow-up, median age was higher in the rupture group (78 years vs 75
years). There were significant differences in diastolic pressure and diameter
(Figures 9.4 to 9.7), but not in Ep or p, between the outcome categories.
9.4.2 Last follow-up data by outcome and gender
In males, diastolic pressure and maximum diameter remained significantly higher
in the rupture group (Table 9.4 and Figure 9.8). In females, diameter was the only
variable that was significantly different between the outcome groups; the rupture
group had larger AAA diameter than the intact AAA group (Table 9.4 and Figure
9.8). Ep and P were not significantly different between the outcome groups for
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either males or females. This is reflected in the 10-fold difference in the median of
both variables (Table 9.4).
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Figure 9.4. Differences in median (IQR and range) diastolic blood pressure








118 54 10 28
Intact AAA Symptomatic surgery
Asymptomatic surgery Rupture
Box plots represent the median and IQR; whiskers represent the range
Outcome
Figure 9.5. Differences in last follow-up diastolic blood pressure between intact







Mann Whitney U test
p<0.008
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Intact AAA Ruptured AAA
Box plots represent the median and IQR; whiskers represent the range
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Figure 9.6. Differences in median (IQR and range) maximal aortic diameter













54 10N = 118
Intact AAA Symptomatic surgery
OutCOmC Asymptomatic surgery Rupture
Box plots represent the median and IQR; whiskers represent the range
Figure 9.7. Differences in last follow-up maximal diameter between intact AAA













Mann Whitney U test
o<0.001
Intact AAA Ruptured AAA
Box plots represent the median and IQR; whiskers represent the range
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Table 9.4. Median (IQR) diastolic pressure and maximum diameter at last follow-
up for 163 males and 47 females by outcome groups.
Rupture Elective Elective Intact Kruskal-
symptomatic asymptomatic Wallis, p
Males (n) 17 8 48 90
DBP 89 72 84 80 0.012
(mmHg) (52-110) (60-120) (60-109) 59-106)
Dmax 59 48 56 48 0.0001
(mm) (42-114) (42-58) (47-102) (30-80)
Ep (105Nm"2) 3.53 2.92 3.28 3.52 0.481
(2.45-5.31) (1.48-3.93) (2.53-4.98) (2.27-4.70)
p (a.u.) 23.2 20.0 22.1 22.9 0.618
(15.9-39.5) (11.6-24.6) (16.3-32.5) (15.9-31.8)
Females (n) 11 2 6 28
DBP 88 76 86 82 0.490
(mmHg) (67-120) (75-78) (68-92) (53-116)
Dmax 57 57 51 47 0.054
(mm) (40-79) (52-62) (46-70) (33-72)
Ep (105NnT2) 2.75 4.34 2.88 3.16 0.352
(1.66-4.24) (3.94-4.73) (1.67-4.07) (2.51-4.2)
p (a.u.) 18.6 30.3 19.8 21.3 0.139































































■ Diameter, Ep and (3 had increased significantly.
■ Diameter was no longer correlated with Ep or (3.
■ The correlation between diameter and distensibility in males at baseline was no
longer evident.
■ The rupture group were older, had higher diastolic blood pressure and had larger
AAA diameter than the intact group.
■ There were no significant differences in distensibility between the outcome
groups.
9.6 Discussion
The average time between last follow-up and the outcome event was 3 months but this
ranged from 2 days to 3 years. This may still have been too long to observe any
changes in blood pressure, diameter or distensibility occurring immediately prior to
rupture. In male patients at last follow-up, Ep and p were no longer related to diameter.
This suggests that AAA progression may be associated with a change in the
relationship between diameter and distensibility. In female patients, there was no such
relationship either at baseline or last follow-up. This may reflect a difference in the
structure ofAAA in females. In other words, AAA in females may be more advanced
in terms ofwall degradation than AAA of similar diameter in males. This may also
explain their increased propensity to rupture. Although the correlations between
variables differed between the sexes, when the absolute values for each of the variables
were compared there were no differences between the genders.
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Diastolic pressure remained significantly higher in the rupture group compared with
the intact AAA group while systolic, PP and MAP were not significantly different.
This suggests that diastolic pressure may be an important determinant of the risk of
rupture. The details of this relationship may become clearer in Chapter 11 (Cox
analysis).
Finally, in order to fully investigate any differences between males and females whose
AAA ruptured, last follow-up data were divided by outcome and gender. The picture
remained the same in the group as a whole in that diameter and diastolic pressure were
higher in the rupture group than in the intact group in males and females. However,
diastolic pressure was not significantly different in the female ruptured AAA group,
possibly because of small numbers. Distensibility was not significantly different
between the outcome groups in either sex. This may suggest that the absolute value of
Ep or p is not as indicative of risk of rupture as the relationship between diameter and
distensibility or between relative change in Ep and p and rupture. These relationships
will be investigated in Chapter 10.
9.7 Conclusions
There was no relationship between diameter and distensibility and no difference in
distensibility between the outcome groups at last follow-up. The lack of relationship
between diameter and distensibility in females, coupled with the evidence that females
appear to suffer AAA rupture more frequently than men, suggests that diameter alone
may not reflect the dynamics ofadvanced (structurally closer to rupture) AAA. The
absolute value ofdistensibility is perhaps not as indicative of risk of rupture as the
relationship between diameter and distensibility.
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Chapter 10: The relationship between outcome and changes
a ' * i CT
in AAA distensibilitv, diameter and blood pressure
10.1 Introduction
This chapter describes change in the measured variables between baseline and last
follow-up, and penultimate and last follow-up in relation to outcome and gender.
Further details of the numbers ofpatients in each part of the analysis are given in
Appendix III.
10.2 Change in variables from baseline to last follow-up by outcome
There were no relationships between outcome and change in SBP, Dmax or
distensibility. There was a significant difference in median change in DBP between the
outcome groups (Table 10.1).
10.3 Change in variables from penultimate to last follow-up
10.3.1 Change in variables from penultimate to last follow-up by outcome
To take account of the fact that the greatest change in diameter and distensibility may
take place immediately prior to rupture, the differences between the penultimate and
the last follow-up were examined. 163 subjects provided penultimate and last follow-
up data. The median (IQR) time interval between the penultimate and the last follow-
up was not statistically different (Mann Whitney p=0.55) between the rupture group
[5.5 (2.7-17.3) months] and the intact AAA group [6.1 (2.6-27.8) months]. Change in
variable per month was calculated, as the time intervals between the outcome groups
were approximately the same. Rate of change in diameter and distensibility between






















































































































































































































































































































































































10.3.2 Change in variables from penultimate to last follow-up by gender
There were no significant differences in the rate of change per month in any of the
variables between males and females (Table 10.3).
10.3.3 Relationships between rate of change in diameter and distensibilitv
In order to investigate the hypothesis that diameter and distensibility may change at
differing rates during AAA progression, the changes in these variables were correlated.
There were no statistically significant relationships between rate of change in diameter
and rate of change in distensibility in intact or ruptured AAA (Tablel0.4). There was a
tendency for larger aneurysms to expand more rapidly but this did not attain statistical
significance (Table 10.5). Rate of change in Ep and p did not appear related to
aneurysm diameter.
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Table 10.3. Median (IQR) rate of change in variables per month from penultimate to







































*n= 42 for BP variables
Table 10.4. Correlation between rate of change in diameter and rate of change in
distensibility in the intact and ruptured AAA groups.
Intact AAA Ruptured AAA
Change in Ep Change in p Change in Ep Change in p
(105Nmf2/month) (a.u./month) (105Nm"2/month) (a.u./month)
Change in Dmax r=0.17 r=0.19 r=0.22 r=0.09
(mm/month) p=0.09 p=0.06 p=0.35 p=0.70
Spearman's rank correlation
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Table 10.5. Median (IQR) rate of change in diameter and distensibility per month










30.0-44.8 54 1.85 0.20 0.85
(0.0-4.0) (-0.96-1.12) (-4.7-6.0)
44.9-53.6 55 1.1 -0.22 -0.8
(0.0-2.8) (-1.1-1.0) (-9.9 - 5.2)
53.7-109.9 54 2.1 0.32 1.4
(0.1 -4.3) (-0.6-1.7) (-6.5 - 8.4)
p (Kruskal-Wallis) 0.37 0.43 0.51
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10.4 Summary
Between penultimate and last follow-up:
■ DBP increased at a higher rate in the rupture group than in the intact AAA group.
■ The rate of change in SBP, Dmax and distensibility was not significantly different
between the outcome groups.
■ The rate of change in DBP and SBP, Dmax and distensibility was not significantly
different between males and females.
■ The rate and direction of change in distensibility was not related to Dmax or
expansion.
10.5 Discussion
There was no difference between aneurysms that ruptured and those that remained
intact with respect to change in diameter and distensibility. AAA in females did not
differ from males in terms of change in diameter or distensibility, despite their higher
relative risk of rupture. This lack of positive findings may have been due to the time
interval from the last follow-up to the outcome event being too long to capture the
changes leading to rupture. Although the change in each variable has been calculated
per unit of time (month), the data cannot show whether the rate of change was
consistent throughout the six-month period. It may be the case that those whose AAA
ruptured had an increased rate of change in diameter and an altered rate of change in
distensibility during only the very last part of this time period, for example, in the last
week. If this were the case, a six-month follow-up interval may not be sensitive enough
to detect anything less than the most marked changes in diameter and distensibility.
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Patients with raptured AAA had a significantly greater increase in DBP per month
compared to those whose AAA remained intact. However, BP changes from minute to
minute and while this analysis aimed to look at change over time it was not possible to
determine whether BP was increasing consistently during this time period or had
simply increased at the time of the last follow-up visit. The change in diastolic pressure
over the 6-month interval between the follow-up visits was 4mmHg in the rapture
group and 1 mmHg in the intact group. This magnitude ofdifference in the rupture
group may not reflect a real difference since the variability ofBP measurement in this
study was 5%. This equates to a difference of about 4mmHg for DBP of 80mmHg.
Dmax appeared to change at approximately the same rate between diameter categories
while distensibility changed at the same rate but not in a consistent direction (Table
10.5). Whether distensibility changes rapidly in the immediate pre-rupture period
remains unanswered at this point in the analysis. It was not clinically practicable to
collect distensibility data more frequently, although what 'frequently enough' actually
is in terms of days or weeks remains unknown. Optimal follow-up may be more
frequent than every three months (outcome occurred, on average, three months after
last follow-up) but this may not be acceptable to patients nor financially viable. The
following stage of analysis attempted to answer the question of the effect of change in
distensibility on the likelihood of rupture.
10.6 Conclusions
There was no association between distensibility and diameter, outcome or gender.
Change in distensibility was not related to outcome. This may have been because the
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time period between last follow-up and the outcome was too long to have detected
rapid changes that may have occurred in distensibility immediately prior to rupture.
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Chapter 11 Multivariate time-dependent analysis
11.1 Introduction
The central hypothesis to be tested in this study was that AAA rupture might be
preceded by a detectable change in wall distensibility and that this might allow a
better prediction of rupture risk on an individual patient basis than AAA diameter
alone. A time-dependent, multivariate analysis model was therefore used (Cox
proportional hazard model, Chapter 4.6).
11.2 Aims
Since the univariate analyses showed few significant relationships between
distensibility and risk of rupture, it was possible that the absolute values ofEp and p
were less important than the relative change in either variable over time. To
investigate whether a measurable change in distensibility occurred prior to rupture,
the statistical model had to take account of changes in each variable over time,
including that between last follow-up and rupture.
11.3 Cox proportional hazard model - additional methodology
The Cox proportional hazard model was used to examine the relationships between the
measured variables (DBP, SBP, MAP, PP, Dmax, Ep and P), co-morbidity, drug and
smoking history, and rupture. Changes in each measured variable were created as
separate variables, calculated by the difference between each follow-up visit per
month, so the model accounted for time-dependent changes in the variables;
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log (variable at latest follow-up) - log (variable at previous follow-up)
days between previous and latest follow-up x 30days
11.3.1 Time-dependent estimation of data at outcome
Patient-specific risk estimation could not be derived directly from these data because
the variables could not be measured at the time of rupture. The variability ofAAA
distensibility was high; more specifically, distensibility did not change at the same
rate or in the same direction for any given patient or size ofAAA. This meant that
distensibility at the last follow-up was not necessarily representative of that at rupture
or other outcome. In addition, several patients only contributed one data set, which
prevented specific linear regressions being produced for them.
The Cox model, however, required an estimate of the change in the variables during
the final time period. Diameter and distensibility at the time ofoutcome event were
estimated from that measured at previous follow-up visits assuming a mean linear
change. 'Averaged' linear regression models for each variable were produced and
applied to the group as a whole using the following procedure. The log values ofeach
variable at two sequential follow-ups (for example, Figure 11.1) were plotted against
each other. Regression lines were plotted for each pair ofdata sets (e.g. baseline and
follow-up 1) up to follow-up 5 to show the linearity of the relationships between the
log values. Linear regression is the equation of the straight line (y = a + bx) that
describes how a dependent variable (y) changes in relation to an independent variable
(x). In this case, y = diameter at first follow-up, x = diameter at baseline follow-up, a
= the value of y when x=0, b = the change in y per unit change in x.
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Figure 11.1. Regression lines ofmaximum diameter between sets of current and
previous follow-up data (visits 1-5), and estimated regression lines between diameter




3.22 log ofprevious follow-up diameter (mm) 4.61
Red circle denotes the median points of the lines and shows their similarity at these
points
In order to maximise the number of subjects contributing valuable data, while at the
same time using the period closest to the outcome event, data from the median follow-
up visit were used. Thus, the regression equation predicting the third follow-up
variables from the second follow-up data was considered likely to be the most
representative of the potential change occurring in diameter, Ep or P between the last
follow-up and the outcome event. The use ofaveraged estimates may have diluted the
significance of the magnitude and rate of change in the variables in the rupture group.
However, actual measurement at the time of rupture was not possible.
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The regression equations for diameter, Ep and P were calculated by the statistical
analysis package and applied to the data at last follow-up producing an estimate of the
data at outcome as follows: (* represents 'multiplied by')
1. Diameter at event = exp (1.0001328*last f-up diameter + 0.000162*days between
last follow-up and event)
2. Ep at event = exp (0.860915*last Ep +0.000589*days)
2. P at event = exp (1.005944*last p - 0.00008028 l*days)
11.3.2 Selection of the variables in the Cox proportional hazard model
Independent variables are those that explain or determine the value of the dependent
variable, which in this case is time to rupture. The choice ofwhich independent
variables to test by the Cox proportional hazard model depends on a balance between
including variables that may be associated with rupture while avoiding too large a
number of variables, which would make interpretation extremely complex. Each
variable chosen was analysed by the regression process (described below) but the final
model included only those having a significant, independent effect on the dependent
variable.
There is no method ofvariable selection that is preferable to another, so two (step¬
wise regression and the 'goodness of fit') have been used to allow a comparison.
I. Stepwise regression involves repeatedly adding the most significant (or
significant is arbitrarily defined, in this case p<0.10) new variable to the existing
model and removing variables that are no longer significant (in this case p>0.05)
following the addition of the new variable. Simple linear regressions are carried
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out on each of the independent variables. The most significant variable equal to
or below the 10% level is chosen and kept as the first variable. Multiple
regression with two variables i.e. the selected variable and each of the other
variables, is carried out and the two-variable regression model accounting for the
lowest significance equal to or below the 10% level is selected. Variables that do
not reach significance at the 5% level once in the model are removed. The
process continues until all the variables have been tested and there are no more
significant new variables to add. The final model consists ofall of the significant,
independent variables.
II. The 'goodness of fit' method creates a regression model for every possible
variable combination and produces the 'goodness of fit' statistic for each model.
A list is produced of the 'best' model for each number of variables i.e. 'best'
two variable model, 'best' three variable model, etc. A score is allocated to each
variable combination. This score rises in increasing intervals with the number of
variables included until the optimum variable combination occurs; thereafter the
score increases by decreasing amounts. The variables producing the 'best' fit
are taken to be those at the point just before the difference between the statistics
becomes relatively smaller, thereby making it unnecessary to add another
variable to the model (Table 11.4).
All continuous variables considered for the model were treated as such. The natural
logarithms for all the variables, except age (which was normally distributed), were
used because the distributions of the variables were skewed. Logarithms could not be
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used for smoking data as some patients had never smoked and zero (pack-years) cannot
be log transformed. The square root ofpack-years was used instead.
11.3.3 Three models
Three models (A, B and C) were created; each was age and sex adjusted. The
variables considered for the models included a combination of the following; DBP,
SBP, MAP, PP, Dmax, Ep, (3, claudication, pack-years smoked, chest pain, leg pain,
angina score, MI, family history ofAAA, coronary artery bypass surgery, beta
blocker use. The specific variables used are detailed in the analysis of each model.
Model A analysed the measured variables and time to rupture using stepwise
regression while model B analysed measured variables, smoking, co-morbidity, drug
use and time to rupture using the same method. Due to the complexity of the inter¬
relationships between the variables chosen for model B, the 'goodness of fit' method
of final model selection, was carried out on the same variables (model C) to verify
whether the results were borne out. Unlike stepwise regression, which composed the
final model from the most significant variable at each step, the 'goodness of fit'
method included the non-significant variables (Table 11.4) in each model and gave
their significance levels.
11.3.4 Cox proportional hazard model output
Parameter estimate - In the linear regression equation y = a+bx, the parameter
estimate is the slope 'b' for each variable i.e. the value 'b' applied to the respective
variable 'x' to produce the regression equation.
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Hazard ratio - (HR) This is a measure of the risk of rupture in those with the
variable relative to those without the variable or with a different value for the
variable. The magnitude of the increased or reduced rupture risk is the proportion of
the hazard ratio above or below 1. For example, a HR of 1.5 equates to an increased
risk of rupture of 50% (i.e. 1.5 x the risk) for a stated change in the original scale of
ordinal variables or in comparison groups for categorical data. In this study the HR
relates to a 10% change on the original scale of the variable, as opposed to the log
scale:
Hazard ratio =1 - there is equal risk between the groups being compared.
Hazard ratio >1 - there is an increased risk of rupture (shorter time to rupture) in
those patients with the variable of interest.
Hazard ratio <1 - there is a decreased risk of rupture (longer time to rupture) in those
patients with the variable of interest.
Hazard function - this is closely related to the survival curve, representing the risk
of dying (in this case, AAA rupture) in a short time interval after a given time,
assuming survival thus far. The hazard function H(t) can therefore be interpreted as
the risk of rupture at time, t. Although a specific time period could not be attached to
t, as will be seen in the models' results, it was possible to interpret it as a shorter or
longer time period from the point of measurement to point of rupture. The Cox
method uses the hazard function as its dependent variable; in other words, time to
rupture was the dependent variable and the independent variables contributed to a
longer or shorter time to rupture.
Cox proportional hazard model is of the form:
h(t) = ho(t) x exp[biXi + b2X2 + ...+bpXp]
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Where ho(t) is the baseline or underlying hazard (when all variables are zero), bj are
the parameter estimates, and X; are the explanatory/ independent variables. The
cumulative hazard, H(t) can be obtained by adding up the hazard over time 0 to t, i.e.
sum of h(i) over i from i=0 to i=t. The probability of surviving up to time t, S(t) can
be estimated by exp[-H(t)].
11.4 Results of Cox proportional hazard model analyses
11.4.1 Model A
Variables considered for entry into the model (all time dependent)
Age Gender (male-1, female-2)
Log maximum diameter Log change in P/ month
Log Ep Log diastolic pressure
Log P Log systolic pressure
Log change in diameter/ month Log mean arterial pressure
Log change in Ep/ month Log pulse pressure
These variables were those at each follow-up period and the change in Dmax, Ep and
P between each follow-up.
Variables entering the final model A
After adjusting for age and sex, gender, Dmax, change in Ep and DBP achieved 5%
significance and were included in the final model (Table 11.1). None of the other
variables considered were significantly related to time to rupture.
152
11.4.2 Interpretation of model A
The increase in risk of rupture associated with female gender was 178% (HR 2.78) in
comparison to males, suggesting that AAA in females were almost three times as likely
to rupture as those in males of the same age, blood pressure, AAA diameter and change
in Ep at any point in time. A 10% increase in diameter equated to a 36% (HR 1.36)
increase in rupture risk at any point in time, when compared to no change in diameter.
A reduction in proportionate change in Ep of 10% resulted in a 38% (1/HR = 1.38)
increase in rupture risk in comparison to no change in Ep. Finally, a 10% increase in
diastolic BP at any point in time equated to a 47% greater risk of rupture in comparison































































































11.4.3 Summary ofmodel A
From this model, it can be concluded that the following variables led to a shorter
time to rupture:
■ Female gender.
■ Higher maximum diameter.
■ Higher diastolic blood pressure.
■ Larger proportionate decrease in Ep.
11.4.4 ModelB
Time dependent variables considered for entry into the model
Log maximum diameter Log change in p/ month
Log Ep Log diastolic pressure
Log p Log systolic pressure
Log change in diameter/ month Log mean arterial pressure
Log change in Ep/ month Log pulse pressure
Hypertension at each follow-up (definition in Chapter 4.4.3)
Non time-dependent variables considered for entry into the model
The square root ofpack-years
Chest pain
Leg pain
Angina score (grade 1 and 2 grouped together)
Family history ofAAA (father, mother or siblings)
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Coronary artery bypass surgery
History ofmyocardial infarction or angina
Beta-blocker use at baseline
Diabetes
Variables entering the final model B
After adjusting for age and sex, gender, Dmax, and smoking achieved 5%
significance and were included in the final model (Table 11.2). None of the other
variables considered were significantly related to time to rupture.
11.4.5 Interpretation ofmodel B
The increased risk of rupture associated with female gender in model B was 140%
(HR 2.40). Interestingly, after adjusting for age, co-morbidity and smoking, a 10%
increase in diameter led to a 60% (HR 1.60) increase in rupture risk which was
higher than that in model A (36%). The hazard ratio of <1 for pack-years smoked







































































11.4.6 Summary of model B
From this model it can be concluded that the following variables led to a shorter
time to rupture:
■ Female gender;
■ Higher maximum diameter;
■ Gender and age or inaccurate reporting may have confounded the effect of
smoking. This is discussed further in section 12.5.
11.4.7 Model C
Using the 'goodness of fit' method, the optimal three-variable, four-variable, five-
variable, etc. regression models selected were listed (Table 11.3).
Table 11.3. The 'best' of the 1-8 variable models using the 'goodness of fit'
method ofmodel selection.
DF# Score Variables included in the model
2 15.3 Age, sex - automatically included in all models
3 30.0 Maximum diameter
4 43.8 Change in Ep, change in p
5 58.2 Maximum diameter, change in Ep, change in p
6 66.0 Maximum diameter, change in Ep, change in p, pack-years
7 68.2 Maximum diameter, Ep, change in Ep, change in p, pack-years
8 69.9 Maximum diameter, Ep, change in Ep, change in P, diastolic
blood pressure, pack-years
#Degrees of freedom = number of variables in the model.
Whilst the variables are referred to on their original scale, the natural logarithms of these
variables were added to the model (except for age, sex and the square root ofpack-years).
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Variables entering the final model C
After adjusting for age and sex, repetitively adding one more variable to the model
increased the score statistic ofthe best model by 14.9, 13.6,14.7, 7.8, 2.2 and 1.7
respectively. The score value increased by 7.8 between the five- and six-variable
models but only by 2.2 between the six- and seven-variable models. The score value
did not increase markedly by adding a seventh or eighth variable, and so the most
appropriate model using this method ofvariable selection was probably the six-































































































11.4.8 Interpretation of model C
Female gender was associated with 127% (HR 2.27) higher rupture risk than male
gender although this was just non-significant; a 10% increase in Dmax was associated
with a 45% increase in rupture risk; a 10% reduction in Ep was associated with a 45%
higher risk of rupture and lower value ofpack-years smoked was associated with a
26% increased risk of rupture. This finding is difficult to explain and is further
discussed in section 12.5.
11.4.9 Summary of model C
From this model, it can be concluded that the following variables led to a shorter time
to rupture:
■ Female gender
■ Higher maximal diameter
■ Lower proportional change in Ep
■ Higher number of pack-years smoked [may have been confounded or biased
(section 12.5)]
11.5 Discussion
Model A examined the relationship between the measured variables and risk of, or
time to, rupture. It did not take into account the effect of co-morbidity, risk factors or
drug therapy. Model A was, therefore, viewed as a haemodynamic model ofAAA
rupture risk, which might be sufficiently simple for clinical use in the out-patient
department and the final conclusions of this thesis have been taken from this model.
However, the presence ofangina and claudication indicate the presence of
atherosclerosis, and it is possible that aortic atherosclerosis may have an effect on
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AAA expansion and rupture. Smoking has also been implicated in rupture risk
(Brown and Powell 1999). The aim ofmodels B and C, therefore, were to assess risk
of rupture while adjusting for these non-measured variables, despite the risk of
obscuring interpretation by including a higher numbers ofvariables.
Two methods of variable selection were used on the same data in recognition of the
fact that there is no preferred method and to allow the results ofB to be verified, or
otherwise, by C. It may be that stepwise regression in model B used such a rigorous
method of final variable selection that variables with a bearing on rupture risk were
excluded. In which case the 'goodness of fit' method, producing model C, may give a
broader picture of factors impacting on rupture risk. Models B and C were more
complex to interpret because of the inclusion of smoking, drug and medical histories.
The difficulties inherent in their inclusion are discussed in Chapter 12.
Age was not significantly related to risk of rupture in any of the models. It seems likely
that this can be explained by the close relationship between diameter and age, where
diameter may have a stronger association with time to rupture than age. However, the
higher relative risk of rupture (2.65) in the 80-89 year age group compared with the 70-
79 year age group suggests that age may remain an important factor in rupture risk (see
Chapter 12).
Female gender and higher Dmax were related to increased rupture risk in all three
models and require little further discussion. Suffice to say that females of the same age,
and with the same AAA diameter and blood pressure, as males may benefit from
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earlier AAA repair. The findings for diastolic blood pressure, proportional change in
Ep and smoking habit require further explanation.
Model A showed that after adjusting for the other measured variables, DBP continued
to have an independent, significant impact on rupture risk. DBP was not included in the
final models B and C. The significant relationship between DBP and time to rupture in
model A may have been confounded or replaced in models B and C by smoking status.
Model A suggested that higher DBP related to shorter time to rupture, while model B
suggested that lower pack-years smoked related to a shorter time to rupture. If smoking
status were confounding the effect ofDBP, those with lower pack-years smoked would
also have higher DBP. However, the Kruskal-Wallis test showed that there were no
significant differences in DBP between tertiles of pack-years smoked (p=0.104).
Nevertheless, the result is approaching statistical significance. Pack-years may have
had some level of confounding effect on DBP. It was not possible to determine exactly
why DBP was no longer significantly related to time to rupture from these data. Further
analysis of the impact ofDBP on rupture risk would require more detailed (more
frequent) collection ofblood pressure and drug data.
Previous workers investigating the relationship between AAA rupture and blood
pressure found that DBP>105mmHg was significantly associated with increased risk
of rupture (Cronenwett 1996). Vardulaki et al (2000) found that diastolic
'hypertension' (DBP>100mmHg) was significantly related to the occurrence ofAAA;
whereas raised SBP, MAP and PP were not. The UKSAT found that MAP was
independently associated with increased rupture risk. It was not clear whether DBP
was actually tested. Thus, it has been concluded that model A's finding that DBP
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(>90mmHg) was significantly associated with an increased risk of rupture,
independently of age, gender, AAA diameter and distensibility, supports previous
findings. In AAA surveillance, recording DBP in addition to diameter may enhance
the accuracy of rupture risk prediction.
Proportionate change in Ep was significantly related to rupture in models A and C,
but not in B. The non time-dependent variables may have interacted in some way to
make change in Ep and (3 non-significant at the 5% level. The equation to calculate
the log change in Ep per month was:
log (latest Ep) -log fprevious Ep)
Days between measurements
=> log (latest value/previous value) x365.25/12
Days between measurements
=> log (B) - log (A) =log (B/A)
Where A is the previous value and B is the latest value of the variable.
Thus log change in Ep is actually the proportionate change in Ep over time. If the
change in Ep is an increase, the log (B/A) ratio is higher than that produced by a
decrease in Ep of the same magnitude (Figure 11.3).
The hazard ratio (and 95% CI) for relative change in Ep was less than one in models
A and C, suggesting that those whose AAA continued to increase in Ep (decrease in
distensibility) had a longer time until rupture and therefore a lower risk of rupture.
Those patients whose AAA Ep began to reduce (increasing distensibility) were more
likely to rupture within a shorter time.
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Figure 11.3: The relationship between the change in Ep [ratio of this change = log
(latest Ep /previous Ep), and time to rupture in model A.
Decrease in Ep Increase in Ep
1 I 1 I ►
shortest Time to rupture (arbitrary time intervals) longest
It would appear from these data that distensibility could theoretically be of use in
rupture risk prediction if the reasons for its high variability could be understood. It is
also clear that follow-up would have to be more frequent than that employed by this
study to ensure 'capture' of the changes in distensibility which may indicate imminent
rupture.
The hazard ratio of <1 for pack-years smoked in models B and C suggests that patients
who smoked less had a shorter time to rupture. This finding was not expected, but it is
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possible that this was due to confounding. Females in this population smoked fewer
cigarettes but had a higher relative risk of rupture and shorter time to rupture. This may
have led to an erroneous association between low pack-years smoked and reduced time
to rupture. Additionally, older patients smoked fewer cigarettes in this study but had a
higher relative risk of rupture (Chapter 12) and tended towards a shorter time to rupture
(model A and Chapter 12).
Beta-blocker use, the presence ofhypertension and concomitant disease i.e. angina, MI
or claudication, were entered into models B and C. However, none had a significant
influence on time to rupture. From a statistical point of view, it is accepted that
different combinations of variables considered by the regression model could produce
different final model combinations. The complexity of the relationship between the
variables means that changing just one variable within the group may lead to quite
different variable interdependence becoming significant.
Despite these factors, significant results have been produced with regard to AAA
distensibility. These results suggest that a larger proportionate decrease in Ep at any
point in time indicates a shorter time to, or higher risk of, rupture. A reduction in Ep
equates to an increase in AAA distensibility. It is possible that, immediately prior to
the final breakdown ofAAA wall matrix, AAA wall distensibility may increase (Ep
decrease) because the tensile strength of the wall has finally been lost, and this leads
rapidly to rupture. Observing distensibility at the same time as diameter may enhance




It would appear that the following variables act independently to reduce the time to
rupture (increase the risk of rupture): female gender; larger diameter; higher diastolic
blood pressure; and a larger proportionate decrease in Ep (an increase in
distensibility).
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Chapter 12. The relationship between factors associated
with vascular disease and AAA distensibilitv
12.1 Introduction
The factors associated with vascular disease and AAA that have been investigated in
this study fall into three categories:
■ Risk factors for AAA - Smoking
Hypertension
Family history
■ Indicators ofatherosclerotic disease - Angina
Myocardial infarction (MI)
Coronary artery bypass graft (CABG)
Claudication
■ Hypertensive/ cardiac drug therapy - Angiotensin converting enzyme (ACE)
inhibitors
p - adrenoceptor antagonists (blockers)
Calcium (Ca) channel blockers
The risk factors for AAA formation are well described and have been discussed in
Chapter 1. Briefly, male gender, age, smoking and hypertension increase the risk of
AAA formation (McSweeney et al 1994a, Cronenwett 1996, Lee et al 1997, Lederle
et al 1997 and Wilmink et al 1999). The presence ofatherosclerotic disease does not
168
appear to directly increase the occurrence ofAAA or rupture but may be indirectly
associated with the progression ofAAA disease.
P-blockade, calcium channel blockade and ACE inhibition increase arterial wall
distensibility directly by influencing arterial smooth muscle behaviour and indirectly
by reducing blood pressure (Bank 1997, Englund et al 1998, Topouchian et al 1999).
As these anti-hypertensive drugs affect vascular tone, their relationship with AAA
expansion and rupture has been investigated. This chapter aims to explore the
relationships between the above factors and AAA wall distensibility, diameter,
expansion and rupture risk.
12.2 Additional methodology
Smoking has been divided into tertiles ofpack-years. Pack-years were calculated by
the number of smoking years x number of cigarettes per day/ 20. Ten patients had
never smoked but this was deemed too small a number to compare between two
outcome categories (rupture or intact AAA); the division into tertiles ofpack-years
avoided confounding by small numbers. A number ofpatients had recently changed
their smoking habits dramatically from a large number of cigarettes to a small number
of cigars or tobacco. In these cases the current smoking habits have been ignored in
favour of the level of exposure to smoking (pack-years).
12.3 Results
There were several anomalies in the co-morbidity data collected. For example,
although 61 (30%) subjects claimed to have had an episode of severe chest pain
lasting more than 30 minutes, 4 stated that the cause was unknown, 32 stated angina
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to be the cause and 64 stated that they had had a myocardial infarction (MI). Some
subjects claimed not to have had chest pain but did think they had either angina or had
had an MI. Although some patients may have had asymptomatic MI, it is also likely
that some subjects gave inaccurate histories.
12.3.1 Prevalence of the factors associated with arterial disease within the study
population.
Table 12.1 describes in detail the prevalence of the factors described above in the
study population. The data were collected at baseline and the results given here are for
the 210 subjects who produced usable data at any point in the follow-up. As can be
seen, the majority (>70%) did not have angina or claudication (Figure 12.1). In spite
of the low numbers with cardiac or peripheral vascular disease, 95% gave a history of
smoking. Self-reported smoking history is however, susceptible to inaccuracies
(Brown et al 1999). Few had diabetes and there was a rather low family history of
AAA in the immediate family members. This latter finding should be viewed bearing
in mind the inaccuracies inherent in anecdotal evidence regarding death from AAA of
these elderly subjects' parents and siblings.
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Table 12.1. Prevalence of risk factors for AAA disease in the study population at





















Grade 1 14 (7%)













































CABG- coronary artery bypass graft. A 1 information was self-reported
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Figure 12.1. The prevalence of atherosclerotic disease, hypertension, pack-years










12.3.2 The effect of associated factors on AAA diameter and distensibilitv.
Age, diameter and distensibility in those with and without the associated factors were
compared. There were no significant differences in AAA diameter or distensibility
between those with angina, claudication, ACE inhibitor, Beta-blocker or Ca-channel
blocker therapy, diabetes, nor in current or ex-smokers when compared with those
who did not have the above factors or who had never smoked (p>0.15). Age was not
significantly different between those with and without hypertension, although
diameter was. At baseline, diameter was higher in hypertensive subjects than
normotensive subjects but distensibility was no different (Figure 12.2 and Table 12.2).
The difference in age between those with any of the above factors and those without
are detailed in Table 12.2. The non-significant results are not given in Table 12.2.
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Hypertension at baseline (>140/90 mmHg)
Boxplots represent the median, interquartile range and range of values, p-
value using Mann-Whitney U test.
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Table 12.2. Significance levels for differences in age and maximum diameter where
significance was reached between those with the associated factor and those without.
Risk factor Variable Median Median p value
(% with factor) (with risk (without
factor) risk
factor)
Hypertension Diameter (mm) 51 47 0.007
(24%)
Antihypertensive P- ACE inhib None
blockers Ca channel
i blockers
gS Age (years) (8%) (27%) (65%)





Diabetes Age (years) 69 73 0.04
(6%)
p-values using Mann-Whitney test except *Kruskal-Wallis test
12.3.3 Relative risk (RR) of AAA rupture in those with the associated factors.
The relative risk (RR) ofAAA rupture in females was more than twice that ofmales.
The relative risk of rupture in the 50-69 years age group was lower than that of the
70-79 year age group but the difference was not significant (95% CI 0.18-3.75). The
RR of the 80-89 year group was more than twice that of the middle age group and this
was significant (Table 12.3). Smoking was analysed in 'current, ex and never'
categories. However, since there were only 10 subjects in the reference category
(never smoked) the confidence intervals for the other two groups were very large and
Current Ex Never 0.016*
Age (years) 71 74 77
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non-significant (CI included 1). Smoking was subsequently analysed in tertiles of
pack-years, which produced the unusual result of a significantly reduced RR in those
in the upper tertile of smoking habit i.e. those who smoked most. The RR of rupture
in the middle tertile was not significant. History of a coronary artery bypass graft
appeared to be related to a reduced RR of rupture while hypertension doubled the risk.
The presence of angina, claudication, antihypertensive therapy or family history had
no significant relationship with risk of rupture.
In summary, female gender, age over 80 years and hypertension at baseline (systolic
>140 mmHg, diastolic > 90 mmHg, Chapter 4) were the only factors which
significantly increased the risk of rupture and which were unconfounded by other
factors (see below). Diameter has been examined in Chapters 9-11.
No factor significantly altered the likelihood ofoperative repair. However, female
gender tended toward a reduced likelihood of surgical repair but did not attain
statistical significance. CABG and family history ofAAA both tended toward
increasing the likelihood of repair but neither reached statistical significance.
176
Table 12.3. Relative risk (RR) ofAAA rupture and operative repair in those with the
associated factors compared with those without.
Baseline risk factor
(n=210)
Rupture RR (95% CI)
(n=28)
Operation RR (95% CI)
(n=69)
Male 1.00 1.00
Female 2.24 (1.55-3.26) 0.66 (0.43-1.01)
Age 70-79 years 1.00 1.00
50-69 years 0.44 (0.18-3.75) 1.25 (0.75-2.09)
80-89 years 2.65 (1.88-3.75) 0.74 (0.13-4.08)
Smoking never 1.00 -
ex 2.76 (0.82-9.34) -
current 1.91 (0.11-32.88) -
Pack-years Min 0-26 1.00 1.00
Med 27-46 0.61 (0.22-1.66) 0.86 (0.17-4.28)
Max 47-192 0.38 (0.21-0.68) 0.94 (O.OO-oo)
Angina 1.15 (O.OO-oo) 1.13 (0.01-oo)
CABG 0.22 (0.05-0.90) 1.46 (0.97-2.2)
Claudication 0.95 (O.OO-oo) 0.84 (0.31-2.30)
Hypertension 2.01 (1.22-3.32) 0.88 (0.09-8.69)
Antihypertensive drugs 0.64 (O.OO-oo) 1.05 (O.OO-oo)
Family history 0.36 (O.OO-oo) 1.73 (0.71-4.21)
RR=1 is comparison group. fnone given, comparison is with those without the
factor.
RR>1 indicates higher risk ofoccurrence; RR<1 indicates lower risk of occurrence, oo
= infinity.
95% CI - if this includes 1 result is not significant. Significant values in bold.
The rupture and operative groups were not exclusive, 5 ruptures were operated.
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12.4 Summary
■ Female gender, age over 80 years and hypertension (BP> 140/90) increased the
risk of rupture.
■ Hypertension was associated with increased AAA diameter and Ep but had no
significant relationship with p.
■ Indicators of atheromatous disease (angina and claudication) did not alter risk of
rupture nor AAA diameter or distensibility.
■ A greater number ofpack-years smoked reduced RR of rupture but was
confounded by two factors, namely; females and elderly smoked less but suffered
ruptured AAA more.
■ Smoking did not alter diameter or distensibility.
■ Use of antihypertensive drugs did not appear to effect an alteration in diameter or
distensibility in this study group.
12.5 Discussion
With the exception of the UKSAT (Brown and Powell 1999), few studies have
investigated risk factors for rupture. As a result some comparisons have had to be
made with risk factors for AAA occurrence instead of rupture. This study was not
designed specifically to investigate the influence of these risk factors. However,
information on co-morbidity, drug, smoking and family history were collected and
their relationship with AAA distensibility and rupture analysed.
Angina and claudication:- Atheromatous plaque within the AAA wall may lead to
altered wall mechanics and consequently altered response to pressure and diameter
change. In this study, angina and claudication were used as indicators of
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atherosclerosis to assess whether this disease process would affect AAA expansion or
risk of rupture. Englund et al (1998) found cardiac disease (defined as angina, MI,
cardiac intervention or ECG evidence) to be significantly related to higher AAA
growth rate. Although no explanation has been offered as to the mechanism, it is
possible that patients with claudication and angina may be more likely to develop
atheromatous plaque within the aorta as well as the lower limb and coronary arteries.
However, Naydeck et al (1999) found that atheromatous plaque was present in the
aorta in 89-96% ofAAA subjects and that the plaque was significantly larger than in
those without AAA. This high percentage of atheromatous plaque in AAA could
prevent any distinction, in terms ofdiameter or distensibility, between those with and
without angina and claudication.
Table 12.2 shows that there were no significant differences in age, diameter, Ep or (3
between those with angina or claudication and those without. Table 12.3 shows that
the RR of rupture in those with angina or claudication was not significant i.e. there
was no difference in risk of rupture in those with or without angina or claudication.
Patients who had undergone CABG had a lower RR of rupture but these subjects may
have died of other causes before rupture could occur. It would appear, therefore, that
in this group of subjects the presence of angina or claudication did not affect wall
distensibility, nor were these subjects different in age, aortic diameter or risk of
rupture to those without angina or claudication.
Smoking:- Smoking is the most important avoidable risk factor for AAA
development (Brown and Powell 1999, Vardulaki et al 2000). Wilmink et al (1999)
suggested that although smoking results in elastolysis, which may be important in
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AAA formation, once significant widening has occurred, abnormalities in collagen
metabolism (which are less obviously smoking related) might be more important for
disease progression. This implies that a change in smoking habit after AAA formation
is unlikely to affect AAA progression. In contrast, MacSweeney et al (1994b)
suggested that smokers have higher growth rates than ex-smokers and that smoking
increases the likelihood ofAAA death. This is supported by the findings of the
UKSAT (Brown and Powell 1999), which showed that current smokers had an
increased risk of rupture compared with ex-smokers. Smoking status in the UKSAT
was determined by measuring plasma cotinine levels. Brown and Powell (1999) found
that self-reported smoking status was not significantly associated with survival (non-
rupture). The present study did not collect cotinine levels and so had to rely on self-
reported smoking status. The confounding effects of inaccurately reported smoking
habit cannot, therefore, be underestimated and are likely to have played a role in the
inexplicable finding of a lower RR of rupture in those who smoked most. Rather than
this group ofpeople having overestimated their smoking habit, it is more likely that
those who claimed never to have smoked or to have stopped had not in fact done so.
In this study population, those who had never smoked were significantly older than
the smokers (Table 12.2) but diameter, Ep and P were not significantly different.
When smoking status was divided into tertiles ofpack-years there remained no
significant differences in diameter, Ep or p between the groups. Table 12.3 shows that
smoking 47-192 pack-years (the upper tertile) carried a reduced RR of rupture
compared with smoking 0-26 pack-years (the lower tertile). To investigate whether
this finding was due to heavy smokers dying ofother diseases, the proportion of
deaths between the smoking tertiles was compared. There were no significant
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differences in the number of deaths in each group (p=0.46) or in the number of
ruptures in each group (p=0.32).
Although this finding suggests that those who smoked least had a shorter time until
rupture, several characteristics of these subjects may have led to confounding of the
smoking data. Females smoked less than males [median (IQR) pack-years 30 (20-40)
and 40 (20-59) respectively, p=0.01] but were more likely to suffer AAA rupture (RR
2.24). Older subjects also smoked less (Spearman's rank correlation r = -0.19,
p=0.006 and median ages in each pack-year tertile, p=0.016, Table 12.2) but were,
again, more likely to suffer AAA rupture (RR 2.65).
Hypertension:- Hypertension has been shown to be related to increased AAA
expansion and rupture with diastolic pressure being a more accurate predictor than
systolic pressure (Cronenwett 1996, Englund et al 1998, Vardulaki et al 2000). In
Cronenwett's (1996) review it is suggested that hypertension is present in a higher
percentage of rupture cases than non-rupture cases, and that more patients with
hypertension subsequently rupture than those without hypertension. In view of the
findings that a reduction in blood pressure increases aortic distensibility (Bank 1997),
it can be assumed that hypertension results in reduced distensibility.
Maximum AAA diameter and Ep were significantly higher in those who were
hypertensive at baseline, p was no different between the two groups. This supports
previous reports that hypertension increases expansion (Cronenwett 1996, Englund et
al 1998) and reduces distensibility (Naydeck et al 1999). It also supports the view that
P is less pressure dependent than Ep (Reneman and Hoeks 1995). The relative risk of
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rupture in the hypertensive was twice that of the normotensive subjects (this was
significant) again supporting the studies discussed above.
Drug therapy:- It is now generally accepted that beta-adrenoceptor antagonists (p-
blockers) increase aortic distensibility by a combination of blood pressure reduction
and smooth muscle relaxation (Savolainen et al 1996, Bank 1997, Englund et al
1998). Ca channel blockers reduce vascular smooth muscle contractility resulting in
vasodilation; ACE inhibitors reduce vasoconstriction and both result in lowered BP.
As a result ofboth lower BP and relaxed SMC, aortic distensibility is increased
following Ca channel blocker and ACE inhibitor use (Bank 1997, Slama et al 1995,
Topouchian et al 1999). For this reason, those taking P-blockers, Ca channel blockers
and ACE inhibitors have been grouped together and compared with those taking none
of the above and where P-blockers alone have been analysed the comparison group
exclude^,.those taking ACE and Ca channel blockers.
Those taking P-blockers, ACE inhibitors and Ca channel blockers were significantly
younger than those taking none of the three aforementioned drugs (Table 12.2).
However, use of these three drugs did not significantly alter diameter, Ep or p. It is
possible that AAA in those on antihypertensive therapy were picked up at an earlier
age simply because of contact with the medical profession. If this was the case,
diameter might also be expected to be smaller in the group using antihypertensive
therapy than in the non-treated group. In fact, diameter was not significantly different.
This suggests that the subjects using any of these three drugs (who had been,
therefore, hypertensive for a period of time) developed AAA at an earlier age than
taking no antihypertensive medication. These data do not clearly support previous
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findings of altered diameter and distensibility with beta-blocker use (Savolainen et al
1996, Bank 1997, Englund et al 1998), but this may be because of the small numbers
taking P-blockers (n=16). Use of any of the three drugs did not significantly alter RR
of rupture (Table 12.3), nor did P-blockers alter time until rupture after adjusting for
age, sex, diameter, distensibility, smoking, concomitant atherosclerotic disease and
pack-years (Chapter 13, model B).
Although these results may appear somewhat inconclusive regarding the effect of P-
blockers, ACE inhibitors and Ca channel blockers on AAA wall distensibility, this
reflects the fact that this study was not specifically designed to address this issue.
More detailed drug history, including changes in drug use over time and blood levels
ofeach drug at the time of distensibility measurement, may be necessary to clarify the
relationship between antihypertensive therapy and AAA distensibility.
12.6 Conclusions
Female gender, age over 80 years and hypertension (BP> 140/90) increased the risk of
rupture, but indicators ofatheromatous disease (angina and claudication) did not. The
relationship between smoking and risk of rupture may have been confounded in this
study by inaccurate self-reporting, and by the influence of age and gender.
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Chapter 13. Discussion of findings
13.1 Introduction
The aim of this study has been to test the variability of distensibility measurement
in AAA, to observe and describe the distensibility of the AAA wall, and to
describe the relationships between distensibility, diameter and risk ofAAA
rupture. The aims and objectives are described in Chapter 3. Each point will be
discussed in turn below.
13.2. Objective 1: To test the variability of the ultrasonic echo-
tracking equipment in the measurement of AAA wall diameter and
distensibility
Intra- and inter-observer CVME for directly measured variables (Dmax and BP)
were low (<10%) while CVME for the derived variables (Ep and P) were higher
(21-35%). The measured variables were all skewed. However, there is no non-
parametric equivalent of the CVME. A logarithmic transformation was applied to
the data on p before the CVME was calculated and the resultant CVME's were
10.2% and 8.6% for observers A and B respectively. This suggested that the high
level of variation was in fact due to the large variation of Ep and p within the study
population rather than due to the technique itself (Wilson et al 2000). Variability of
the Diamove technique was deemed clinically acceptable.
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The following selection criteria were devised to minimise variability and were used
throughout the larger study:-
1) The maximum diameter measurements should be within 5% of the estimated
value, or 2mm if the aneurysm is less than 4 cm wide.
2) At least three consecutive cardiac cycles producing uniform waves should be
selected for analysis.
3) Patients with arrhythmias should be excluded.
13.3. Objective 2: To test the effect of using brachial pressure as
opposed to derived central pressure in distensibility measurement
One year into the study the technology to assess central blood pressure non-
invasively using pulse wave analysis (PWA) became available. The peripheral
pressure waveform was recorded and transformed into the corresponding central
waveform using an integral transfer function. This generated derived central diastolic
and systolic pressures, which could be used in the calculation ofEp and p.
Distensibility calculated using brachial and central pressures could therefore be
compared.
The principle finding of the study was that use ofbrachial pressure as opposed to
central aortic pressure significantly increased Ep by 13% and P by 12%. However, it
was concluded that the systematic nature and the small size of the overestimate
rendered brachial pressure acceptable clinically. There remains a debate amongst
authors regarding the validity of applanation tonometry in central BP measurement
and so brachial sphygmonamometry continued to be used in this study.
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13.4. Objective 3: To describe the range of values of aortic wall
distensibilitv using Ep and B in a population with AAA of > 3.0cm
anteroposterior diameter
13.4.1 Follow-up of the study population
216 subjects were recruited ofwhom 210 (97%) produced usable data. Of those who
produced usable data, 54% were followed for 12 months and 36% of subjects were
followed for more than 18 months.
Follow-up ended because of rupture or repair of the AAA, illness preventing
attendance or death. Significantly more AAA ruptured in females (23%) than in males
(10%). Significantly fewer females than males were operated on electively. However,
in this population the outcome of surgical repair was not significantly different
between the sexes. Whether rupture occurred more often in females because of
differing AAA structure or simply because fewer were operated remains unclear.
13.4.2. Baseline descriptive statistics
The narrow IQR ofdiameter (41-54mm), diastolic pressure (72-90 mmHg) and
systolic pressure (130-160 mmHg) suggested that the group was relatively
homogenous in terms of these variables. However, there was large diversity in wall
distensibility among AAA of the same diameter. This may explain, at least in part,
why AAA behaviour can be so difficult to predict. At baseline, distensibility was
inversely related to diameter but there was no clear pattern of relationship between
distensibility and blood pressure, except that p was less pressure dependent than Ep.
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13.4.3 Outcome events
Baseline age and AAA diameter were greater in the rupture group than in the intact
AAA group, but distensibility did not differ according to outcome. Although AAA in
females were more likely to rupture than in males, there were no statistical differences
in age, blood pressure and diameter between gender groups. The relationships
between the variables were different in each gender, suggesting that female AAA wall
degradation may have occurred at a different rate than in male AAA. The AAA which
ruptured, or were more likely to rupture (female AAA), tended toward being more
distensible and exhibited different dynamic relationships between diameter and
distensibility compared with AAA which were intact at the end of the study. It may be
that AAA wall degeneration in females is more advanced than in males with AAA of
a similar diameter.
13.4.4 Last follow-up
At present it is not known whether the changes in AAA wall structure and
composition leading to rupture occur within days, weeks or months of the event. In
view of the time interval between baseline data collection and the outcome of interest
[median 19.7 (IQR) (9.2-29.9) months], the descriptive statistics at the last follow-up
before outcome were analysed next. The time between last follow-up and the outcome
of interest was, on average, 3 months.
Ep and P were no longer correlated with diameter in spite ofbeing correlated at
baseline. This suggests that the changes in Dmax and distensibility became divergent
during AAA progression. It also suggests that the absolute value ofEp and P were
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perhaps not as indicative of rupture risk as the relationship between diameter and
distensibility.
When looking at these data with respect to gender, it was apparent that the change in
the relationships between diameter and distensibility had taken place in the males.
There had been a correlation between diameter and distensibility in the male study
population at baseline and but this was no longer the case at last follow-up. The
reason for the lack of correlation between diameter and distensibility in females was
not immediately obvious. However, in view of the change in relationships between
Dmax and distensibility in males at the time of last follow-up, the likely explanation
was that there was a difference in the structural integrity of the more advanced AAA,
which was not necessarily dependent on diameter.
As with the baseline data, the correlations between variables at last follow-up differed
between the sexes but there were no differences between absolute values for each of
the variables between the genders. It would appear from this finding, and the
knowledge that females had a higher risk ofAAA rupture, that similar combinations
ofdiameter, blood pressure and distensibility have more serious consequences for
females than males. The female AAA would appear to be unable to withstand the
same dynamic combination ofpressure, diameter, pressure change and resultant
diameter change as the male AAA and therefore may benefit from a different
interventional protocol.
Diastolic pressure may play an important part in the events leading up to rupture. This
was suggested by the finding that diastolic pressure remained significantly higher in
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the rupture group compared with the intact AAA group while systolic, PP and MAP
were not significantly different.
13.5. Objective 4: To describe the natural history of AAA wall
distensibility, as measured by Ep and B
The rate of change ofdiameter, distensibility and blood pressure prior to rupture is
unknown and may vary considerably between different aneurysms. In the rupture
group, the median (IQR) time difference between last data collection and the rupture
was 102 (60- 270) days, which may have been too long to 'catch' the changes in AAA
wall distensibility and diameter leading to imminent rupture.
Nevertheless, univariate analyses were carried out on the change in variables between
the penultimate and the last follow-up. Aneurysms which ruptured did not show
significantly different rates of change in diameter or distensibility per month when
compared to AAA that remained intact. Neither did females, who have been shown to
have a higher relative risk ofAAA rupture, show significantly different rates of
change in diameter or distensibility per month when compared to males. When
change in diameter was correlated with change in distensibility there were no
significant correlations. Again, it was apparent that diameter and distensibility did not
change at the same rate nor did distensibility change in a consistent direction.
The lack ofany significant difference in expansion rates between the rupture and the
non-rupture group suggests that either there was no difference between the rupture
and intact groups, or (perhaps more likely) that the time interval between last follow-
up and rupture was indeed too long to include the vital changes. Although change in
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diameter and distensibility were calculated per unit of time (month), the data could
not show whether the rate of change was consistent throughout the follow-up interval.
If the rate of change in diameter and distensibility altered only during the very last
part of the last follow-up to rupture period, this altered rate of change would have
been diluted by the slower overall rate of change over the total last follow-up to
rupture interval.
The analysis could have been left at this inconclusive point, but it was felt that some
attempt should be made to predict the possible changes in diameter and distensibility
at the time of rupture. The next stage of the analysis addressed this challenge.
13.6. Objective 5. To test the hypothesis that AAA wall distensibility is
related to risk of rupture, and to describe this relationship
13.6.1 The models used in the multiple regression analyses
The Cox proportional hazard model was used to investigate the relationships between
distensibility and rupture adjusting for all the other variables collected (diameter,
blood pressure, smoking, co-morbidity, drug use, family history). Relative change in
diameter and distensibility were included in this analysis to investigate whether they
were related to rupture risk or, more specifically, to investigate whether relative
change in these variables was more relevant to rupture risk than absolute change. The
Cox proportional hazard model was carried out on two sets ofvariables with time to
rupture as the dependent variable. Stepwise regression was used to assess the
influence of each variable on time to rupture, thus producing models A and B. Model
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C used the same variables as model B but used the 'best fit' regression method to
assess the influence of each variable on time to rupture.
13.6.2. The findings of models A, B and C
Model A examined the effect of blood pressure, maximum diameter (and its change),
Ep (and its change) and P (and its change) on time to rupture. There was a
significantly increased risk of rupture associated with female gender, larger maximum
diameter and higher diastolic blood pressure, and a decreased rupture risk associated
with increased proportional change in Ep. The decreased relative hazard for change in
Ep meant that a larger reduction in Ep (relative to the previous follow-up) was related
to a shorter time to rupture.
This model was adjusted for age and sex but did not take co-morbidity, smoking and
drug history into account. It gave a simplified picture of the interactions between
blood pressure, diameter and distensibility in AAA. This analysis was deemed
important as it provided an assessment of the impact of the haemodynamic variables,
which could easily be collected at routine follow-up clinics, on rupture risk. It showed
that ifno other information is collected, gender, diastolic blood pressure, diameter and
changing Ep can provide a more accurate risk assessment than diameter alone. It also
suggests that absolute Ep is not as indicative of rupture as the relative change in Ep
over time.
Model B examined the effect ofblood pressure, Dmax, Ep and p (and their change),
hypertension, smoking, beta-blocker use, claudication, angina, family history, MI and
CABG on time to rupture. Patients who smoked fewer cigarettes had a shorter time to
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rupture but this finding was possibly due to confounding; females smoked fewer
cigarettes but had a higher risk of rupture. In addition, self-reported smoking status is
known to be inaccurate. Plasma cotinine levels would have provided a more accurate
assessment of smoking status, but could not be collected in this study.
In spite ofbeta-blocker use, the presence ofhypertension and previous history of
angina, MI and claudication, being entered into the model none of these had a
significant influence on time until rupture. Diastolic BP was significantly related to
time until rupture whereas the presence ofhypertension was not.
Model C assessed the same variables as model B but used the 'goodness of fit'
regression method. This included the non-significant variables in each model and
gave their significance levels, unlike stepwise regression used in model B which
composed the final model from only the most significant variable at each step. It was
thought that model B may have used such a rigorous method of final variable
selection that variables with a bearing on rupture risk were excluded. The 'best fit'
method, producing model C, was thought to have produced a broader picture of
factors impacting on rupture risk.
The final model C was the best 6-variable model, which included age, sex, diameter,
change in Ep, change in p and smoking. These findings were similar to those of
model A in that female gender, higher AAA diameter and a decrease in Ep were
related to a shorter time to rupture.
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Although diastolic BP did not feature in model C, it can be seen from Table 11.4 that
it was included in the 8-variable model. Determining which model to use as the final
model was an arbitrary choice. It was based on the balance between creating an over-
complex model, which is difficult to interpret, and omitting variables that impact upon
rupture risk. The conclusions drawn from the final model C regarding diastolic BP
and rupture risk should not be that diastolic BP was not relevant to rupture risk
assessment, but that it was not as strong a predictor of time to rupture as the variables
which were included.
The findings ofmodels A and C suggest that Ep does play a statistically significant
part in predicting time until rupture. It is possible that increasing Ep and diameter,
followed by a period ofEp reduction alongside a continued increase in diameter, may
indicate an increased likelihood of rupture.
The high variability of distensibility cannot be easily explained nor overlooked. There
was no clear pattern of underlying distensibility that could be matched to AAA
expansion. There are several factors that may have caused variation in distensibility.
The immediate effect of cigarette smoking on aortic distensibility is not yet
understood. Cigarette smoking in the minutes before distensibility measurement was
not accounted for nor avoided. Likewise, the timing of beta-blocker ingestion and the
effect of a transient, anxiety-induced increase in blood pressure could not be
accounted for but may have temporarily affected aortic distensibility. These points do
not detract from the information provided by distensibility but they do limit the
clinical applicability of the findings.
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13.7. Objective 6: To assess whether smoking, concomitant vascular
disease or medication influence aneurysm size, growth or distensibility
13.7.1 Angina and claudication
Atheromatous plaque within the AAA wall may lead to altered wall mechanics and
consequently altered response to pressure and diameter change. However, since
atheromatous plaque occurs in such a high proportion ofAAA it may not provide any
distinctive change in behaviour indicative of rupture. In this study, angina and
claudication were used as indicators of atherosclerosis to assess whether this disease
process would affect AAA distensibility or risk of rupture. The presence ofangina or
claudication did not affect wall distensibility, nor were these subjects different with
respect to age, aortic diameter or risk of rupture.
13.7.2 Smoking
In this study population, those who had never smoked were significantly older than
the smokers, but diameter, Ep and [1 were not different between these groups. There
were no significant differences in diameter, Ep or p between the groups divided into
tertiles ofpack-years. This finding could not be attributed to heavy smokers dying of
other diseases as there were no significant differences in the number of deaths in each
tertile group ofpack-years smoked (p=0.46), nor were there any significant
differences in numbers of ruptures in each group (p=0.32).
Although this finding suggests that those who smoked least had a shorter time until
rupture it may have been confounded by three factors:
- Females smoked less than males and were more likely to rupture (RR 2.24).
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- Older subjects smoked less, but were more likely to rupture (RR 2.65).
- Self reported smoking status is known to be inaccurate and invariably results in the
underestimation of smoking habit.
13.7 3 Hypertension
Hypertension has been shown to be related to increased AAA expansion and rupture
(Englund et al 1998, Vardulaki et al 2000), with diastolic pressure perhaps being a
more accurate predictor than systolic pressure. Maximum AAA diameter and Ep were
significantly higher in those who were hypertensive at baseline, but (3 was no different
between the two groups. This supports previous reports that hypertension increases
expansion (Cronenwett 1996, Englund et al 1998) and reduces distensibility (Naydeck
et al 1999). The RR of rupture in the hypertensive group was twice that of the
normotensive subjects (this was significant), this finding is consistent with that of
previous work (Cronenwett 1996).
13.7.4 Antihypertensive therapy
Previous studies have suggested that beta-blockers, Ca channel blockers and ACE
inhibitors increase aortic distensibility by a combination ofblood pressure reduction,
smooth muscle relaxation and vasodilation, and reduced vasoconstriction (Savolainen
et al 1996, Bank 1997, Englund et al 1998, Topouchian et al 1999).
In this study, those taking antihypertensive medication were significantly younger
than those taking none of the three aforementioned drugs but did not have
significantly smaller AAA diameter. This may suggest that the subjects using any of
these drugs developed AAA at an earlier age than those not requiring antihypertensive
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medication, which in turn, may suggest that a period ofuntreated hypertension may
lead to the formation ofAAA at an earlier age. However, beta-blocker, ACE inhibitor
and Ca channel blocker use did not appear to significantly alter Ep or p. Although
these data do not clearly support previous findings (Savolainen et al 1996, Bank 1997,
Englund et al 1998, Topouchian et al 1999), this may simply reflect the fact that this
study was not specifically designed to examine the effect ofantihypertensive therapy
(circulating levels of P-blockers, ACE inhibitors or Ca channel blockers) on AAA
distensibility or rupture.
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Chapter 14. Conclusions and future studies
14.1 Conclusions
Ultrasonic echo-tracking technology can reliably measure AAA wall diameter and
distensibility and is thus suitable for the purpose ofclinical follow-up. Use of brachial
pressure systematically overestimates Ep and p. It would be preferable to use intra-
aortic pressure but this can not be measured non-invasively at present. The use of
pulse wave analysis technology to non-invasively derive central pressure may be a
useful surrogate, but its utility is still the subject ofmuch debate in the literature.
Diameter and distensibility appear to be related in the early stages ofAAA formation
but this relationship becomes weaker as the AAA develops. The rate and direction of
change in distensibility is more likely to indicate wall breakdown and rupture risk
than absolute distensibility. An increase in distensibility alongside increasing AAA
diameter indicates a shorter time to rupture than a decrease in distensibility for the
same AAA expansion. However, the change in distensibility indicating imminent
rupture may occur so close to the event that it may not be possible to 'catch' this
change at 6-month follow-up intervals.
14.2 Future studies
The relationships between distensibility and aneurysm wall matrix degradation
require further investigation. It would be useful to measure distensibility immediately
prior to surgical repair of an aneurysm, where, simultaneously, a wall sample could be
obtained and its structure analysed histologically and biochemically. Unfortunately
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this will always be restricted to relatively large or advanced AAA and a comparison
cannot be made with small or early AAA.
Advancing our understanding of the final events leading to rupture is essential ifan
improvement in aneurysm management is to be achieved. Our knowledge is limited at
present because the time period during which the final breakdown of collagen
(leading to rupture) occurs is not known. It is may be different for each aneurysm. A
study designed to follow AAA patients on a more frequent basis would shed much
light on this process but is perhaps not practicable. The present study achieved an
average time lag of 3 months between the last measurement and rupture. It would be
exciting to recruit subjects with large or rapidly expanding aneurysms who were
willing to attend monthly, for example, and monitor various measures ofAAA
degeneration including serum and plasma markers, diameter and distensibility.
198
Appendix I; Questionnaire
The WHO (Rose et al 1977) and Edinburgh Claudication (Leng and Fowkes
1992) questionnaires on angina and claudication were combined with questions
on medical, drug and family histories. Clinical data were collected at each
follow-up visit in the form of blood pressure measurement, AAA diameter
measurement and calculation of change in diameter with each cardiac cycle,
pulse and pulse pressure, Ep and p.
One question in the claudication section was missed out in error. Claudication
therefore, has been defined as probable, not definite in the analysis without any
resultant bias. The question missed out was;
What do you do if you get the pain when you are still walking?
1. Stop
2. Slow down
3. Continue at same pace
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AAA: MEASURES OF WALL COMPLIANCE
ASSESSMENT FORM
Study type
i ii iii iv







3. Date ofBirth 00.00.00 4. Age 00 yrs











AAA STUDY: MEASURES OF COMPLIANCE
CONSENT FORM FOR PATIENT OBSERVATION
I (name) of
(address)
Hereby consent to being included in a study of aneurysms, the nature and effect
ofwhich have been explained to me by Sister Katie Wilson.
I understand that I have an aortic aneurysm, which is a swelling of my main
blood vessel, the aorta. In order to check the size, compliance and growth ofmy
aneurysm it will be necessary to carry out an ultrasound examination of my








Patient Info Sheet D GP Info D
GP Sticker 0 Medical Record Sticker 0
CLINICAL DETAILS
11. Smokine
11.1 Do you smoke yD nD
Ifno go to Q11.12
11.2 If yes, cigarettes yD nD
11.3 pipe yD nD
11.4 cigars yD nQ
11.5 How many, cigarettes □□ /day
11.6 oz tobacco D D/week
11.7 cigars D D/week
11.8 How many years have you smoked throughout your life? UO years
11.9 How many cigarettes have you smoked per day throughout that period?
□□ /day
11.10 oz tobacco DD /day
11.11 cigars DD /week
11.12 Have you ever smoked regularly since you left school? yDnD
Ifno, goto Q11.21.
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11.13 What did you usually smoke ? cigarettes
11.14 pipe
11.15 cigars
11.16 How many cigarettes
11.17 oz tobacco
11.18 cigars
11.19 For how many years did you smoke?
11.20 How long since you finally gave up smoking?











yD12.01 Do you ever get chest pain or discomfort ?
Ifno, go to Q12.08
12.02 Do you get this when walking uphill or in a hurry? y d
If no go to Q 12.7
nD
nD
12.03 Do you ever get this when you walk at an ordinary pace?
yD nD
12.04 When you get any pain what do you do ?
Stop D Slow down D Continue at same pace D
12.05Does it go away when standing still or sitting down? y d n d
12.06 How soon? < 10 mins D > 10 mins D
12.07 Where do you get this pain or discomfort ?
Mark place with an X
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12.08 Have you ever had severe chest pain across the front of your chest lasting
for half an hour or longer?
YD N □
12.09 What was the cause? Unknown D
Angina D
MI □
12.10 Has patient ever had coronary artery bypass surgery ? Y D N D
If yes, year ofmost recent CABG graft DDDD
13. Leg Pain
13.01 Do you get a pain in either leg when walking ? yD N D
13.02 Does this pain ever begin when you are standing still or sitting
YD N □
13.03 Do you ever get pain in your calf or calves ? yD N D
13.04 Do you ever get it when you walk uphill or in a hurry
Y □ N □
13.05 Do you ever get it when you walk at an ordinary pace on the level
YD N □
13.06 Does this pain ever disappear while you are still walking
YD N □
13.07 What happens if you stand still ?
Usually disappears in 10 mins or less yD N D
13.08 Usually continues for more than 10 mins yD N D
13.09 Have you ever had surgery on the arteries of your legs other than for
varicose veins YD N □
13.10 Specify
13.11 Have you had surgery to remove toes ? yD N D
13.12 leg below knee yD N D
13.13 leg above knee yD N O
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14 Previous medical history
14.01 Has patient ever been treated for hypertension ? yD nD
14.02 Diabetes Y □ N □
14.03 Ifyes to diabetes Diet yD nD
14.04 Oral Y □ N □
14.05 Ins Y □ N □
14.06 Hx ofmajor disease
15 B Blockers yD nD
other drugs
16 Family history
16.1 Father yD nD
16.2 Mother Y □ N □
16.3 Brothers yD N D
16.4 If yes, number D
16.5 Sisters Y D N D
16.6 If yes, number D
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Study Details













22.01 Aortic diameter minnn.QQmm
22.02 max □□.□□ mm
22.03 meanOn.OD mm
23.00 Change in diameter □□.□□mm
24.00 Press. Strain Elast. Modulus (Ep) □□.□□ 105 Nm2







2 3 4 5
6 7 8 10 11 12 13 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
16-FEB-1917 20-SEP-1917 27-APR-1924 04-MAR-1915 27-MAR-1923 15-JUL-1924 12-OCT-1927 08-MAY-1915 19-APR-1929 25-JAN-1926 04-MAY-1918 16-SEP-1923 11-SEP-1930 12-JUN-1933 12-MAY-1925 11-FEB-1925 07-MAR-1923 04-SEP-1918 18-JUL-1922 20-DEC-1926 26-MAY-1919 27-SEP-1933 14-FEB-1934 26-FEB-1916 25-AUG-1920 19-OCT-1929 22-MAR-1921
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07- 28-
JUN-99 MAR-97 24-APR-99 28-JAN-99 12- 17-MAY-96 MAR-98 20- 06- 31- 14- 31- 28-JUL-99 APR-96 JUL-95 JUL-97 OCT-95 MAY-97




170.00 198.00 16.00 150.00 130.00 188.00 132.00 112.00 140.00 136.00 192.00 100.00 148.00 128.00 150.00 112.00 118.00 180.00 124.00 130.00 130.00 124.00 122.00 192.00 158.00 120.00 148.00
90.00 96.00 70.00 100.00 74.00 90.00 88.00 70.00 100.00 80.00 76.00 70.00 78.00 62.00 98.00 68.00 68.00 90.00 74.00 82.00 80.00 68.00 80.00 94.00 92.00 80.00 86.00
80.00 102.00 46.00 50.00 56.00 98.00 44.00 42.00 40.00 56.00 116.00 30.00 70.00 66.00 52.00 44.00 50.00 90.00 50.00 48.00 50.00 56.00 42.00 98.00 66.00 40.00 62.00
48.80 53.80 51.10 50.60 39.30 34.90 47.60 52.80 44.00 37.80 50.20 28.80 35.00 49.90 47.80 48.40 54.70 49.30 40.30 44.80 49.50 44.30 29.60 61.20 37.80 32.80 43.00
4.04 3.80 1.92 3.21 1.31 5.09 3.55 1.97 4.66 5.36 3.03 0.60 1.60 1.57 2.28 6.05 1.35 4.43 2.91 1.27 3.43 2.19 0.84 2.91 2.91 1.48 3.61
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Appendix Ilia: Number of follow-up visits producing usable
data
Baseline 1st 2nd 3rd 4th 5 th"10th n
follow- follow- follow- follow- follow-up
up up up up
y V V V V V 32
V V S V - Y 2
S - V V V V 2
V - - V 1
S V V S - 30
V - - V S 1
S V V - - 24
V ■/ - V - 4
V - V - 1
S _ _ _ s 1
S </ - - - 25
S V - - - 2
S V - - - - 26
V - V - - - 2
V - - - - 1
V - - - - - 39
- V V V 1
- s V V s - 3
- V V V - - 4
- s - - - 2
- - - - - 4
- - y^* - - - 3
- - - - - - 6
193 14 3 - _ 210

















Appendix IIIc: Summary of the number of subjects in each
stage of analysis
Baseline analysis 193
Last fo llow-up analysis 210
Baseline - last follow-up 154 (193 at baseline - 39 baseline with only 1 data
set)
Penultimate -last followup 164* (210 at last follow-up - 46 who only had 1 data
set)
* this number includes one subject on whom only blood pressure data were collected,
hence n = 163 in Table 10.2
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REVIEW ARTICLE
Expansion Rates of Abdominal Aortic Aneurysm: Current Limitations in
Evaluation
K. A. Wilson*1, K. R. Woodburn1, C. V. Ruckley1 and F. G. R. Fowkes2
1Department of Vascular Surgery, Royal Infirmary of Edinburgh, and 2Wolfson Unit for Prevention of Peripheral
Vascular Diseases, University of Edinburgh, U.K.
Objectives: Literature on the expansion rate of infrarenal aortic aneurysm is scant. This revieiv was carried out to assess
whether there is a normal rate of expansion for infrarenal aortic aneurysms.
Design and methods: Review of literature relating to abdominal aortic aneurysm (AAA) measurement and expansion
rates. Articles were identified from a search of the computerised Medline database from 1966 onwards.
Results: Nine studies produced expansion rates for 3.0-5.0 cm AAA ranging from 0.17 to 0.57 cm per year. Evaluation
of these studies showed that they are not wholly comparable in terms of source population, sample size, disease definition
and period of assessment.
Conclusions: It is not possible to discuss with confidence the "normal" expansion rate of infrarenal aortic aneurysms
at any diameter. To elucidate fully the behaviour of AAA, a clear and universal definition of AAA is required in order
that it may be used within a large, multicentred prospective cohort study.
Key Words: Aortic aneurysm; Expansion rate; Risk of rupture; Definition.
Introduction
Approximately 900 people per year die from ruptured
abdominal aortic aneurysm (AAA) in Scotland.1 Many
of these patients do not survive to reach hospital
following rupture but of those who do, 54.7% will die2
despite considerable advances made in recent years
in surgical and anaesthetic technique, graft materials
and postoperative care. The prevalence of AAA is
around 5% in patients aged 65 years and increases
with age.3,4 There would appear to be evidence of a
recent rise in prevalence in Western countries; surgical
workload is also increasing.5^7 Scottish hospital ad¬
missions for AAA rose from 11.5 per 100 000 in 1984
to 33.8 per 100 000 in 19942 and the number of new
cases has increased steadily from 283 in 1980 to 612
in 1991.8
It is generally held that around two-thirds of patients
with untreated AAA die from rupture of the aneur¬
ysm/' but this is based on 50-year-old data" and no
* Please address all correspondence to: Katie Wilson, Vascular Sur¬
gery, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh
EH39YW, U.K.
reliable natural history data are available. The annual
risk of rupture progressively increases with aneurysm
size to around 60% if the diameter is greater than
10 cm.10 Most patients whose aneurysms rupture die
without reaching hospital, and virtually all who reach
hospital and are not treated within a short time die.
In patients who undergo emergency surgery for rup¬
ture the 30-day mortality is at best 30%,11,12 and more
commonly 50%.13,14 By contrast, elective surgery for
aneurysm carries a mortality of 5% or less15,16
depending on the surgeon's selection policies. A re¬
duction in mortality can therefore be achieved by
elective surgery in patients at high risk of rupture.
Currently the decision to operate on an asymptomatic
aneurysm is made chiefly on the basis of diameter,
expansion rate and patient fitness.
Aetiology of Aneurysms
Normal aortic wall
The normal aorta is a highly elastic artery with three
layers. The innermost layer, the tunica intima, consists
1078-5884/97/060521+06 $12.00/0 © 1997 W.B. Saunders Company Ltd.
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of a single layer of endothelial cells supported by
elastin-rich collagenous tissue. Myointimal cells, which
are similar in structure to smooth muscle cells, are
scattered throughout the subendothelial tissue. It is
here that the accumulation of lipids and intimal thick¬
ening of atheroma occurs.1' The tunica media consists
of concentric sheets of elastin, collagen and a small
number of smooth muscle cells, and in aneurysmal
disease undergoes the most significant changes. The
tunica adventitia forms the outer layer of the aorta
and consists of collagen with scattered elastin fibres.
The role of collagen and elastin
The collagen and elastin have quite distinct mechanical
roles in the aorta. Collagen can only expand by 4% of
its original length but provides tensile strength at
high pressures preventing over-distension. Elastin can
expand by 50-70% of its original length, allowing
stress to be distributed uniformly throughout the wall.
At low pressures elastin bears most of the stress/
pressure load on the aortic wall maintaining the equi¬
librium between mural haemodynamic stress and the
resultant deformation. During aneurysm formation the
collagen layer is changed to become densely struc¬
tured, less pliable and thickened.1' The result is an
arterial wall which has little ability to stretch in re¬















Fig. 1. Pressure-diameter curves of the abdominal aorta compiled
from males in the three different age groups; young, middle-aged
and elderly. With increasing age the pressure-diameter curves be¬
come less steep, the aortic diameter increases and the non-linear
behaviour becomes less obvious. Thus, with age the aorta becomes
less distensible and dilates. (Reproduced from Sonneson B, Lanne
T, Vernersson E, Hansen F. Sex differences in the mechanical prop¬
erties of the abdominal aorta in human beings. ] Vase Surg 1994;
20(6): 959-969).
The human aorta undergoes expansion throughout
life, with a more rapid rate occurring over the age of
60 years.19 Several authors have suggested that . .
ageing plays a far greater role in the widening of the
aorta ..than has previously been acknowledged.19"21
Sonesson et al.21 found that the healthy male aorta
expands by 30% between the ages of 25 and 70 years
and, perhaps more importantly, the fractional diameter
change (aortic wall excursion during the cardiac cycle)
at 71 years is 14% of that at 5 years. This can be
illustrated by comparing the exponential pressure-
diameter curve of a 25-year-old with the more linear
curve found in the elderly (Fig. 1). Fractional diameter
change is, however, dependent on several physio¬
logical variables, namely mean arterial pressure, car¬
diac output, stroke volume, heart rate and vessel
diameter. This makes it difficult to compare the results
of different studies.
Evidence for the effect of ageing on aortic diameter
is, however, limited and aortic changes similar to those
previously described as aneurysmal growth occur in
12.5-25% of the population with increasing age.20 This
implies that the threshold for distinguishing between
normal and abnormal aortic diameter is age-
dependent.20 It is suggested that at any age level an
upper limit for aortic diameter should be chosen which
will result in 6% of the population having a diameter
greater than the chosen limit, and that this will be
sufficiently accurate in the prediction of aneurysm
expansion. At this level a 60-year-old male with an
Eur J Vase Endovasc Surg Vol 13, June 1997
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aortic diameter of 24 mm would be followed up,
whereas a 75-year-old with aortic diameter of 36mm
would not. These "safe" thresholds are dependent on
growth rate, which can be used to dictate intervals
between scans.
Aneurysm Formation and Expansion
Aneurysmal formation and expansion occurs in re¬
sponse to the loss of elastin and collagen fibres, which
provide resistance to stretching of the wall. Proteolytic
activity is due to elastase and collagenase, which are
principally produced by macrophages and neutrophil
polymorphonuclear cells. These inflammatory in¬
filtrates are often found in AAA walls. However, the
respective roles of elastase and collagenase in the
formation of aneurysms have not yet been clari¬
fied.22,23
The roles of elastolysis, collagenolysis, inflammatory
cells and hypertension in the pathogenesis of an¬
eurysms were analysed using two in vivo rat models.22
The fragmentation of elastin and attenuation of the
media was found to lead to a limited increase in
AAA diameter. At this early stage, collagen fibres
and intimal/plaque thickening maintain the structural
integrity and cylindrical shape of the aorta. The ad-
ventitia also appears to increase in circumferential area
in order to maintain its original thickness.23
Subsequently, inflammatory infiltrates, lymphocytes
and macrophages cause dissociation of the collagen
fibres; the loss of tensile strength leads to the haemo-
dynamic equilibrium becoming unbalanced, with re¬
sulting expansion in size of the aorta. Complete
rupture is avoided by a complex remodelling process
involving neosynthesis of collagen fibres and trans¬
formation of the cylindrical aorta to a more spherical
aneurysm which compensates for the haemodynamic
changes. Plasmin and thioglycollate continue to cause
dissociation of the elastin and collagen fibres, leading
to progressive dilatation and degeneration of the wall
(Fig. 2).18,22,23 Hypertension has also been found to be
associated with increased inflammation, remodelling
and aortic dilatation, and to be a risk factor for AAA
expansion.22
Stereological analysis of volume fractions of the
components of aneurysm walls show that collagen
and ground substance were increased by up to 77%,24,25
whereas the volume fractions of elastin and smooth
muscle cells were reduced (elastin by 63-92%24,26~28).
Thus, in comparison with normal aortic walls, both
the composition, in terms of volume fractions, and














Fig. 2. Pathogenesis of abdominal aortic aneurysm. Modified from
McSweeney et al.w
Although atherosclerosis and aneurysm commonly
co-exist, the former is thought to be more a pre¬
disposing factor rather than the single instigator of
aneurysm formation. When associated with ath¬
erosclerotic occlusion AAA is usually limited to the
infrarenal aorta, unlike the variety which is not as¬
sociated with atherosclerosis when AAA is commonly
part of a general arteriomegaly, and therefore multi¬
focal. A comparison of the collagenase activity in
patients with and without abdominal aortic aneurysms
showed that this enzyme was localised in the aneur¬
ysmal wall and was inactive in the vessel wall affected
by atherosclerosis. In fact only the aneurysmal walls
produced measurable collagenase activity.29
The complexity of the process of aneurysm for¬
mation is evident. The precise mechanisms behind the
proteolytic activity remain to be clarified, although the
overall sequence of events has become more apparent
in recent years.
Disease Definition
Several definitions of abdominal aortic aneurysm are
used at present, which produces very different results
in evaluating the incidence and prevalence of the
disease.30 Moher et al.30 used three definitions to evalu¬
ate disease frequency, case prevalence and prevalence





Eur ] Vase Endovasc Surg Vol 13, June 1997
524 K. A. Wilson et al.
Table X. Comparison of estimates of mean annual growth rates at various initial diameter measurements.44
Growth rate (mm/month)
Author No. studied 3.0-3.9 cm 4.0^.9 cm 5.0-5.9 cm Total >6 cm
Bernstein et al.46 49 0.26 0.51 — 0.39
Kremer et al,x 35 0.19 0.18 — 0.17
Bernstein and Chan16 110 0.39 0.36 0.43 0.37 0.64
Cronenwett et al.39 67 0.79 (T) 0.45 (T) — 0.57 (T)
0.19 (AP) 0.5 (AP) 0.22 (AP)
Delin et al.37 35 0.54 0.47 0.47 0.52 0.7
Sterpetti et al?1 125 0.25 0.4-0.56 — 0.48
Collin et al?7 50 — — — 0.22
Nevitt et al?5 103 0.26 0.46 — 0.32
Limet et al?s 114 0.53 0.69 — — 0.74
International Society of Cardiovascular Surgery (SVS/
ISCVS) define an aneurysm as a 50% dilatation of the
normal artery adjusted for gender and radiological
modality;31 (2) Sterpetti et al.32 suggest a ratio of infra-
renal to suprarenal diameters of ^1.5; and (3) Collin33
defines an abdominal aortic aneurysm as the maximal
infrarenal diameter being 4.0 cm or more, or exceeding
the maximum diameter of the aorta between the origin
of the superior mesenteric and left renal arteries by at
least 0.5 cm.
According to the definitions above,30AAA frequency
was found to range from five33 to 2332 (no units were
given). Prevalence rate among the control group was
3.5,33 or 12.1%,32 and sibling prevalence ratio or relative
risk was found to be 0.332 compared with 1.631 found
by the SVS/ISCVS definition.
The latter finding shows most effectively the con¬
sequences of differing definitions. Sterpetti's32 study
suggests that siblings are at less than half the risk of
the normal population of developing an aneurysm,
whereas the SVS/ISCVS31 data suggest that "they are
at 1.6 times the risk. The conclusion to be drawn from
this comparison of studies is that it is only possible to
compare studies with similar definitions, which limits
the ability of investigators to pool information from
several sources. A definition which is sensitive enough
to capture small aneurysms which are likely to become
dangerous is essential; however, until a clear and
uniform definition is used the true epidemiology of
aortic aneurysm will not be elucidated.
Limitations in Assessment of Expansion Rates
Assessment of expansion rate
Aneurysm expansion rates are highly variable, both
over time and between different aneurysms.34 It has
been well documented that rate of expansion tends to
increase exponentially in relation to size at dia¬
gnosis.34"37 Thus most authors assess growth rates and
patterns in subsets of initial diameter (Table 1).
There is considerable variation in the estimates of
"normal" expansion rates of AAA within each subset
of initial diameter. Small aneurysms (3.0-3.9 cm dia¬
meter) have been observed growing at a rate of
0.19-0.79 cm/year,38,39 and aneurysms of 4.0-4.9 cm
diameter can expand at anything between 0.18 and
0.69 cm/ year.35,38
Examination technique
The effect of using differing examination techniques
might also have produced a source of incomparability.
While some authors suggest that there is no significant
difference between radiological modalities, i.e. ultra¬
sound vs. CT scan,30 there are studies that have found
that aortic aneurysm size is greater if assessed by
ultrasound,40 while other studies suggest that CT scan¬
ning is the more accurate method of size de¬
termination.41 While the heterogeneity may originate
elsewhere, the examination technique employed in the
assessment of aortic aneurysm size further complicates
meaningful interpretation of the available literature.
Errors in methodology
Many studies based on autopsy findings and referrals
are subject to considerable selection bias.21'42^14 It may
also be the case that the group of patients who are
operated on are different from those who rupture or
are not considered for surgery, which would com¬
promise the comparability of the groups. The precision
of scan measurements is usually + 5 mm (or within
5%35), in which case a growth rate of 2 mm per year
could take 3 years to be recognised, depending on the
original size of the aneurysm.20
The large variation in findings among the studies
in Table 1 may be due to two quite distinct factors. The
authors included in Table 1 may have been comparing
Eur J Vase Endovasc Surg Vol 13, lune 1997
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different populations, in which case the rates observed
are real and different for each group included. Or,
abdominal aortic aneurysms as a group exhibit little
or no homogeneity in growth patterns at any stage.
In order to investigate this, it is necessary to assess
the comparability of these studies, and indeed these
authors used a variety of definitions to categorise their
subjects.
Selection bias
Within the studies, the populations varied in that some
authors included only patients unfit for surgery while
others observed all patients. The result is that any
effect of the cardiac, respiratory or cerebrovascular
conditions preventing surgery have not been evalu¬
ated. Aneurysms in patients with co-existing cardio¬
respiratory disease might have different dynamic
characteristics from those with no other serious dis¬
ease.
Similarly, Limet et al.3' used a cohort of all patients
admitted to hospital with AAA and observed those
unfit for surgery. However, those being admitted to
hospital because of a symptomatic or expanding an¬
eurysm may be a different group from those who only
require care at an outpatient clinic. A selection process
has taken place among these patients which may
overestimate the mean expansion rate within the gen¬
eral population of AAA sufferers.
Nevitt et al.i5 claimed that because their population-
based study included assessment of ultrasound scans
of all patients with AAA, their results were not subject
to the same confounding factors as autopsy or ad¬
mission studies. At specialist referral centres, patients
are selected according to severity of disease or symp¬
toms and do not reflect the spectrum of disease in the
community.
Sample size
Sample size also has an important influence on the
validity of findings. For example, inferences made
about the representativeness of the observed char¬
acteristics in a sample of the general population are
more likely to be correct if the sample size is large. It
is not within the remit of this article to assess the
optimal sample size for each study reviewed; however,
it is important to note the very different sample sizes




Most prospective observational studies suffer losses
to follow-up which reduce the validity of the data.
Bernstein et al.46 followed patients for 10 years but
gave no indication of the numbers lost in this way nor
assessed the effect on their results. The effect of losses
to follow-up is dependent on the causes. For example,
if patients are lost to follow-up the rate of growth could
possibly be an overestimate of "normal" expansion
because those with little or no growth may be less
motivated to attend outpatient appointments. On the
other hand, if patients are lost because they die as a
result of aneurysm rupture, estimates of expansion
rate may be underestimated.
Itwould appear, therefore, that in view of the diverse
nature of the studies reporting AAA growth rate, most
of which are retrospective observation studies, meta¬
analysis cannot be reliably performed. This is due to
the lack of homogeneity in the patients studied, the
definitions employed, and the outcomes measured.
Conclusions
The healthy male aorta expands by 30% between the
ages of 25 and 70 years and, perhaps more importantly,
the fractional diameter change (aortic wall excursion
during the cardiac cycle) at 71 years is 14% of that at
5 years. The expected rate of change in aortic diameter
is used as an important predictor of the risk of rupture,
but the few studies which have assessed expansion
rates have produced quite different results.
Evaluation of these studies shows that they are not
wholly comparable in terms of source population,
sample size, disease definition and period of as¬
sessment, thus limiting the value of pooled data. For
this reason it is not possible to derive with confidence
the expansion rates of aneurysms at any diameter. The
possibility remains that abdominal aneurysms, as a
group, exhibit little or no homogeneity in growth
patterns at any stage. While the SVS/ISCVS definition
of an aneurysm as a 50% dilatation of the normal
artery adjusted for gender and radiological modality31
may be the most realistic definition currently available,
it fails to take fully into account the effects of ageing,
and until a clear and uniform definition is adopted
the true epidemiology and natural history of aortic
aneurysm will remain obscure.
Acknowledgments
K. Wilson is funded by the British Heart Foundation.
Eur J Vase Endovasc Surg Vol 13, June 1997
526 K. A. Wilson et al.
References
1 Naylor AR, Webb J, Fowkes FGR, Ruckley CV. Trends in
abdominal aortic aneurysm surgery in Scotland. Eur J Vase Surg
1988; 2: 217-221.
2 Unpublished data. Information and Statistics Division, NHS in
Scotland, 1996.
3 Fowkes FGR, MacIntyre CCA, Ruckley CV. Increasing in¬
cidence of aortic aneurysm in England and Wales. Br Med ] 1989;
298: 33-35.
4 Barabas AP. Ehlers-Danlos syndrome. In: Greenhalgh RM, Man-
nick JA, eds. The cause and management of aneurysms. London:
WB Saunders, 1990: 57-67.
5 Crawford ES. Marfan's syndrome. In: Greenhalgh RM, Mannick
JA, eds. The cause and management of aneurysms. London: WB
Saunders, 1990: 69-78.
6 Castleden WH, Mercer JC. Abdominal aortic aneurysms in
western Australia: descriptive epidemiology and patterns of
rupture. Br J Surg 1980; 72: 109-112.
7 Melton JL, Bickerstaff LK, Hollier L, et al. Changing in¬
cidence of abdominal aortic aneurysms: a population based
study. Am J Epidemiology 1984; 120: 379-386.
8 Samy AK, Whyte B, McBain G. Abdominal aortic aneurysm in
Scotland. Br J Surg 1994; 81: 1104-1106.
9 Estes JE. Abdominal aortic aneurysm: a study of 102 cases.
Circulation 1950; 2: 258-264.
10 Darling RC, Messina CR, Brewster DC, Ottinger LW. Aut¬
opsy study of unoperated abdominal aortic aneurysms: the case
for early resection. Circulation 1977; 56 (Suppl. II): 161-164.
11 Jenkins AMcL, Ruckley CV, Nolan B. Ruptured abdominal
aortic aneurysm. Br / Surg 1986; 73: 395-398.
12 Harris PL. Reducing the mortality from abdominal aortic an¬
eurysms: need for a national screening programme. Br Med J
1992; 305: 697-699.
13 Johnstone KW. Ruptured abdominal aortic aneurysm: six year
follow-up results of a multi-centre prospective study. Canadian
Society for Vascular Surgery Aneurysm Study Group. / Vase
Surg 1994; 19: 888-900.
14 Katz DJ, Stanley JC, Zelenock GB. Operative mortality rates
for intact and ruptured abdominal aortic aneurysm in Michigan:
an eleven-year statewide experience. / Vase Surg 1994; 19: 804-
815.
15 Mutirangura P, Stonebridge PA, Clason AE, McLure JH,
Wildsmith JAW, Nolan B, Ruckley CV, Jenkins AMcL. Ten
year review of non-ruptured aortic aneurysms. Br J Surg 1989;
76: 1251-1254.
16 Bernstein EF, Chan EL. Abdominal aortic aneurysm in high-
risk patients. Ann Surg 1984; 200: 255-263.
17 Millis JM, Brown SL, Busuttil RW. Thoracic and abdominal
aneurysms. In: Bell PRF, Jamieson CW, Ruckley CV, eds. Surgical
management of vascular disease. London: WB Saunders, 1992: 797-
825.
18 McSweeney STR, Powell JT, Greenhalgh RM. Pathogenesis of
abdominal aortic aneurysm. Br J Surg 1994; 81: 935-941.
19 Lanne T, Hansen F, Mangell P, Sonnesson B. Differences
in mechanical properties of the common carotid artery and
abdominal aorta in healthy males. / Vase Surg 1994; 20: 218-225.
20 Grimshaw GM, Thompson JM. The abnormal aorta: a statistical
definition and strategy formonitoring change. Eur J Vase Endovasc
Surg 1995; 10: 95-100.
21 Sonesson B, Hansen F, Stale H, Lanne T. Compliance and
diameter in the human abdominal aorta—the influence of age
and sex. Eur J Vase Surg 1993; 7: 690-697.
22 Anidjar S, Dobrin PB, Cheifec G, Michel J-B. Experimental
study of determinants of aneurysmal expansion of the abdominal
aorta. Ann Vase Surg 1994; 8: 127-136.
23 Halloran BG, Baxter BT. Pathogenesis of aneurysms. Sem Vase
Surg 1995; 8: 85-92.
24 He CM, Roach MR. The composition and mechanical properties
of abdominal aortic aneurysms. J Vase Surg 1994; 20: 6-13.
25 Menashi S, Campa JS, Greenhalgh RM, Powell JT. Collagen
in abdominal aortic aneurysms: typing, content and degradation.
/ Vase Surg 1987; 6: 578-582.
26 Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in
abdominal aortic aneurysm. Athersclerosis 1987; 65: 13-21.
27 DubickMA, Hunter GC, Perez-Lizano E, Mar G, Geokas MC.
Assessment of the role of pancreatic protease in human aortic
aneurysms and occlusive disease. Clin Chim Acta 1988; 177: 1-10.
28 Rizzo RJ, McCarthy WJ, Dixit SN, Lilly MP, Shively MP,
Flinn WR, Yoa JST. Collagen type and matrix protein content
in human abdominal aortic aneurysms. J Vase Surg 1989; 10:
365-373.
29 Busuttil WR, Abou-Zamzam AM, Machleder HI. Collagenase
activity of the human aorta. Arch Surg 1980; 115: 1373-1378.
30 Moher D, Cole CW, Hill GB. Epidemiology of abdominal
aortic aneurysms: the effect of differing definitions. Eur ] Vase
Surg 1992; 6: 647-650.
31 Johnstone KW, Rutherford RB, Tilson MD, Shah DM, Holl¬
ier M, Stanley JC. Suggested standards for reporting on arterial
aneurysms. J Vase Surg 1991; 13: 444-450.
32 Sterpetti AV, Schultz RV, Feldhaus RJ, Cheng SE, Peetz DJ.
Factors influencing enlargement rate of small abdominal aortic
aneurysms. J Surg Res 1987; 43: 211-219.
33 Collin J. A proposal for a precise definition of abdominal aortic
aneurysm: a personal view. / Cardiovase Surg 1990; 31: 168-169.
34 Stonebridge PA, Draper T, Howlett J, Allan PL, Prescott
R, Ruckley CV. Growth rate of infrarenal aortic aneurysms. Eur
J Endovasc Surg 1996; 11: 70-73.
35 Limet R. Determination of level of expansion and incidence of
rupture of abdominal aortic aneurysms. Bull Mem Acad R Med
Belg 1992; 147(6-7): 253-261.
36 Masuda Y, Takanashi K, Takasu J, Morooka N, Inagaki Y.
Expansion rate of thoracic aortic aneurysms and influencing
factors. Chest 1992; 102(2): 461^66.
37 Delin A, Ohlsen H, Swedenborg J. Growth rate of abdominal
aortic aneurysms as measured by computed tomography. Br J
Surg 1985; 72: 530-532.
38 Kremer H, Weigold B, Dobrinski W, Schreiber MA, Zollner
N. Sonographische verlaufsbeobachtungen von bau-
chaortenaneurysmen. Klin Wochenschr 1984; 62: 1120-1125.
39 Cronenwett JL, Murphy TF, Zelenock GB, et al. Actuarial
analysis of variables associated with the rupture of small ab¬
dominal aortic aneurysms. Surgery 1985; 98: 472^483.
40 Ellis M, Powell JT, Greenhalgh RM. Limitations of ultra¬
sonography in surveillance of small abdominal aortic aneurysms.
Br J Surg 1991; 78: 614-616.
41 Gomes MN, Hakkal HG, Schellinger D. Ultrasonography
and CT scanning: a comparative study of abdominal aortic
aneurysms. Comp Tomog 1978; 2: 99-110.
42 Pleumeekers HJCM, Hoes AW, Van Der Does E, Van Urk H,
Grobbee DE. Epidemiology of abdominal aortic aneurysms. Eur
J Vase Surg 1994; 8: 119-128.
43 Bengtsson H, Bergqvist D, Sternby NH. Increasing prevalence
of abdominal aortic aneurysms. A necropsy study. Eur ] Surg
1992; 158: 19-23.
44 McFarlane MJ. The epidemiologic necropsy for abdominal
aortic aneurysm. JAMA 1991; 265: 2085-2088.
45 Nevitt MP, Ballard DJ, Hallett JW. Prognosis of abdominal
aortic aneurysms. N Engl J Med 1989; 321: 1009-1014.
46 Bernstein EF, Dilley RB, Goldberger LE, Gosink BB, Leopold
GR. Growth rates of small abdominal aortic aneurysms. Surgery
1976; 80: 765-773.
47 Collin J, Araujo L, Walton J. How fast do very small ab¬
dominal aortic aneurysms grow? Eur J Vase Surg 1989; 3: 15-17.
48 Limet R, Sakalihassan N, Albert A. Determination of the
expansion rate and incidence of rupture of abdominal aortic
aneurysms. J Vase Surg 1991; 14: 540-548.
Accepted 23 December 1996
Eur J Vase Endovasc Surg Vol 13, June 1997
Venous Homograft as Arterial Substitute in Limb injuries 471
Larger series of patients and longer follow-up have
to be gained in order to validate our results and
to define preservation characteristics, immunological
interactions and clinical use of this conduit.
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Relationship Between Abdominal Aortic Aneurysm Wall Compliance
and Clinical Outcome: a Preliminary Analysis
K. Wilson*, A. Bradbury, M. Whyman, F. Hoskins1, A. Lee2, G. Fowkes2,
P. McCollum3 and C. Vaughan Ruckley
Vascular Surgery Unit, 1Department of Medical Physics, 2Wolfson Unit for the Prevention of Peripheral Vascular
Diseases, University of Edinburgh, Royal Infirmary, Edinburgh EH3 9YW and 3Nineivells Hospital and Medical
School, Dundee DDI 9SY, U.K.
Background: Aortic compliance, as measured by the pressure-strain elastic modulus (Ep) and stiffness (B), may allow a
more precise estimate of abdominal aortic aneurysm rupture risk than size alone.
Aim: To determine the relationships between AAA compliance, size, growth, and clinical outcome.
Methods: One-hundred and twelve patients with initially non-operated AAA (86 men, 26 women, mean age 73 years),
recruited from five centres, underwent baseline compliance measurements and were then followedfor a median of 7 (range
2-18) months; 85 patients underwent repeated measurements (median 3, range 2-5) 3-6-monthly over a median of 12
(range 3-18 months).
Results: Seven patients have ruptured and 16 have undergone repair of non-ruptured AAA. AAA that ruptured had
significantly lower Ep and B (more compliant). In AAA that ruptured or required repair there was an inverse relationship
between diameter and Ep and B. In those undergoing repeated measurements AAA expansion was only associated zvith
a significant increase in Ep and B in non-operated patients.
Conclusions: Baseline AAA compliance was significantly related to rupture and the future requirement for operative
repair. Failure of compliance to increase with size may be a marker for rapid growth, developmental symptoms and
rupture.
Introduction
Ruptured abdominal aortic aneurysm (AAA) is as¬
sociated with a 30-day combined community and hos¬
pital mortality of 90%. By contrast, the mortality
associated with elective repair is currently 10% or
less in many centres.1 The decision to operate on an
asymptomatic AAA involves weighing the risk of
rupture against the risk of operative repair for that
individual patient. The risk of rupture is currently
estimated primarily on the basis of maximal diameter
and growth rate, although both variables are known
to be inaccurate predictors of rupture. As no size of
AAA appears to be entirely free from the risk of rapid
expansion and rupture,2 a method which provides
a more precise quantification of risk for individual
patients is urgently required. It is hypothesised that
compliance, which relates directly to aortic wall be¬
haviour and composition, might provide such in¬
formation. The aim of the present study was to
investigate, for the first time, the relationship between
* Please address all correspondence to: K. Wilson.
AAA wall compliance, maximum diameter and
growth rates in a series of patients, with initially non-
operated and asymptomatic AAA.
Patients and Methods
One-hundred and twelve patients with non-operated
AAA, recruited from five different centres, underwent
baseline compliance measurements, and were fol¬
lowed for a median of 7 (range of 2-18) months. The
mean age of the patients was 73 years. There were 86
men and 26 women. Patients were not operated on
initially, either because of small size or because of co¬
morbidity which, in the opinion of their surgeon,
precluded AAA repair. All patients gave fully in¬
formed consent and the study was approved by the
local ethics committees. A subset of 85 patients under¬
went repeated compliance measurements (median 3,
range 2-5) at 3-6-monthly intervals over a median
follow-up period of 12 (range 3-18) months.
The decision to subsequently operate or not upon a
1078-5884/98/060472 + 06 $12.00/0 © 1998 W.B. Saunders Company Ltd.
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patient in this study group was left entirely to the
discretion of the consultant surgeons responsible, who
were unaware of compliance data. Although it could
be argued that stipulating criteria for operation would
have allowed the end-points of the study to be defined
more precisely, in the opinion of the authors and
the relevant ethics committees this would have been
unsatisfactory for two reasons. Firstly, at the outset
of the study it was not possible to know whether
compliance would or would not relate to future an¬
eurysm behaviour. Secondly, any influence exerted by
the authors on the decision to operate might have
biased the results of the study. The requirement for
surgery was precipitated by onset of symptoms (ab¬
dominal and/or back pain) in two cases, and in 14
cases because, in the opinion of the responsible con¬
sultant, the AAA had enlarged to a point where the
benefits of repair outweighed the potential risks.
Compliancewasmeasured bymeans of an electronic
echo-tracking device (Diamove, Teltec, Lund, Sweden)
interfaced with a B-mode real-time ultrasound scanner
(EUB-240, Hitachi, Tokyo, Japan) fitted with a 3.5 MHz
linear array transducer. An echo-tracking phase-locked
loop circuit restored the position of an electronic gate
relative to the moving echo and yielded the echo
movement per unit time. The instrumentwas equipped
with dual echo-tracking which made it possible to track
simultaneously two separate echoes from opposing
vessel walls. The difference between signals indicated
instantaneously the change in vessel diameter. The
calculated smallest detectable movement was 7.8 pm,
the repetition frequency of the echo-tracking loops
was 870 Hz, and the time resolution was therefore
approximately 1.2 ms. The data acquisition unit com¬
prised a 486 personal computer (Toshiba) linked to a
12-bit analogue-to-digital converter (Analogue De¬
vices, Norwood, U.S.A.). Change in maximal AAA
diameter with cardiac cycle was measured over an
lis period.
Strain (fractional diameter change) was defined as:
maximal systolic diameter -maximal diastolic diameter
Strain = ; — —
maximal diastolic diameter
The arterial wall distensibility was initially expressed
as pressure strain elastic modulus (Ep) where:
^ ^ systolic pressure - diastolic pressure
strain
The constant K = 133.3 and allows Ep to be converted
from mmHg to Newton (N/m2).
Because of the non-linear pressure-diameter re¬
lationship of the normal arterial wall, Ep is pressure
dependent. Previous workers have observed a linear
relation in vitro between the logarithm of relative
pressure and distension ratio. This index is called
stiffness (B) and appears to characterise the entire
deformation behaviour of the arterial wall, without
pressure dependence, within the physiological range.
Stiffness may therefore be a more useful index of aortic
compliance than Ep; although whether this re¬
lationship holds true for the human aneurysmal aorta
in vivo is unknown. The higher Ep and B, the less
distensible the artery and the lower the compliance.
For a more detailed discussion of these concepts the
reader is referred to two recent reviews.3,4
Systolic and diastolic blood pressures were meas¬
ured in the brachial artery in the usual way by aus¬
cultation following inflation and deflection of a
sphygmomanometer. Brachial pressure is known to be
lower than aortic pressure. However, previous au¬
thors3,4 have concluded that although Ep and B are
consequently under-estimated, this is a systematic
error that is likely to affect equally the members of any
particular study group. Furthermore, if compliance is
to prove a clinically useful variable worthy of routine
measurement, its value must be established in relation
to brachial pressure rather than a scientifically more
robust but impracticable direct intra-arterial measure¬
ment of blood pressure. Mean arterial pressure (MAP)
was diastolic pressure plus one-third pulse pressure.5
Because variables were highly skewed, linear as¬
sociations between pairs were assessed using Spear¬
man's rank correlation. Data was entered on the
Edinburgh University mainframe computer for stat¬
istical analysis.
Results
Baseline compliance measurements, size and
subsequent outcome
Seven patients have ruptured and 16 have undergone
operative repair for non-ruptured AAA; two for symp¬
toms (abdominal and/or back pain) and 14 due to
increase in size. Seven patients have died of unrelated
causes.
Patients who went on to rupture had a greater
baseline maximal AAA diameter than those who were
operated for non-rupture, who in turn had larger AAA
than those who did not rupture or undergo repair.
Patients who ruptured had lower baseline Ep and B
than those who were operated for non-rupture, who
in turn had lower baseline Ep and B than those who
neither ruptured nor were operated (Table 1).
Eur J Vase Endovasc Surg Vol 15, June 1998
474 K. Wilson et at.
Table 1. Comparison of baseline size, Ep, and B in those patients who went on to rupture, required
operative repair of non-ruptured AAA, and those who did not.
Baseline compliance Rupture Operated Not operated p value*
measurements (n= 7) (non-rupture) or ruptured
median (range) (n = 16) (n = 89)
Maximal diameter (mm) 54.9 49.2 45.0 p<0.01
(46.9-72.0) (42.4-70.3) (28.8-77.2)
Strain - Ep (N/m2) 2.16 2.45 2.79 p<0.01
(1.59-3.72) (1.22-7.58) (0.55-9.46)
Stiffness - B (arbitrary units) 15 17.3 18.2 p<0.01
(9.1-23.0) (9.9-51.5) (4.0-71.6)
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Fig. 1. Correlation between baseline maximal diameter and Ep in
patients with non-ruptured AAA that required operative repair;
Spearman coefficient, r= — 0.45, p = 0.074.
10 20 30 40 50 60 70 80
Baseline size (mm)
Fig. 2. Correlation between baseline maximal diameter and B in
patients with non-ruptured AAA that required operative repair;
Spearman coefficient, r= —0.47, p = 0.067.
Relationship between baseline compliance and size
In patients who subsequently ruptured there was a
non-significant inverse relationship between baseline
maximal diameter and baseline Ep (Spearman co¬
efficient, r = — 0.25, p= 0.6) and between baseline max¬
imal diameter and baseline B (Spearman coefficient,
r=-0.11, p = 0.84).
Patients who underwent operative repair of non-
ruptured AAA also demonstrated a non-significant
inverse relationship between baseline maximal dia¬
meter and baseline Ep (median 2.45, range 1.22-7.58,
N/m2) (Spearman coefficient, r= — 0.45, p = 0.074) (Fig.
1), and between baseline maximal diameter and base¬
line B (median 17.3, range 9.9-51.5, arbitrary units)
(r= -0.47, p = 0.067) (Fig. 2).
By contrast, in the 89 patients who neither ruptured
nor required operative repair {n = 89), there was a
significant positive correlation between baseline max¬
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Fig. 3. Relationship between baseline maximal diameter and Ep in
patients with AAA which did not rupture or require operative
repair; Spearman coefficient, r= 0.27, p<0.01.
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Fig. 4. Relationship between baseline maximal diameter and B in
patients with AAA which did not rupture or require operative
repair; Spearman coefficient, r= 0.24, p = 0.018.
and baseline Ep (median 2.79, range 0.55-9.46, N/m2)
(Spearman coefficient, r— 0.27, p<0.01) (Fig. 3); and
between baseline maximal diameter- and baseline B
(median 18.2, range 4.0-71.6, arbitrary units) (r= 0.24,
p = 0.018) (Fig. 4).
Change in size and compliance over time
In the subset of 85 patients undergoing repeated com¬
pliance measurements, two patients have ruptured,
eight have undergone operative repair ofnon-ruptured
AAA and four have died of unrelated causes. Due to
small sample size, statistical analysis has been re¬
stricted to a comparison of the (non-rupture) operated
group and the non-operated groups.
Although there was a significant increase in size in
both the operated non-rupture and the non-operated
groups over the period of the study, only the non-
operated group demonstrated a significant increase in
Ep and B; that is, an increase in stiffness (Table 2).
Conclusions
Numerous attempts have been made to predict, on
the basis of physical characteristics, which AAA will
rupture and which are safe to observe.6,7 Previous
work has focused upon absolute size (maximal an¬
terior-posterior or transverse diameter, cross-sectional
area), relative size (standardised on the basis of patient
build, age and sex),8 shape (circular vs. elliptical cross-
sectional profile on computed tomography),9 wall
thickness and blistering10 and expansion rate.11,12 An¬
eurysm size and expansion may, in turn, be affected
by other factors such as hypertension13 and continued
smoking.14
Unfortunately, the predictive value of these vari¬
ables, while perhaps being useful in population stud¬
ies, is insufficient to quantify risk on an individual
patient basis. Rupture of small AAA, though un¬
common, is well recognised, suggesting that other
factors more directly related to aortic wall behaviour
may be more important and worthy of study.15 Flow-
ever, to date, little work has been performed defining
the mechanical properties of the aneurysm wall itself.
Aneurysmal dilation of the aorta is associated with
a significant decrease in elastin and smooth muscle
content and an increase in collagen and ground sub¬
stance. In vitro studies comparing the tensile strength
of excised normal and aneurysmal human aorta ob¬
tained at surgery or post-mortem have indicated that
aneurysmal tissue is much less distensible; and that
this loss of compliance is related to loss of elastin
from the wall.16,17 Aortic compliance, as measured by
Doppler ultrasound assessment ofpulse wave velocity,
is reduced in adults at increased risk of athero¬
sclerosis18 and suchmeasurements have been proposed
as a useful screening test for premature vascular
disease.19
In this prospective study, baseline compliance meas¬
urements have been made in order to determine
whether differences in compliance might predict rup¬
ture and/or the future requirement for operative
Table 2. Comparison of maximal diameter, growth, Ep and B in operated and non-operated patients
who underwent repeated compliance measurements.





Maximal diameter (mm) 48.1 (43.5-56.6) 53.1 (46.2-68.6) p = 0.03
Strain Ep (N/m2) 2.85 (1.22-6.05) 3.44 (1.1-6.54) p = 0.74
Stiffness B (arbitrary units) 18.6 (9.9-51.5) 20.45 (9.3-45.4) p = 0.84
Non-operated AAA 44.3 (28.8-77.2) 49.6 (31.4-80.9) II O O
Maximal diameter (mm)
Strain Ep (N/m2) 2.42 (0.55-9.23) 3.64 (0.95-8.65) p = 0.0038
Stiffness B (arbitrary units) 18.1 (4.0-71.6) 25.2 (7.5-60.3) p = 0.002
' Wilcoxon signed rank test for paired, non-parametric data.
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intervention on account of symptoms or expansion.
Both compliance and maximal diameter varied widely
in the rupture, the non-rupture operated, and the non-
rupture non-operated groups. The principal finding is
that AAA which subsequently ruptured or required
operative repair, while being significantly larger at
baseline, possessed significantly lower Ep and B. In
other words, size for size, AAA which rupture or
require elective repair appear to be more compliant
than those AAA that do not.
The fundamental question is, therefore, whether
such compliance data can be used independently of
diameter to predict which AAA are at risk of rupture.
In this respect, interesting relationships between com¬
pliance and size in the different clinical groups were
observed. The relationship between compliance and
size in the non-operated, non-ruptured group was
similar to that found in a previous retrospective study
of 60 patientswith non-operated, non-ruptured AAA.20
In these patients, as their AAA increases in size there
is a significant increase in both Ep and B; that is, the
aneurysm becomes stiffer and less compliant as it
grows. By contrast, in patients who subsequently rup¬
ture or require operative intervention, Ep and B fail
to increase or even fall as the AAA grows.
It is possible that a single baseline compliance
measurement might be misleading if both size and
compliance were to change between that time and the
time the AAA ruptures or is repaired. For this reason,
repeated measurements were performed in a subset of
patients to determine whether a change in compliance
over time might relate to future clinical outcomes.
The principal finding is that the relationship between
compliance and size observed in the clinical groups is
also observed in individual AAAs over time. Thus,
while there was a significant increase in size in both
operated and non-operated AAA, only the non-op¬
erated AAAs demonstrated a significant increase in
Ep and B. In the operated AAA, increasing size was
not associated with a significant increase in stiffness.
Taken together, these preliminary data suggest that,
while a single baseline compliance measurement may
be able to distinguish those AAA that subsequently
rupture or require operative repair, changes in com¬
pliance over time are likely to be a better predictor of
future behaviour. In particular, failure of compliance
to decrease with size, and/or an increase in the com¬
pliance of a large AAA over time, may be markers
for above average growth, onset of symptoms, and
rupture.
One might speculate that small AAA are more com¬
pliant than large AAA because they retain many of the
features of the normal arterial wall in that a significant
proportion of the wall still comprises elastin. As AAA
enlarge, elastin is replaced with collagen and com¬
pliance decreases; that is, they become stiffer. Once
AAA reach a certain size, which may vary considerably
between different patients, it may be possible to dif¬
ferentiate AAA on the basis of compliance meas¬
urements into two types:
(a) Type IAAA. Further enlargement is accompanied by
further increases in stiffness. This increase in stiffness is
due to increasing collagen deposition and/or re¬
modelling in the aortic wall which actually confers
strength to the AAA such that the risk of rupture is,
in fact, low.
(b) Type II AAA. Further enlargement is not associated
with an increase in stiffness and, in fact, stiffness may
even fall. This may be because of a failure to lay down
and remodel collagen, leading to the production of an
aortic wall which is weak or "thinning". It is these
AAA that may be at risk of rupture.
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A 10-year Follow-up of Patients Presenting with Ischaemic Rest Pain of
the Lower Limbs
S. R. Walker*, S. W. Yusuf and B. R. Hopkinson
Department of Vascular and Endovascular Surgery, Queens Medical Centre, Nottingham NG7 2UH, U.K.
Objectives: To determine the 10-year outcome of patients presenting with rest pain.
Methods: One hundred and three consecutive patients presenting with ischaemic rest pain in 1987 were followed up
after 10 years. Hospital notes, death certificates and telephone interviews with patients were used to determine outcome.
Results: Follow-up data is available for 97 (94%) patients. Thirteen patients are alive (13.7%) after 10 years, 12 presented
with rest pain alone and one had ulceration. Three of these had amputation. The commonest cause ofdeath was myocardial
infarction (n=21, 25%). In those who had died, the median age of onset ofsymptoms was 72 years (49-93) for rest pain,
74 years (56-87) for ulceration and 71.5 years (45-85) for gangrene. Their survival after admission was a mean of 39
months with rest pain, 33 months with ulceration and 42 months with gangrene. The overall 5-year survival was 31%
and the 10-year survival 13%.
Conclusion: Patients presenting with ischaemic rest pain have a poor prognosis. The presence or absence of ulceration
or gangrene does not influence the outcome. Most patients die from smoking-related diseases.
Key Words: Critical limb ischaemia; Risk factors; Survival.
Introduction
Patients presenting with symptomatic peripheral vas¬
cular disease have widespread arterial disease. In
patients with intermittent claudication, 50-60% will
have an improvement in their symptoms following
changes in lifestyle, e.g. cessation of smoking and
commencement of regular exercise.1,2 However, 34—
45% of these patients are dead within 6 years due to
ischaemic heart disease.3 The prognosis in patients
presenting with rest pain is worse. They are often
elderly and frail and despite aggressive mangement
their long-term survival may be poor. In 1987, a study
on a cohort of 103 patients with rest pain presenting
to this hospital and reported by Berridge et al7 showed
that this group of patients often have multi-system
disease with multiple risk factors. This is now a long-
term follow-up of the same group of patients with the
aim of assessing survival, factors that affect survival
and causes of death.
* Please address all correspondence to: S.R. Walker, Department of
Vascular and Endovascular Surgery, E Floor West Block, Queens
Medical Centre, Nottingham NG7 2UH, U.K.
Methods
Design
A retrospective review of the outcome in patients with
rest pain at a minimum follow-up of 10 years.
Patients
One-hundred and three consecutive patients admitted
to hospital in 1987 for treatment of lower limb isch¬
aemic rest pain. This included patients with rest pain
alone, those with rest and ulceration, and those with
rest pain and gangrene. Patients with a history of
previous vascular reconstruction within the preceding
6 months were excluded. Ten years later data was
available on 97 of these 103 patients (94%).
Data collection
Data on risk factors including age, sex, diabetes, hyper¬
tension, renal failure, ischaemic heart disease, ad¬
mission haemoglobin concentration, white cell count
1078-5884/98/060478+ 05 $12.00/0 ©1998 W.B. Saunders Company Ltd.
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A prospective randomized multicentre
comparison of expanded polytetrafluoroethylene
and gelatin-sealed knitted Dacron grafts for
femoropopliteal bypass
B. I. Robinson*, J. P. Fletcher*, P. Tomlinson*, R. D. M. Allen*, S. J. Hazelton*,
A. J. Richardson* and K. Stuchberyt
*Department of Surgery, University of Sydney and Westmead Hospital, Westmead, NSW 2145,
Australia and tDepartment of Surgery, Alfred Hospital, Melbourne, Australia
Purpose: To compare graft patency between expanded polytetrafluoroethylene (PTFE) and
gelatin-sealed knitted Dacron for femoropopliteal bypass. Methods: A prospective, multicentre
trial was performed in 108 patients randomized to receive either a PTFE or Dacron prosthetic
graft. Distal anastomosis was above knee in 75 and below knee in 33 patients. Results: Primary
patency at 1, 2 and 3 years was 72, 52 and 52% for PTFE, and 70, 56 and 47% for Dacron
(P = 0.87). Secondary patency at 1, 2 and 3 years was 74, 54 and 54% for PTFE and 78, 70
and 53% for Dacron (P = 0.39). The most significant predictors of early graft failure were
poor vessel run-off (P = 0.04) and critical limb ischaemia (P = 0.04). Conclusion: There was
no difference in graft patency between PTFE and Dacron for femoropopliteal bypass. © 1999
The International Society for Cardiovascular Surgery. Published by Elsevier Science Ltd. All
rights reserved.
Keywords: Dacron, femoropopliteal bypass, polytetrafluoroethylene
It is generally accepted that autologous saphenous
vein is the first choice for femoropopliteal bypass
grafting although some consider polytetrafluoroe¬
thylene (PTFE) grafts equally acceptable or even
preferable for primary above-knee arterial recon¬
struction [1, 2], Choice of the most suitable syn¬
thetic prosthetic graft for femoropopliteal recon¬
struction remains controversial. Retrospective
studies comparing PTFE with knitted Dacron at 5
years with respect to graft patency have varied from
similar patency rates [31 to superiority of Dacron
over PTFE [4],
The aim of this study was to compare graft pat¬
ency between PTFE and gelatin-sealed knitted Dac¬
ron graft by a prospective, randomized trial.
Correspondence to: John P. Fletcher
Methods
The study was approved by the institutional ethics
committees of the participating hospitals. Patients
requiring a femoropopliteal bypass for disabling
claudication or critical limb ischaemia, and who had
absent or unusable saphenous vein, were considered
eligible for entry into the study. Between October
1991 and November 1995, 108 consecutive patients
receiving a prosthetic graft for femoropopliteal
bypass were recruited into the trial. Patients were
randomized at each of the participating centres to
receive either a PTFE or a Dacron graft (Gelsoft,
Vascutek, UK).
Demographic and risk factors assessed were age,
sex, ischaemic heart disease, hypertension, diabetes,
smoking, indication for surgery (disabling claudi¬
cation or critical limb ischaemia comprising rest
pain, ulceration or gangrene), previous vascular pro¬
cedure involving the same extremity, arteriographic
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Pathogenesis of abdominal aortic aneurysm. British Journal of
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aortic aneurysm expansion rate: effect of size and beta-adrenergic
blockade. Journal of Vascular Surgery, 1994, 19, 727-731.
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there is considerable heterogeneity with respect to
compliance. There was no relationship between
growth rate and Ep or /3.
In summary, therefore, the present study has con¬
firmed that abdominal aortic aneurysm are signifi¬
cantly less compliant than the normal aorta, that
compliance is inversely related to size, and that
among abdominal aortic aneurysm of similar size
compliance varies 10-fold. Compliance does not,
however, appear to be related to growth rate. Taken
together these data suggest that if aortic wall com¬
pliance is related to rupture, and because the authors
are currently conducting a prospective study to
determine whether this is the case, then this predic¬
tive information would largely be independent of,
and so additional to, that currently derived from size
and growth rate alone.
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Figure 3 Scatter plot showing the relationship between growth rate and
elastic modulus (Ep); r = — 0.09, P = 0.25 Spearman's rank correlation
that this loss of compliance is related to loss of elastin
from the wall [21, 22]. Aortic compliance, as meas¬
ured by Doppler ultrasound assessment of pulse
wave velocity, is reduced in adults at increased risk
of atherosclerosis [23] and such measurements have
been proposed as a useful screening test for prema¬
ture vascular disease [24],
The echo-tracking system used in the current
study has been used previously to define the mechan¬
ical properties of the normal human aorta. In young
(20- to 30-year-old) healthy subjects the compliance
of the normal distal aorta in man has been estimated
to be Ep = 0.7 N/m2 ( ± s.d. 0.25) and fi = 5.97
( ± s.d. 1.45) units [25], As part of the normal age¬
ing process aortic diameter increases and compliance
decreases, such that by the seventh decade of life Ep
= 3.37 N/m2 ( ± s.d. 1.01) and fi = 23.50 units
( ± s.d. 7.57) [25], Although both Ep and fi increase
exponentially with age, the increase is less in female
subjects, and the large standard deviations in the
above data indicate that there is considerable varia¬
bility between individuals [26, 27]. There also
appear to be marked differences between different
arteries in the same individual. For example, the
decrease in carotid compliance with age is signifi¬
cantly less than that found in the aorta [28], These
workers also determined compliance in 37 patients
with abdominal aortic aneurysm in whom the mean
maximal diameter was 41.6 mm ( ± s.d. 14), the Ep
5.04 N/m2 ( ± s.d. 2.53) and /3 = 34.87 units ( ±
s.d. 24.46). Abdominal aortic aneurysms were sig¬
nificantly less compliant than normal sized aortas
from an age-matched population in terms of Ep but
not /3. The individual variation in compliance
appeared to be even greater in the aneurysmal than
in the normal aorta population but no significant
correlation was found between abdominal aortic
aneurysm diameter and either Ep or fi, and growth
rate was not measured. The present study has
obtained similar values for Ep and fi in abdominal
aortic aneurysm, and has demonstrated for the first
time that in a series of non-operated, non-ruptured
abdominal aortic aneurysm, there is an inverse
relationship between maximal diameter and com¬
pliance.
A study using M-mode echocardiography to meas¬
ure aortic distensibility in 30 patients with abdomi¬
nal aortic aneurysm also found that aneurysmal dila¬
tation was associated with decreased compliance
[29]. These authors reported a median Ep of
31.2 N/cm2, and commented on the wide variation
in compliance between different abdominal aortic
aneurysm . However, unlike the current larger study,
they did not report a significant relationship between
Ep and aortic diameter, and they did not calculate
stiffness (fi). In a histological study of 15 operated
patients they found a significant inverse correlation
between compliance and elastin content of the
aortic wall.
The present study indicates that larger abdominal
aortic aneurysm tend to grow more quickly, although
abdominal aortic aneurysm of similar size showed
considerable heterogeneity in this respect. This has
been observed by some [30] but not all [31] previous
workers. In general, the growth rates observed in the
current study, median 0.16 mm per month or
1.9 mm per year, are low in comparison with pre¬
vious data: probably because patients exhibiting
rapid expansion had been operated on.
There was a highly significant positive correlation
between Ep and fi. Although both terms are
expressions of compliance, Ep is said to be pressure
dependent and /3 not so. This is confirmed by the
significant correlation between mean arterial press¬
ure and Ep, but not between mean arterial pressure
and /3. However, it must be remembered that these
expressions were derived from data that relate to
normal arteries and the same may not be true of ane¬
urysmal tissue. In normal arteries, compliance
decreases as the wall is distended by increasing press¬
ure. In abdominal aortic aneurysm, compliance var¬
ies less with mean arterial pressure, as abdominal
aortic aneurysm may be stiff throughout the physio¬
logical pressure range. This is suggested by previous
work that indicated that Ep is related to mean
arterial pressure in normal subjects but not in
patients with abdominal aortic aneurysm [29]. Both
large size and rapid expansion are thought to be
associated with an increased risk of rupture. There
was a significant positive correlation between Ep and
size, and also a tendency for larger aneurysms to
exhibit greater stiffness; although the strength of
these relationships indicates that within a population
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Table 1 Spearman's rank correlation coefficients and significance values describing the relationship between maximum aortic diameter*, mean arterial
pressure, growth rate, elastic modulus and stiffness
Max. aortic diameter* Mean arterial pressure Elastic modulus (Ep) Stiffness (8)
(mm) (mmHg) (N/m2) (arbitrary units)
Growth rate (mm/month) r = 0.59 r = 0.04 r = - 0.09 r = - 0.13
P < 0.001 P < 0.77 P = 0.25 P= 0.15
Stiffness (/3) (arbitrary units) r= 0.16 r = - 0.08 r = 0.96
P= 0.11 P < 0.61 P < 0.001
Elasticity (Ep) (N/m2) r = 0.22 r = - 0.31
P < 0.05 P < 0.031
Mean arterial pressure (mm/Hg) r= 0.15
P = 0.13
*At the time of compliance measurement.
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Figure 1 Scatter plot of the relationship between abdominal aortic aneu¬
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Figure 2 Scatter plot showing the relationship between abdominal aortic
aneurysm diameter and elastic modulus (Ep); r = 0.22, P < 0.05; Spear¬
man's rank correlation
of similar size showed a 10-fold variation with regard
to both Ep and /3. There was no significant relation¬
ship between growth rate and Ep, (Figure 3) or
between growth rate and (3.
Discussion
Numerous attempts have been made to predict, on
the basis of physical characteristics, which abdomi¬
nal aortic aneurysm will rupture and which are safe
to observe [11, 12]. Previous work has focused upon
absolute size (maximal antero-posterior or transverse
diameter or cross-sectional area), relative size
(standardized on the basis of patient build, age and
sex) [13], shape (circular versus elliptical cross-sec¬
tional profile on computed tomography) [14], wall
thickness and blistering [15], and expansion rate [16,
17]. Aneurysm size and expansion may in turn be
affected by patient factors, such as hypertension [18]
and continued smoking [19].
Unfortunately, the predictive value of these para¬
meters, while perhaps relevant to population studies,
are insufficiently accurate to quantify risk on an indi¬
vidual patient basis. Rupture of small abdominal
aortic aneurysm, though less common, is well recog¬
nized, which suggests that other factors more directly
related to aortic wall behaviour may be more
important and worthy of study [20], However, to
date, little work has been performed defining the
mechanical properties of the aneurysm wall itself.
In vitro studies that compared tensile strength of
excised normal and aneurysmal human aorta
obtained at surgery or post mortem have indicated
that aneurysmal tissue is much less distensible, and
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quantification of risk is required. It is possible that
compliance, which relates to aortic wall composition
and behaviour, might provide further information.
The aim of the present study was to investigate, for
the first time, the relationship between abdominal
aortic aneurysm wall compliance, maximum diam¬
eter and growth rate in a series of patients with non-
operated, asymptomatic abdominal aortic aneurysm.
Methods
Sixty patients were recruited from five separate vas¬
cular surgical centres in Scotland with asymptomatic
abdominal aortic aneurysm that were not operated
on due to small size, low growth rate, unacceptable
operative risk, advanced age or patient wishes were
studied. There were 50 men and 10 women of
median age 73 years (range 56-81). On entry to the
study, the median size of abdominal aortic aneurysm
was 43 mm (range 29-67 mm). Growth rate
(mm/month) was derived from repeat ultrasound
scans (median 2, range 2-10) performed 3-6 times
monthly over a median period of 21 months (6-48).
Ethical approval was obtained and patient consent
given.
Compliance was measured at the end of follow-
up by means of an electronic echo-tracking device
(Diamove, Teltec AB, Sweden) interfaced with B-
mode real-time ultrasound scanner (EUB-240, Hita-
chi, Japan) fitted with a 3.5-MHz linear array trans¬
ducer. An echo-tracking phase-locked loop circuit
restored the position of an electronic gate relative to
the moving echo and yielded the echo movement per
unit of time. The instrument was equipped with dual
echo-tracking loops, which made it possible to track
two separate echoes simultaneously from opposing
walls. The difference between signals indicated,
instantaneously, the change in vessel diameter. The
smallest detectable movement was 7.8 pan, the rep¬
etition frequency of the echo-tracking loops was
870 Hz, and the time resolution was therefore
approximately 1.2 ms. The data acquisition unit
comprised a 486 personal computer (Toshiba)
linked to a 12-bit analogue to digital converter
(Analogue Devices, Norwood, USA). Change in
maximal abdominal aortic aneurysm diameter with
cardiac cycle was measured over an 11-second per¬
iod. Strain (fractional diameter change) was
defined as:
Strain =
maximal systolic diameter — maximal diastolic diameter
maximal diastolic diameter
The arterial wall distensibility was initially
expressed as pressure strain elastic modulus (Ep)
[6] where:
^ systolic pressure — diastolic pressure
Ep = K X ;
strain
The constant K = 133.3 allows Ep to be converted
from mmHg to N/m2.
Because of the non-linear relationship of the nor¬
mal arterial wall, Ep is pressure dependent. Previous
workers have observed a linear relation in vitro
between the logarithm of systolic/diastolic pressure
ratio. This index is called stiffness (j8) and appears
to characterize the entire deformation behaviour of
the arterial wall, without pressure dependence and
within the physiological range. Stiffness may then be
a more useful index of aortic compliance than Ep;
although whether this relationship holds true for the
human aneurysmal aorta in vivo is unknown. Stiff¬
ness (/3) has been defined as [7]
_ ln(Psystolic/P diastolic)
(.D systolic — D diastolic)//} diastolic
In = natural log
For a more detailed discussion of these concepts
the reader is referred to two recent reviews [4, 8].
The higher the Ep and /3 the less distensible the
artery and the lower the compliance
Systolic and diastolic blood pressures were meas¬
ured in the brachial artery by auscultation after
inflation and deflation of a sphygmomanometer.
Mean arterial pressure was diastolic pressure plus
one-third pulse pressure [9]. Because the distri¬
bution of variables was highly skewed, linear associ¬
ations between pairs were assessed using Spearman's
rank correlation. The data were entered on the Edin¬
burgh University mainframe computer and analysed
using the statistical package SPSS [10].
Results
At the time of compliance measurements, median
(range) diastolic pressure was 80 mmHg
(60-122 mmHg); systolic pressure was 139 mmHg
(100-210 mmHg); pulse pressure was 61 mmHg
(20-130); and mean arterial pressure was 98 mmHg
(79-139). Abdominal aortic aneurysm size, Ep, /3
and growth rate did not differ between male and
female patients.
Table 1 shows that there was a significant positive
correlation between mean arterial pressure and Ep,
and between Ep and /3, but not between mean
arterial pressure and /3. There was a significant posi¬
tive correlation between growth rate (median
0.16 mm/month, range 0.0-0.61) and maximal
aortic diameter (median 43 mm, range 29-77)
(.Figure 1). There was a significant positive corre¬
lation between maximum diameter and Ep (median
Ep 2.42 N/m2, range 0.55-9.46) (Figure 2), but not
between maximum diameter and /3 (median 17.7
units, range 4.0-57.3). Abdominal aortic aneurysm
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Aim: Aortic compliance as measured by the pressure-strain elastic modulus (Ep) and stiffness
((3), may allow a more precise estimate of rupture risk. The aim of this study was to determine
the relationships between compliance, maximal aneurysm diameter and growth rate.
Methods: Sixty abdominal aortic aneurysm patients of median age 73 years, were studied.
Growth rate was derived from repeat ultrasound scans obtained over a median period of 21
months (range 6-48). At the end of follow-up. patients underwent measurement of maximum
aortic diameter, Ep and (3 using the Diamove echo-tracking system. Results: Growth rate
correlated positively (r = 0.6, P < 0.01) with maximum diameter on entry to the study There
was a positive correlation between mean arterial pressure and Ep (r = 0.3, P = 0.03), but
not between mean arterial pressure and (3 (r = 0.8, P = 0.61). A positive correlation was
found between final maximum diameter and Ep (r = 0.22, P = 0.04) but not (3 (r = 0.16,
P = 0.11). There was no significant relationship between growth rate and Ep or p. Conclusion:
Large aneurysms tended to be less compliant. Within a population of abdominal aortic aneur¬
ysm of similar maximum diameter there was a 10-fold variation in Ep and p. Compliance and
growth rate were not related. If aortic compliance is related to risk of rupture then this
predictive information is likely to be largely independent of that currently obtained from size
and growth rate. © 1999 The International Society for Cardiovascular Surgery. Published by
Elsevier Science Ltd. All rights reserved.
Keywords: abdominal aortic aneurysm, compliance, rupture risk
Introduction
Ruptured abdominal aortic aneurysm is associated
with a 30-day combined community and hospital
mortality of 90% [1]. By contrast, the mortality asso¬
ciated with elective repair is reported to be less than
5% in a number of centres [2, 3], Following success-
Correspondence to: K. Wilson, Vascular Surgery Unit, Edinburgh
University, Royal Infirmary of Edinburgh, Lauriston Place, Edin¬
burgh EH3 9YW, UK
ful repair of abdominal aortic aneurysm, patients
may return to a near normal life expectancy [4]. The
decision to operate on an asymptomatic abdominal
aortic aneurysm involves weighing the risk of rupture
against the risk of operative repair for the individual
patient. The risk of rupture is estimated primarily
on the basis of maximum diameter and growth rate,
although both parameters are known to be inaccur¬
ate predictors of rupture. As no size of abdominal
aortic aneurysm appears to be entirely free of risk
of rapid expansion and rupture [5] on an individual
patient basis, a method that provides a more precise
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Ultrasonic measurement of abdominal
aortic aneurysm wall compliance:
A reproducibility study
K. A. Wilson, MSc, P. R. Hoskins, PhD, A. J. Lee, PhD, F. G. R. Fowkes,
FRCPE, C. V. Ruckley, CBE, FRCSEd, and A. W. Bradbury, FRCSEd,
Edinburgh, Scotland, United Kingdom
Purpose: The purpose of this study was to examine the intraobserver and interobserver
error associated with ultrasonic echo-tracking compliance measurement in patients with
abdominal aortic aneurysm.
Methods: Two observers independently measured brachial blood pressure by sphygmo¬
manometer and maximum aortic diameter, pressure strain elastic modulus (Ep) and
stiffness using an ultrasopic echo-tracker. The observer was blind to several variables:
pulse pressure, diameter change, Ep, and stiffness. In study 1, observer A measured com¬
pliance in 13 patients at 30 to 60 minutes apart. In study 2, observers A and B each mea¬
sured compliance on 23 patients at two visits, 2 weeks apart.
Results: There were no significant differences within observer A's compliance measure¬
ments. The coefficients of variation of method error (CVj^e) for directly measured vari¬
ables were systolic blood pressure, 7.3%; diastolic blood pressure, 5.4%; and maximum
aortic diameter, 2.6%. CVj^ values for derived variables were Ep, 21.2%, and stiffness,
17.6%. No differences were found between observers A and B and visits 1 and 2. CV^
values were 7.9% or less for directly measured variables and 32.7% or less for derived
variables. These CV^ values were greatly reduced when the calculation was made with
the use of log transformed data.
Conclusion: The high CVM£ value for derived variables is largely due to their wide varia¬
tion within this population. This technique can measure abdominal aortic aneurysm diam¬
eter and compliance with an acceptable level of intraobserver and interobserver error.
(J Vase Surg 2000;31:507-13.)
The decision to operate on a patient with an
asymptomatic abdominal aortic aneurysm (AAA)
involves weighing the risks of rupture against those of
operative repair. Although cohort studies indicate that
rupture is related to maximum AAA diameter (Dmax),
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growth rate, and blood pressure (BP), none of these
variables reliably predicts the behavior of individual
aneurysms.1 Because no size of AAA is entirely free
from risk of rupture, a variable that provides a more
precise quantification of risk is required. Previous work
has suggested that AAA wall compliance (expressed as
elastic strain modulus [Ep] and stiffness and measured
by means of a commercially available ultrasound echo-
tracking system [Diamove; Teltec AB, Sweden]) may
be related to future growth rate and risk of rupture.2
Compliance is a measure of the relationship
between stress (force per unit area ofwall) and strain
(fractional deformation of wall). In the context of
the normal arterial wall, compliance is most accu¬
rately described by the change in volume of a seg¬
ment of artery in relation to pulsatile change in BP.3
However, measurement of changes in wall thickness
in response to changes in pressure and vessel volume
are necessary to calculate true vessel compliance.4 At
present, neither variable can be reliably measured in
the aorta in vivo. Arterial wall distensibility (which
describes the relationship between relative diameter
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Fig 1. Longitudinal view ofAAA with the cursor tracking
the anterior and posterior walls.
change and pressure) has been used by a number of
researchers4-6 as a surrogate measure of compliance.
Peterson et al3 introduced the equation Ep = K
(P systolic - P diastolic )/([D systolic-D diastolic]/
D diastolic), where K = 133.3, P = pressure, and D
= aortic diameter. Ep is a measure of the structural
distensibility of the artery, rather than a measure of
the elasticity of the arterial wall material.4
Hayashi7 proposed the term stiffness ([$) to
describe the viscoelastic behavior of arteries within
the physiologic pressure range: (3 = ln(P systolic/P
diastolic)/([D systolic - D diastolic]/D diastolic).
Both Ep and stiffness are inversely related to disten¬
sibility and compliance. These concepts are dis¬
cussed more fully in two recent reviews.8'9
Measurement of aortic compliance with the use
of an echo-tracking device (Diamove) is reproducible
in healthy subjects with no aneurysm.10 However,
this may not be true in patients with AAA because of
cardiorespiratory comorbidity, obesity, and variable
aneurysm morphologic condition. Preliminary data
have suggested a relationship between aortic compli¬
ance, future growth, and rupture.2 However, before
it can be used to aid the selection of patients for
repair, it is essential to quantify the reproducibility of
this method. The aim of this study therefore was to
examine, for the first time, the intraobserver and
interobserver variability associated with a commercial
ultrasonic phase-locked echo-tracker in the measure¬
ment of AAA compliance with the use of an ultra¬
sound echo-tracking technique.
METHODS
The use of the echo-tracking ultrasound system
(Diamove) has been discussed in detail previous¬
ly/, 11-14 a 3.5-MHz linear array transducer was
used to provide a standard real-time B-scan image.
The transducer was placed over the AAA to obtain a
longitudinal section at the point of maximal antero¬
posterior diameter. The anterior and posterior vessel
walls were echo tracked after the initial placement of
a cursor within the vessel (Fig 1). During the track¬
ing, the ultrasound pulses were time shared equally
between the B-scan image and the A-scan line of
interest, allowing the pulsatile changes in vessel
diameter to be monitored. A phase-locked loop
restored the position of an electronic gate relative to
the moving echo; the compensatory movement of
the gate yielded the movement of the echo.
Electronic gates were represented on the screen
by two cursors. These locked onto the echoes from
the posterior lumen/wall interface of the anterior
wall and the anterior interface of the posterior wall of
the AAA and subsequently measured the Dmax. The
output signal from the echo-tracking circuits repre¬
sented the distance between the vessel walls. The rep¬
etition frequency was 870 Hz, producing a time res¬
olution of 1.15 msec. The calculated smallest
detectable movement was 8 (im. Data acquisition
and analysis were performed on a Pentium 24X com¬
puter (Datalink Computers, Edinburgh, Scotland).
The pressure-diameter curve was registered on the
computer in real time, and at least three consecutive
waves were analyzed. The Diamove software auto¬
matically identified the start and end of each cardiac
cycle. The operator manually selected the wave forms
of interest, and an average wave was produced (Fig
2). Brachial artery pressures were entered, and the
derived variables, including Ep and stiffness, were
then displayed on the screen. Pulse pressure and
diameter change were calculated by Diamove.
BP was measured from the brachial artery in the
right arm with a hand-held sphygmomanometer.
The right arm was used to prevent bias, based on the
assumption that neither arm was more prone to
hemodynamically significant vascular disease. The
cuff was wrapped around the upper arm and inflated
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Fig 2. Average wave with calculations of Ep, stiffness, diameter change, systolic and diastolic
pressure, and pulse pressure.
until the radial pulse could no longer be felt. The
stethoscope was placed over the brachial artery at
the antecubital fossa. Systolic pressure was registered
as the pressure where the first Korotkoff sounds
(phase 1) were heard, although cuff pressure was
reduced. Diastolic pressure was registered as the
pressure where the final Korotkoff sounds (phase 5)
disappeared.15
Two recordings of diameter change over 4 to 11
seconds were collected on each patient, during each
session, with brachial artery pressure measured each
time. The best of the two pressure-diameter traces
was selected for analysis on the basis of the following
criteria: (1) The maximum diameter measurements
were within 5% of the estimated value (estimated
diameter being taken from a static image of systolic
diameter) or 2 mm, if the aneurysm was less than 4
cm wide; (2) at least three consecutive cardiac cycles
producing uniform waves were available for analysis;
(3) any obvious arrhythmias were excluded; and (4)
if all of above were the same, the wave form with the
largest diameter and pulsatile diameter change was
selected because this was assumed to indicate the
point of highest stressrstrain ratio.
Observer A underwent 5 months of training in
the Departments of Radiology and Vascular Surgery
at the University of Edinburgh. Observer B received
2 months of training in the Department of Vascular
Surgery at the University of Edinburgh before the
study began.
Observers were blind to Dmax, Ep, and stiffness
because these variables were only shown on the
computer screen once analysis had been performed
at the end of the study. The observers examined each
patient alone and were therefore blind to each
other's BP measurements.
Ethics committee approval was given for this
study, and informed written consent was obtained
from each patient.
Data collection
Study 1. Observer A performed two AAA com¬
pliance measurements during two sessions 30 to 60
minutes apart on each of 13 patients during a single
visit to the Vascular Studies Unit.
Study 2. Observers A and B performed two
AAA compliance measurements on a further 23
patients during each of two visits to the Vascular
Studies Unit.
Statistical methods. Data were analyzed with
the use of a statistical package (SPSS-X; SPSS, Inc,
Chicago, 111).16 Medians of the variables in studies 1
and 2 were compared with the Wilcoxon signed rank
test to check for systematic bias between the sessions
and the observers. The coefficient of variation
expresses the SD of a single set of measurements as
a percentage of the sample mean. However, in this
study, we undertook to express the degree of vari¬
ability between two sets of measured data. For that
reason Bland and Altman's coefficient of variation of
method error (CVME)17 was used. Spearman's rank
correlation coefficient17 was used to assess the linear
association of all measurements between and within
observers and visits.
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Table I. Intraobserver variability in the measurement of AAA wall compliance and brachial artery BP made
by observer A at two sessions that were 30 to 60 minutes apart (n = 13 patients)
Session 1 ' Session 2'
Variable Median IQR Range Median IQR Range
Systolic BP (mm Hg) 140 126-160 122-186 138 123-148 116-184
Diastolic BP (mm Hg) 81 72-83 58-98 77 70-88 58-93
Pulse pressure (mm Hg) 60 56-73 41-108 62 43-67 36-113
Maximum diameter (mm) 51.1 38-56 31-68 50 41-54 31-69
Minimum diameter (mm) 50.3 37-55 29-67 49 39-53 29-68
Diameter change (mm) 1.18 0.82-1.5 0.52-2.38 1.33 0.83-1.59 0.42-2.82
Elasticity (10s N/m2) 3.75 2.2-5.83 1.41-7.07 2.61 1.90-5.49 1.21-8.36
Stiffness 28.08 17.18-40.56 9.85-48.40 21.43 13.5-39.66 8.2-54.25
IQR, Interquartile range.
"WUcoxon signed rank tests for differences between sessions were all nonsignificant (P> .05).
Table II. Median and interquartile range for variables when measured by each observer at each session
Parameters
Visit 1 Visit 2
Observer A Observer B P value" Observer A Observer B P value'
Svstolic BP (mm Hg) 140 (121-157) 138 (126-156) NS 140 (121-152) 135 (124-152) NS
Diastolic BP (mm Hg) 76 (68-82) 76 (69-84) N'S 78 (70-81) 78(72-90) <.05
Pulse pressure (mm Hg) 61 (46-76) 58 (53-74) NS 58 (48-76) 54 (49-70) NS
Maximum diameter (mm) 51.2 (43.3-54.8) 51.9 (44.4-55.4) <.05 52.3 (45.4-54.5) 51.0 (44.6-56.1) NS
Diameter change (mm) 1.3 (0.9-2.0) 1.4 (1.0-1.9) NS 1.0 (0.8-2.2) 1.2 (0.7-2.0) NS
Elasticity (10s N/m2) 2.8 (2.0-4.5) 3.0 (2.0-4.7) NS 3.3 (2.5-4.8) 3.5 (2.0-4.6) NS
Stiffness 19.8 (13.5-29.5) 21.3 (14.2-34.0) NS 23.1 (16.5-33.9) 24.6 (14.8-33.6) NS
NS, Not significant.
•Wilcoxon signed rank test of interobserver differences at each visit.
RESULTS
Study 1: Intraobserver variation. Table I
shows the median and interquartile range of the vari¬
ables measured by observer A during sessions 1 and 2.
There were no statistically significant differences
between the first and second sessions with regard to
the distributions of any of the compliance measure¬
ments. The intraobserver CVME values for measure¬
ments by observer A were low for the direcdy mea¬
sured variables (systolic BP, 7.3%; diastolic BP, 5.4%;
and Dmax, 2.6%). The intraobserver CVME values of
the derived variables were higher (Ep, 21.2%, stiff¬
ness, 17.6%, and diameter change, 18.2%).
Study 2: Interobserver variability. Table II
shows the median and interquartile range of each
variable obtained by observers A and B at each visit.
Significant interobserver differences were found
only with regard to Dmax at visit 1 (P < .05) and
diastolic BP at visit 2 (P< .05).
All variables reached a high (r > 0.5) and signifi¬
cant (P < .05) degree of intraobserver and interob¬
server correlation (Table III). Intraobserver and
interobserver measurement of Dmax demonstrated
a significant and high degree of correlation (r > 0.96
and r > 0.94, respectivelv). CVME values for intraob¬
server and interobserver variation were 10% or less
for the variables direcdy measured by the observers
(diastolic BP, systolic BP, and Dmax) and 35% or less
for the mathemarically derived parameters (Table
IV). However, when the values were log trans¬
formed before the calculation of the CVME value,
the CVME value was much reduced. For example,
sdffness in Table IV became, for observer A, 10.2%,
for observer B, 8.6%, for visit 1, 6.6%, and for visit
2, 10.22%. This is not the correct usage of this test;
we have only calculated stiffness to show the effect
of skewness on CVME values.
DISCUSSION
There were no statistically significant differences
in intraobserver measurements of any of the compli¬
ance variables. Significant interobserver differences
were only found in diastolic BP at visit 2 and Dmax
at visit 1. Intra- and interobserver CVME values for
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Table III. Median and interquartile range of variables obtained at two sessions by two observers and
Spearman's rank correladon coefficients for intraobserver and interobserver measurements of parameters in
study 2
Intraobserver correlation (r) Interobserver correlation (r)
Parameters Median (IQR) Observer A Observer B Visit 1 Visit 2
Svstolic BP (mm Hg) 140 (123-153) 0.62* 0.81* 0.85* 0.72*
Diastolic BP (mm Hg) 78 (70-84) 0.81* 0.78* 0.87* 0.82*
Pulse pressure (mm Hg) 58 (50-73) 0.50t 0.83* 0.84" 0.56}
Maximum diameter (mm) 51.6 (45-55) 0.98* 0.96* 0.95* 0.94*
Diameter change (mm) 1.3 (0.86-2.0) 0.85* 0.77* O.SO* 0.91*
Elasticity (10s N/m2) 3.1 (2.1-4.6) 0.64} 0.62} 0.82* 0.66*
Stiffness.. 22.3 (15.5-32.6) 0.71* 0.68* 0.77* 0.74*




Table IV. Coefficients of variation of method error (CVME) between intraobserver and interobserver mea¬
surements of BP, aortic diameter and diameter change, elasticity, and stiffness from study 2
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directly measured variables were low (<10%),
although CVME values for the derived variables were
higher (<35%).
Variability of the Diamove echo-tracking device
has not previously been reported in patients with
AAA. However, present data are comparable with
those obtained in a previous methodologic study10
that used healthy subjects with normal aortas (Table
V). A third study also investigated aortic compliance
in four young (aged, <35 years) subjects with no
aneurysm18 and reported on four compliance mea¬
surements from each subject during one visit. These
authors18 expressed their methodologic error for Ep
and stiffness in terms ofSD. SD was not appropriate
for the analysis of this group of subjects with AAA
because compliance measurements were not normal¬
ly distributed and were highly variable. The results
of Lanne et al18 are therefore less comparable with
the present findings than those of Hansen et al.10
The present study is also unique in that measure¬
ments were taken in two disdnct sessions up to 2
weeks apart.
BP and maximum aortic diameter were the two
variables directly measured by the observers and
therefore the only variables that were prone to
observer bias. The low CVME value for these vari¬
ables indicates that this echo-tracking equipment can
be reliably used in the follow-up of AAA maximal
diameter. There may, however, be some random
error in the values calculated for Ep and stiffness
because these are derived values and are thus not
directly measured. The use of brachial artery pressure
rather than central aortic pressure will tend to under¬
estimate Ep and stiffness.10 However, the error will
be systematic, affecting all patients approximately
equally. Invasive measurement of aortic pressure is
not practicable for routine compliance follow-up.
Most previous studies that used Doppler phase-
locked loop echo tracking have assumed that brachial
BP is consistently related to aortic pressure.7-10'11>18
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JOURNAL OF VASCULAR SURGERY
March 2000
Table V. Comparison of coefficients of variation ofmethod error of compliance variables between different
studies of subjects with AAA and with no AAA
Systolic BP Diastolic BP Maximum Diameter
Study Subjects (n) Vessel (%) (%) diameter (%) change (%o) Elasticity (%) Stiffness (%)
Hansen et al10 8F Normal 2 3 5 16 21 21
Lanne et al18 4M Normal — — — — 6* 6"
Wilson etaJ 13 F8cM AAA 7 5 3 18 21 18
(present study)
F, Female; M, male.
*SDs are quoted in the text.
The high CVME values of both Ep and stiffness
must be viewed in the context of the wide range of
compliance observed in this particular study group
(Table I). For example, Ep varied by a factor of
12.75, ranging from 0.74 to 9.44 105 N/m2, and
stiffness varied by a factor of 12.0, ranging from 5.6
to 66.8 105 N/m2. It should also be noted that,
with the exception of BP, the variables measured
were all skewed to the right. Because there is no
nonparametric equivalent of the CVlVIE value, the
effect of this skewness on the values of CVME cannot
be ascertained. However, if a logarithmic transfor¬
mation had been applied to the data before the
CVme value was calculated, the resultant CVME
value would have been substantially reduced. For
example, the nontransformed CVME value from
observer A for intraobserver stiffness was 32% and
for observer B, 25.6%. After transformation, these
CVme values were 10.2% and 8.6%, respectively. The
use of the CVME value calculated from transformed
data does not allow direct comparison of variabilities
with previous studies. However, it does suggest that
the Bland and Altman17 test for CVME value is not
applicable to skewed data. More importantly for this
study, it also suggests that the high level of variation
is in fact due to the large variation of Ep and stiffness
within the study population rather than because of
the technique. The diameter and compliance varia¬
tions that were observed between visits in study 2
may also reflect a certain degree of real variation in
AAA wall movement.
When the raw data were examined, there were two
particular subjects in whom markedly different diame¬
ters were measured; these patients were difficult to
scan because ofobesity and cardiac and respiratory dis¬
ease. We did not remove these subjects from the study
because it would have biased the assessment of repro¬
ducibility. Nevertheless, approximately 10% of these
study subjects could not be satisfactorily scanned
because of the factors mentioned earlier. Excluding
such patients would have increased the apparent
reproducibility of the technique.
The longitudinal view of the AAA was more
informative than the transverse because it allowed a
true anteroposterior measurement to be made per¬
pendicular to the aneurysms' long axis. Three com¬
pliance measurements were made at each examina¬
tion. Each was slightly different because of slightly
differing BP and because of the cursors inevitably
locking onto different layers of the wall. Slight
changes in the angle of the probe may also have
increased the variability of diameter change, but this
was not investigated specifically in this study.
The echo-tracking technique involves placing the
cursors onto the echoes of the anterior and posteri¬
or walls while the vessel is moving with each cardiac
cycle. Tracking of the same points within the wall
structure is difficult because the quality of the B-
mode imaging does not allow easy differentiation
between thrombus, calcification, intima, and media.
It is likely that improvements in the image quality
and echo-tracking technology will reduce the effect
of these factors on reproducibility.
The learning curve associated with echo-tracking
compliance measurements was steep for observer A
who had no previous experience with ultrasonic
scanning. However, intensive training by radiology
staff in the recognition of abdominal structures and
variations in AAA wall morphologic features meant
that the curve leveled off after about 3 months. At
this point, the measurements from observer A were
within 2 mm of those reported by the ultrasound
department. Observer B was subsequently taught
the technique by observer A. This may have intro¬
duced some systematic bias into the study, although
observer B had previous experience scanning AAA,
thus reducing the learning curve considerably. At
the time of the study, observer A had 2 years of
experience with the equipment; observer B had 3
months of experience because it was not possible to
Eur J Vase Endovasc Surg 21, 175-178 (2001)
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The Relationship Between Abdominal Aortic Aneurysm Distensibility and
Serum Markers of Elastin and Collagen Metabolism
K. A. Wilson1, J. S. Lindholt3, P. R. Hoskins2, L. Heickendorff3, S. Vammen3 and A. W. Bradbury*4
1Vascular Surgery Unit, University Department of Clinical and Surgical Sciences, University of Edinburgh, U.K.,
2University Department ofMedical Physics, University of Edinburgh, U.K., 3Department of Surgery,
Hospital of Viborg, Denmark and department of Vascular Surgery, University of Birmingham, U.K.
Background: abdominal aortic aneurysm (AAA) distensibility may be an independent predictor ofgrowth and rupture,
possibly because it reflects changes in aortic wall structure and composition.
Aim: to determine whether AAA distensibility is related to circulating markers of elastin and collagen metabolism.
Methods: sixty-two male patients of median age (IQR) 68 (65-72) years with asymptomatic AAA of median (1QR)
diameter 42 (37-45) mm were prospectively studied. Pressure-strain elastic modulus (Ep) and stiffness (ft) were measured
using an ultrasonic echo-tracker (Diamove). Serum elastin peptides (SEP), plasma elastin-ocrantitrypsin complex (E-
AT), procollagen IIl-N-terminal propeptide (PIIINP) were measured by enzyme-linked immunoassay.
Results: age and smoking adjusted Ep and f) were significantly inversely related to SEP (r =—0.33 and r =—0.31
respectively, both p<0.02) and E-AT (r =—0.27 and r =—0.27 respectively, both p<0.05) both of which indicate
elastolysis. By contrast, there was a significant positive correlation between PIIINP, indicative of increased collagen turn¬
over, and both Ep and /? (both r=0.45, p<0.01 unadjusted correlations).
Conclusion: increased elastolysis is associated with increased AAA wall distensibility; whereas increased collagen turn¬
over is associated with reduced distensibility.
Key Words: Aneurysm; Elasticity; Elastolysis; Collagenolysis.
Introduction
Abdominal aortic aneurysm (AAA) distensibility may
be an independent predictor of growth and rupture,
possibly because it reflects changes in aortic wall
structure and composition.1,2 There is general agree¬
ment that AAA formation is associated with de¬
gradation and/or redistribution of elastin and collagen
in the media.3 This, in turn, appears to be due to an
increase in elastase and collagenase activity.4
Elastolysis has been shown previously to be associated
with increased levels of serum-elastin-peptides
(SEP).5"7 Alpha,-antitrypsin (AT) inhibits circulating
elastase by forming elastase-alpha,-anti trypsin com¬
plex (E-AT) and increased serum E-AT levels may also
be indicative of increased elastolysis.7'8 Increased type
III collagenase activity has been linked to AAA growth,
and possibly rupture.4,9"11 Increased collagen turnover
has been associated with an increase in serum type III
* Please address all correspondence to: A. W. Bradbury, Department
of Vascular Surgery, University of Birmingham, Birmingham Heart¬
lands Hospital, Bordesley Green East, B9 5SS.
procollagen aminoterminal propeptides (PIIINP) and
high levels of PIIINP have been found in patients with
AAA.9"12 The aim of this study was to determine
whether AAA distensibility is related to circulating
markers of elastin (SEP, AT, E-AT) and collagen (PII¬
INP) metabolism.
Methods
Arterial distensibility describes the relationship be¬
tween fractional diameter (D) change and blood pres¬
sure (P).13-15 Specifically, pressure-strain elastic
modulus (Ep)2 is defined as:
Ep =Kx (P systolic—P diastolic)/[(D systolic —D dia¬
stolic)/D diastolic]
where K = 133.3, and stiffness ((3)16,17 as:
P = ln(P systolic/P diastolic)/[(D systolic—D dia-
stolic)/D diastolic].
1078-5884/01/020175 + 04 $35.00/0 ©2001 Harcourt Publishers Ltd.
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Table 1. Markers of elastin and collagen metabolism.
Variable Median IQR
Elastin-peptides (SEP) (mg/1) 29.4 25.0-37.4
Elastase <x,-antitrypsin (E-AT) (mg/1) 5.7 4.2-7.6
0^-antitrypsin (AT) (g/1) 1.3 1.2-1.4
PIIINP-collagen (mg/1) 34.5 25.7-42.1
Fig 1. Spearman's rank correlations between Ep and serum elastin
peptides.
Both Ep and (3 are inversely related to distensibility.18,19
The use of the echo-tracking ultrasound system
(Diamove, Teltec AB, Sweden) has been described in
detail previously.14,18,20 A 3.5 MHz linear array trans¬
ducer was used to provide a real-time B-scan image
of a longitudinal section of the AAA at the point of
maximal antero-posterior (AP) diameter. The pressure-
diameter curve was registered on the computer in
real time. Blood pressure was measured in the right
brachial artery by sphygmomanometry21,22 and pulse
pressure, diameter change (Dch), Ep and (3 were cal¬
culated by the software.
Non-commercial enzyme-linked immunosorbent as¬
says (ELISA) were used for determination of SEP, AT
and E-AT as previously described.6 PIIINP levels were
measured by the method of Jensen23 and Ristelli.24
Age was normally distributed; however, diameter,
Ep and (3 were not. Therefore, non-parametric de¬
scriptors and log transformed analyses of Ep and (3
were performed (SPSS-9). Results for Spearman's rank
correlation on untransformed data and Pearson partial
correlation adjusted for age and smoking were very
similar. Pearson's correlation cannot easily be il¬
lustrated and so scatterplots of Spearman's correlation
have been used. Smoking status was defined as current
or ex-smokers; there were no non-smokers. A prob¬
ability level of <0.05 was taken to denote statistical
significance. The study received local ethics committee
approval and was reported to the Danish Central
Control of Registers. All patients provided written,
informed consent.
Results
There were sixty-two males of median (IQR) age 68
(65-72) years with screen-detected AAA of median
(IQR) antero-posterior (AP) diameter 42 (37-45) mm.
The median (IQR) Ep was 3.56 (2.52-5.35) 105Nm~2
and the median (IQR) (3 was 24.4 (18.5-35.8) arbitrary
units (a.u). Circulating markers of elastin and collagen
metabolism are shown in Table 1.
After adjusting for age and smoking status, Ep and
P were significantly inversely related to both SEP and
E-AT (Table 2. Figures 1 and 2 represent the unadjusted
correlations). By contrast, there was a significant posi¬
tive correlation between PIIINP and both Ep and P
(Table 2, Fig. 3 unadjusted correlations). Dmax was
not related to any of the circulating markers.
Discussion
The principal findings of the present study were that
after adjusting for age and smoking status, both Ep
and P were significantly inversely related to circulating
SEP and E-AT; that is, patients with evidence of in¬
creased elastolysis had more distensible aneurysms.
By contrast, AAA distensibility was inversely related
Table 2. Pearson's partial correlation coefficients (p values) for serum markers of matrix
degradation, distensibility and diameter, adjusted for age and smoking status.
Serum markers Elasticity Stiffness Diameter
Elastin-peptides (SEP) -0.33 (0.01) -0.31 (0.02) -0.20 NS
Elastase arantitrypsin (E-AT) -0.27 (0.04) -0.37 (0.04) 0.11 NS
^-antitrypsin (AT) -0.10 NS -0.06 (NS) -0.08 NS
PIIINP-collagen 0.45 (0.01) 0.45 (0.01) 0.21 NS
Elasticity — — 0.49 (0.01)
Stiffness — — 0.46 (0.01)
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Fig. 2. Spearman's rank correlation coefficients between elastase
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Fig. 3. Spearman's rank correlation coefficients between propeptide
of type III procollagen (PIIINP) and Ep.
to PIIINP, a marker of increased collagen neosynthesis.
Previous work from this group has shown that AAA
of similar size exhibit markedly different degrees of
distensibility.1 We had hypothesised that this was due
to differences in the absolute and relative amounts of
elastin present in the aorta. This current study may
now provide support for that contention in that AAA
distensibility was significantly inversely related to
circulating of E-AT complex. This complex may be
indicative of smoking-induced lung damage; however,
adjustment for smoking did not diminish this re¬
lationship. At present it is not possible to determine
absolutely whether this elastase originates in aortic or
lung tissue. Previous authors have shown markers of
elastin degradation to be indicative of aortic matrix
degeneration.6,25,26 The SEP ELISA measures a wide
spectrum of peptides, including some which may be
more specific to the aorta (serine-, cysteine- and
metallo-dependent proteases). Our finding that SEP
levels were also inversely related to distensibility sug¬
gests that distensibility may indeed be reflecting aortic
elastin degradation, induced by other proteases than
elastin. SEP and E-AT were not related to AAA dia¬
meter, suggesting that AAA wall degradation may not
be uniform within AAA of the same diameter.
Our preliminary longitudinal data had also sug¬
gested that distensible AAA were more likely to rup¬
ture. Specifically, while most aneurysms tend to
become less distensible as they expand, those that fail
to grow stiffer as they enlarge or become suddenly
more distensibility appear to be at particularly high
risk of rupture. This observation can also be explained
in terms of the present data on PIINP.
An increasing level of PIIINP, indicating collagen
neosynthesis, was related to increasing Ep and P (re¬
duced distensibility). This new collagen is less dis¬
tensible than the elastin it is replacing. Previous
workers have suggested that high levels of PIIINP are
in fact associated with AAA expansion and rupture.9
While this appears to contradict our previous con¬
tention that AAA undergoing an increase in dis¬
tensibility are more likely to rupture, it is possible that
the strength of the new collagen may be compromised
in some of the subjects because of the higher rate of
turn-over.4 Satta et al.9 found that inAAA development,
PIIINP and diameter increased exponentially with time
and, in cases of rupture, rate of collagen turn-over
was significantly higher than in non-ruptures. In some
cases very high levels of collagen neosynthesis and
PIIINP release may, in fact, be associated with failure
of collagen maturation, depauperisation of fibres and
the laying down of collagen that is structurally weak.
Furthermore, those aneurysms which fail to lay down
collagen as they grow may be least able to withstand
the increased wall tension predicated by the law of
Laplace and thus show higher distensibility.
These findings are significant in that they show, for
the first time, that distensibility may be indicative of
the AAA wall matrix degeneration and regeneration
process. The importance of these findings is that dis¬
tensibility, which is easily measured non-invasively,
may provide a more detailed picture of the changing
AAA wall matrix than diameter alone. More spe¬
cifically, distensibilitymay indicate the terminal break¬
down of collagen which eventually leads to rupture
of the AAA wall. In conjunction with currently used
risk factors, namely diameter, expansion rate and
symptoms, this may allow surgeons to further specify
which AAA require immediate surgery and which can
safely expand or remain at a size previously thought
t=0.36
p<0.01
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dangerous, with little risk of rupture. It is quite pos¬
sible, however, that each AAA is unique and it is the
change in distensibility within each aneurysm that is
of greater significance than differences between a level
of "normal" distensibility and that of the aneurysm.
A large prospective observation study is ongoing,
investigating distensibility, diameter, expansion and
outcome. This study will provide much more detail
of the predictive value of distensibility in relation to
risk of rupture, need for operation and safe expansion
without rupture. In addition, a larger study in¬
vestigating changes in markers of elastolysis and colla-
genolysis in relation to the natural history of AAA
diameter and distensibility is required.
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Comparison of Brachial Artery Pressure and Derived Central Pressure in
the Measurement of Abdominal Aortic Aneurysm Distensibility
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University of Edinburgh, 2Clinical Pharmacology and Research Unit, University of Edinburgh,
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4Wolfson Unit for Prevention of Peripheral Vascular Disease, University of Edinburgh,
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Objective: AAA distensibility (Ep, ft) may predict growth and risk of rupture. However, distensibility measurements
based on brachial rather than central pressure may be inaccurate. Our aim was to compare AAA distensibility using
non-invasive brachial and derived central aortic pressure.
Design: brachial and central pressures were measured prospectively by automated sphygmomanometry (Omron) and
pulse wave analysis (SphygmoCor) respectively. AAA distensibility was calculated using brachial (Epb, ftb) and central
(Epc, pc) pressures by ultrasonic echo-tracking (Diamove). Twenty-eight patients (18 males) were selected on a first come
basis from a larger study ofAAA patients. There were no exclusion criteria, so 54% had cardiac dysfunction (MI, angina)
and 14% were hypertensive (BP>140/90 mmHg).
Results: median (IQR) age was 74 (70-77) years, median AAA (IQR) diameter was 44 (40-51) mm. Central and
brachial systolic pressures were significantly different, [140 (121-153) vs 144 (130-164) mmHg respectively, p <0.01].
Central and brachial diastolic pressures were not significantly different [76 (72-86) vs 76 (71-86) mmHg respectively,
p = 0.5]. Epc (3.0, [2.2-4.9]) and pc (22.2 [15.5-33.2]) ivere significantly lower than Epb (3.6, [2.4—5.1] 105Nm~2) and
Pb (24.7 [17.1-33.0] a.u., all p<0.001. Brachial and central derived distensibility remained significantly different after
adjusting for age and diameter (p<0.001).
Conclusion: the use of brachial pressure leads to a small, systematic overestimate of Ep (18%) and ft (11%) independent
of age and AAA diameter. This systematic error will not bias follow-up of changes in distensibility.
Key Words: Abdominal aortic aneurysm; Blood pressure; Distensibility.
Introduction
The decision to operate on a patient with an asympto¬
matic abdominal aortic aneurysm (AAA) involves
weighing the risks of rupture against those of operative
repair. Although cohort studies indicate that rupture
is related to maximum AAA diameter (Dmax), growth
rate and blood pressure (BP), none of these variables
reliably predict the behaviour of individual an¬
eurysms.1 As no AAA is entirely free from risk of
rupture, a variable that provides a more precise quan¬
tification of risk is required.
Previous work has suggested that, in addition to
maximal diameter, AAA wall distensibility, expressed
as pressure-strain elastic modulus (Ep) and stiffness
* Please address all correspondence to: A. W. Bradbury, Department
Vascular Surgery, BirminghamHeartlands Hospital Bordesley Green
East, Birmingham B9 5SS, U.K.
((3), measured by means of a commercially available
ultrasound echo-tracking system (Diamove), may be
related to future growth rate and risk of rupture.2 We2
have previously shown that when AAA diameter and
aortic stiffness increase concomitantly (decreasing dis¬
tensibility), aneurysm rupture is less likely than when
AAA diameter increases but stiffness decreases (in¬
creasing distensibility). We3 also reported that AAA
wall distensibility might indicate matrix degeneration
in terms of collagen and elastin integrity, since dis¬
tensibility decreases with elastin degeneration and
collagen deposition, but in the final stages of collagen
breakdown distensibility increases.3 These findings
suggest that serial simultaneous measurement of dia¬
meter and distensibility might provide a better under¬
standing of the degeneration occurring in the aortic
wall matrix than simply assessing diameter. They also
suggest that the absolute value of AAA distensibility
is less important than its change over time.
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Arterial wall compliance describes the change in
volume of a segment of artery, in relation to pulsatile
change in BP.4 However, measurement of change in
wall thickness in response to change in pressure and
vessel volume is necessary to calculate true vessel
compliance.4 At present, neither variable can be re¬
liably measured in the aorta in vivo. Arterial wall
distensibility, which describes the relationship be¬
tween relative diameter change and pressure, has been
used by a number of workers5"7 as a "surrogate"
measure of compliance.
Ep4 is a measure of the structural distensibility of
the artery, rather than a measure of the elasticity of
the arterial wall material,7 where:
Ep = K (P systolic —P diastolic)/
[(D systolic—D diastolic)/D diastolic]
and K = 133.3, P = pressure and D = aortic diameter.
Stiffness index (P)8 also describes the visco-elastic be¬
haviour of arteries within the physiological pressure
range, where:
p = ln(P systolic/P diastolic)/
](D systolic—D diastolic)/D diastolic]
P is less pressure dependent than Ep,8 both are
inversely related to distensibility and compliance.
These concepts are discussed more fully in two re¬
views.9,11' Both can be measured using ultrasonic echo-
tracking equipment described in the Methods section.
Poiseuille's law describes the flow of fluids and
shows that blood "flow is directly proportional to
the difference between inflow (aortic) and outflow
(peripheral) pressures".11 Further studies have shown
that systolic pressure increases along the arterial tree
from the aorta to the peripheral arteries by
10-35 mmHg12"14 due to differences in vessel stiffness
and wave reflections. In contrast diastolic pressure
and median arterial pressure (MAP) fall only slightly
- which provides the pressure gradient for forward
flow of blood along a pressure gradient.12"14 The net
result is an increase in pulse pressure peripherally.12"14
The aim of this study, therefore, was to compare
AAA distensibility (Ep and P) calculated using brachial
BP with that calculated from derived central BP (es¬
timated by pulse wave analysis) using two non-in¬
vasive methods of BP measurement, as would be the
case in a clinical setting. Thus any possible un¬
derestimation of BP due to sphygmomanometry tech¬
nique would be constant between the techniques.
Methods
Central blood pressure can now be assessed non-
invasively using pulse wave analysis (PWA). PWA
allows accurate recording of peripheral arterial pres¬
sure waveforms, and construction of the cor¬
responding central pressure waveform and
augmentation index. The technique uses applanation
tonometry, which is based on the principle that when
opposing curved surfaces of a vessel are flattened until
parallel with each other, circumferential pressures are
equalised. In other words, when an arterial wall is
flattened (applanated) by the tip of the tonometer, the
contact pressure between the transducer and the wall
equals the intra-arterial pressure. This technique can
be accurately applied to peripheral arteries such as
the radial or the carotid, and can also be used on the
femoral artery to derive aortic pulse wave velocity.
The peripheral waveform is recorded and transformed
into the corresponding central waveform using an
integral transfer function, which has previously been
validated using invasive recordings.15"1' Both wave¬
forms can then be analysed and a number of variables
measured including central systolic, diastolic, mean
arterial and pulse pressures.
Twenty-eight subjects (18 male) were studied. These
subjects had known AAA and were recruited on a
"first-come" basis from a larger prospective study
investigating AAA distensibility and rupture. In order
to truly replicate the normal clinical setting there were
no exclusion criteria and, as a result, 54% of these
patients had some cardiac dysfunction (angina or MI).
Only 14% had hypertension according to the British
Hypertension Society guidelines (pressure >140/
90 mmHg).18
PWA was used to determine central pressure non-
invasively (Sphygmocor, SCOR; PWV Medical, Syd¬
ney, Australia).19 Pressure waveforms were recorded
from the radial artery using a high fidelity micro-
manometer (SPC-301, Millar Instruments, Texas,
U.S.A.) and fed directly into a portable micro¬
computer.20 The integral system software allowed on¬
line recording of the radial waveform and, after 20
sequential waveforms were collected, an averaged
peripheral and corresponding central waveform was
generated. Central aortic pressure was then calculated
from the waveform21 using a validated transfer func¬
tion.15"17,20 To evaluate the quality of the recorded wave,
the software calculates two parameters of the wave
variability allowing the observer to accept the wave¬
form according to pre-stated levels of acceptable vari¬
ability; namely wave amplitude >100 mV, standard
deviation of systolic and diastolic peak <5%. The val¬
idation and reproducibility of the SphygmoCor tech-
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nique in pulse wave analysis and the measurement of
central pressure has been discussed previously and
found to be acceptable.20,22 There was a short time
delay between tonometric and brachial pressure meas¬
urements; however, both were carried out alternately
first or second to avoid a time-dependent bias.
BP was measured from the brachial artery in the
right arm using an oscillometric sphygmomanometer
(model 711, Omron, Japan); and phase locked loop
echo-tracking (Diamove, Teltec, Sweden) was used to
measure aortic Ep and (3. The echo-tracking ultrasound
system has been described in detail previously.9,10
Briefly, a 3.5 MHz linear array transducer was used to
provide a standard real time longitudinal B-scan image
of the AAA at the point of maximal antero-posterior
(AP) diameter. The vessel walls were tracked after
initial placement of a cursorwithin the vessel. A phase-
locked loop restored the position of an electronic gate
relative to the moving echo while the compensatory
movement of the gate yielded the movement of the
echo.
Data acquisition and analysis were carried out on a
Pentium computer (DCS, Edinburgh). The pressure-
diameter curve was registered on the computer in
real time and at least three consecutive waves were
analysed. The Diamove software automatically iden¬
tified the start and end of each cardiac cycle. The
operator manually selected the waveforms of interest
and an average wave was produced. Brachial artery
pressures were entered and the calculated variables,
including Ep and p, were then displayed on the screen.
Distensibility calculated using derived central pressure
is referred to as Epc and pc, whereas distensibility
calculated using brachial pressure is referred to as Epb
and pb.
Statistical analysis was carried out using SPSS Base
8.0.23 The data were skewed so median and in¬
terquartile ranges (IQR) were calculated. Spearman's
rank correlation was used to examine the correlation
between brachial and central variables, Wilcoxon
signed rank test was used to evaluate the differences
between central and peripheral derived variables. In
order to examine whether age and diameter con¬
founded the observed relationships, the data were
first logarithmically transformed to normality. Linear
regression was then used to calculate predicted (log)
distensibility adjusted for the effect of age and dia¬
meter.
Results
The mean (range) age of the subjects was 74 (63-84)
years and the median (interquartile range (IQR)] AP
diameter was 44 (40-51) mm. The median (IQR) bra¬
chial pressures were systolic 144 (130-164) mmHg,
diastolic 76 (71-86) mmHg, and the median (IQR)
central pressures were systolic 140 (121-153) mmHg,
diastolic 76 (72-86) mmHg. The amplification ratio
(peripheral PPxentral PP) was 1.1.
There was a significant positive correlation between
the central and brachial pressures (Table 1). Derived
central systolic pressure, pulse pressure and MAP
were significantly higher than the brachial equivalents
(Table 1). There were no differences with regard to
diastolic pressure (p = 0.5).
There was a significant correlation between Epc and
brachial Epb (r = 0.90, p< 0.001) (Fig. 1) and between
Pc and pb (r = 0.90, p< 0.001) (Fig. 2). However, the
Wilcoxon signed rank test showed that median Ep
and P were significantly higher (p<0.01) when using
brachial pressure rather than central pressure: [Epb 3.6
(2.4-5.1) vs Epc 3.0 (2.2-4.9) 105Nm"2, p<0.001]; [pb
24.7 (17.1-33.0) vs pc 22.2 (15.5-33.2) a.u, p<0.01].
In order to examine whether the difference in dis¬
tensibility derived from central and brachial pressures
were confounded by age or AAA diameter, predicted
log values for central and brachial-derived dis¬
tensibility adjusted for age and diameter were cal¬
culated and compared. The differences between
distensibility calculated using brachial and derived
central pressures remained significant (both p< 0.001).
Median (IQR) Epb predicted from brachial pressure
was 1.22 (1.08-1.45) 105Nm~2, and Epc predicted from
central pressure was 1.11 (0.94-1.35) 105Nm~2. Sim¬
ilarly, pb predicted from brachial pressure was 3.18
(3.05-3.37), and pc predicted from central pressure was
3.07 (2.94-3.32).
Discussion
This study compares, for the first time, the use of non¬
invasive brachial artery pressure and derived central
aortic pressure in the measurement of AAA dis¬
tensibility.
Previous work using invasive intra-aortic pressure
measurement and non-invasive assessment of aortic
distensibility (ultrasonic echo-tracking) suggested that
using peripheral blood pressure to calculate dis¬
tensibility underestimates Ep and P by 25-30%.24,25
However, in one of these studies24 systolic pressure
was the same or lower in the brachial artery than in
the aorta, diastolic pressure higher in the brachial
artery, and consequently pulse pressure was lower in
the brachial artery. In the second study,2' systolic and
diastolic pressures were higher in the brachial artery
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Table 1. Wilcoxon signed rank test comparing brachial and central pressures and pressure-strain elastic modulus (Ep) and stiffness
(|i) derived from brachial and central pressures.
Brachial Central % Differences Significance
Median (IQR) Median (1QR) (Two tailed)
Systolic (mmHg) 144 (130-164) 140 (121-153) + 3 0.001
Diastolic (mmHg) 76 (71-86) 76 (72-85) 0 0.5
Pulse pressure (mmHg) 65 (50-79) 60 (44-75) + 8 0.001
Mean arterial pressure 100 (89-110) 99 (89—106) + 1 0.003
(mmHg)
Ep (105Nm-2) 3.6 (2.4-5.1) 3.0 (2.2-4.9) +18 0.001







Fig. 1. Scatter plot of correlation between Ep calculated using






Fig. 2. Scatter plot of Spearman's rank correlation between p cal¬
culated using brachial and central aortic pressures.
than in the aorta, and pulse pressure was lower in the
brachial artery. Not only are these findings difficult to
explain physiologically, but they are also in contrast
to the majority of other data.11"14 The most likely ex¬
planation may be that because the authors compared
invasive aortic pressure measurement with sphyg-
momanometrically determined brachial artery pres¬
sure, the error was dependant on the method of
measurement rather than the site of measurement.
Indeed, the inaccuracy of sphygmomanometric blood
pressure measurements has been previously re¬
ported.26
As the pressure wave travels through the arterial
tree from the large, elastic arteries to the smaller,
muscular vessels, the speed and amplitude of the wave
increase because of decreasing vessel compliance. The
pressure contour also becomes distorted along the
arterial tree: the systolic portion becomes narrowed
and elevated; the incisura is damped and eventually
disappears: a hump appears in its place in the diastolic
portion. This damping of the high frequency com¬
ponents of the pressure wave is attributed to the
viscoelastic properties of the arterial wall. Reflection,
vascular tapering and transmission velocity enhance
the peaking of the pressure wave. The result is that
in the young there is a pronounced difference in central
and peripheral pressures, systolic pressure increasing
distally whilst diastolic pressure remains essentially
unchanged,27 i.e. there is amplification of the waveform
(Fig. 3).
Ageing of the arterial tree reduces vessel dis-
tensibility (increases stiffness) and markedly reduces
the difference between central and peripheral systolic
pressure while increasing pulse pressure, especially in
the aorta. This is because stiffer arteries transmit the
pressure wave at a higher velocity, i.e. pulse wave
velocity is increased. The result is that a larger than
normal reflected pressure wave returns to the heart
earlier, augmenting late systolic peak pressure.12 Thus,
whilst age increases aortic systolic pressure, peripheral
systolic pressure is much less affected, so the gradient
between central and peripheral systolic pressure is
reduced.14 Pauca et al.u examined a group of subjects
aged 48-77 (median 61) years and found the ascending
aortic systolic pressure to be 12mmHg lower than
Eur ] Vase Endovasc Surg Vol 22, October 2001







Fig. 3. Central arterial waveform (lower panel) and peripheral
waveform (upper panel) in a young (right) and an elderly (left)
subject. Reproduced from Wilkinson et al. 1998.17
radial systolic pressure and ascending aortic diastolic
pressure to be 1 mmHg higher than radial pressure. In
the present study, the median central-brachial pressure
difference was 6mmHg for systolic pressure but there
was no difference in diastolic pressure. The am¬
plification ratio (peripheral pulse pressure:central
pulse pressure) of 1.1 reflects the older age of our
study population (68-84, median 74 years).
Aortic pressure was that in the aortic arch and not
at the site of the AAA. Abdominal aortic pressure
remains extremely difficult to measure non-invasively
at present. However, the PWA-derived ascending aor¬
tic pressure is the closest approximation available and
is considerably closer than the brachial artery. Previous
work has suggested that in evaluating ascending aortic
dilation and distensibility in Marfan's syndrome, the
pulse pressure in the carotid arterymay be more useful
than that from the brachial artery.28 It may also be the
case that aortic arch pressure is more representative
of pressure at the site of the AAA than that at the
brachial artery. However, this requires further study
and a comparison of distensibility calculated using
invasive aortic pressure at the site of the AAA with
that using derived central pressures.
The principle finding of the study was that use of
brachial pressure as opposed to central aortic pressure
significantly increased Ep by 18% and (3 by 11%. This
is of a similar magnitude to that of the previous
authors.10,15 The error was a systematic overestimate
of Ep and (3; however, the margin of error in calculation
of P was relatively smaller because it is less pressure
dependent than Ep. The importance of these findings
is that this non-invasive method of aortic wall dis¬
tensibility measurement can be used successfully in
the clinical setting. Use of non-invasive, derived aortic
pressure would enhance the accuracy of distensibility
measurement; however, the error caused by using
non-invasive brachial pressure is deemed small and
systematic. Previous findings of this group2,3 suggest
that routine follow-up of distensibility and diameter
could provide a greater understanding of AAA wall
degeneration than diameter alone. If this is the case
then the systematic nature of the error should not bias
the measurements because it is the change in the
measurements over time that provides the important
information and not the absolute values.
In conclusion, we view the overestimate of Ep and
P (by 18% and 11% respectively) to be small and,
therefore, acceptable clinically. The linearity of the
relationship between central and peripherally derived
distensibility shows that the error is a small and sys¬
tematic overestimate and would not bias follow-up
comparison of changes in distensibility within each
patient. However, since the discrepancy between cent¬
ral and peripheral systolic pressure (i.e. pressure am¬
plification) is age-dependent, greater differences
between Epb/pb and Epc/Pc rnay occur in younger
individuals, and care must be exercised when com¬
paring measures of distensibility based on peripheral
blood pressure measurements between age groups.
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